Mycobacterial Acyl-CoA Corboxylases. by Miranda, Anabela Medo.
MYCOBACTERIAL ACYL-CoA CARBOXYLASES
ANABELA MEDO MIRANDA
MOLECULAR MICROBIOLOGY GROUP 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF SURREY 
UK
THIS THESIS IS SUBMITTED IN FULFILMENT OF THE DEGREE OF
DOCTOR OF PHILOSOPHY
1999
ProQuest Number: 27693967
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27693967
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
NO MATTER. TRY AGAIN. 
FAIL AGAIN. FAIL BETTER.
Samuel Beckett, 1906-1989
TUDOVALEAPENA
QUANDO A ALMA NAO É PEQUENA.
Fernando Pessoa, 1888-1935
Acknowledgements
I am most grateful to the Institute Nacional de Saude and Fundaçâo para a Ciência e 
Tecnologia in Portugal, who sponsored my studies at Surrey University as well as to 
the Wellcome Trust for further support of this project.
I would like to thank my supervisor. Professor Jeremy Dale, for his help and 
direction throughout my PhD studies, and for all the interesting and challenging 
scientific debates that made me realise how much it takes to become a good 
scientist. I will ever be indebted to Sue Wall for having taught me most of what I 
know about practical molecular biology, for all the support I received in the past 
years and for caring during the difficult times. At last, but not least, I would like to 
thank Grainne Sheridan for her great help and encouragement especially at the 
writing up stage of my PhD, which made the whole process more bearable.
I also have to thank all my colleges, past and present, in the Microbial Genetics 
Laboratory (MGL), for all the good moments inside and outside the laboratory 
which kept me sane. I am grateful, in particular, to Norazmi Mod. Nor and Mansour 
Al-Zarouni for creating the friendly and cosy environment of the “upstairs” MGL 
where I have always enjoyed working.
Thank you to the many people in the School of Biological Sciences who have 
always been helpful, especially in the virology laboratory, stores and washing up 
room.
My thanks also go to the many friends both Portuguese and non-Portuguese 
speaking I made during my stay in this country, that broadened my view of other 
cultures and places. Finally, thank you to my family and my friends Isabel, 
Francisco and Teresa for letting me know, at all times, that I am not alone.
Table o f Contents 
Abstract i
Chapter 1 : General Introduction
1.1. Tuberculosis 1
1.1.1. The Origin and Spread of Tuberculosis 1
1.1.2. Global Burden of Tuberculosis 3
1.1.3. The Biology of the Genus Mycobacterium 4
1.2. The Mycobacterial Envelope 7
1.2.1. Envelope Components 7
The plasma membrane 9
The Cell Wall 9
The capsule 13
1.2.2. Ultrastructure and Physical Organisation of the Envelope 14
1.3. Lipid Synthesis in Mycobacteria 18
1.4. Acyl-Co A Carboxylases 25
1.4.1. Mechanism of Action of Biotin Enzymes 25
1.4.2. Biotinylation of Protein Domains 26
1.4.3. Structure of Biotin Enzymes 30
1.4.4. Mycobacterial Acyl-CoA Carboxylases 31
1.4.5. Regulation of Acyl-CoA Carboxylases 34
1.5. This Thesis 37 
Chapter 2i Materials and Methods
2.1. Materials 39
2.2. Bacterial Strains Used 41
2.3. Recipes and Protocols 41
2.3.1. Culture media 41
2.3.2. General buffers and stock solutions 42
2.3.3. Polymerase Chain Reaction 43
2.3.4. Synthesis of oligonucleotide primers, primer deprotection and precipitation 43
2.3.5. Small scale preparation of plasmid DNA 44
2.3.6. Phenol/Chloroform extraction of DNA 44
2.3.7. DNA precipitation 45
2.3.8. Quantitation of nucleic acids in aqueous solution 45
2.3.9. Agarose gel electrophoresis 45
2.3.10. DNA extraction from gels and purification of DNA from solution 46
2.3.11. Restriction endonuclease digestion of DNA 46
2.3.12. Dephosphorylation of DNA 47
2.3.13. Ligation of DNA fragments 47
2.3.14. Transformation of E. coli DH5a 47
Preparation ofE. coli DHScc competent cells 47
2.3.15. Transformation of E. coli JMl 10 47
Preparation ofE. coli JMl 10 competent cells 48
2.3.16. Transformation of mycobacteria 48
Preparation of mycobacterial competent cells 48
2.3.17. Chromosomal DNA extraction from mycobacteria 49
2.3.18. Southern blotting 49
Gel electrophoresis and Southern transfer 49
Prehybridisation and hybridisation 50
Chemiluminescent detection 51
2.3.19. Digoxygenin labelling of DNA 51
2.3.20. SDS-PAGE and Western blotting 52
Sample preparation 52
Denaturing (SDS) discontinuous polyacrylamide gel electrophoresis:
Laemmli gel method 52
Transfer of proteins onto nitrocellulose membranes filters 53
Immunoblotting 53
2.3.21. Surface Enhanced Laser Desorption Ionization - SELDI 54
2.3.22. Acetyl-CoA carboxylase assay 54
2.3.23. Determination of protein concentration 55
2.3.24. Microbial Adhesion to Hydrocarbon (MATH) 55
2.3.25. Sensitivity tests to tetracycline and minocycline 56
2.3.26. Automated DNA sequencing 56
2.3.27. Sequence analysis 56
2.3.28. Statistical analysis 56
Chapters: Strategies for Biotin Depletion and Their Impact on the Activity 
of M. smegmatis Acyl-CoA Carboxylase
3.1. Introduction 57
3.2. Experimental Strategy for the Intracellular Depletion of Biotin 58
3.3. Effect of Biotin Depleting Conditions on the Growth of M. smegmatis 60
3.4. Assessment of Cell-Surface Characteristics 64
3.4.1. Susceptibilities to tetracyclines of varying hydrophobicities 64
3.4.2. Hydrophobicity measurements 6 6
3.5. Acyl-CoA Carboxylase Activity 68
Optimising conditions for enzyme extraction 6 8
Measurement of acyl-CoA carboxylase activity under biotin depleting conditions 11
3.6. Discussion 73
Chapter 4: Mutagenesis Affecting the Carboxyl Terminus of the AccAl 
Subunit of M. tuberculosis Acyl-CoA Carboxylase
4.1. Introduction 78
4.2. Construction of the Expression Systems for the AccAl suhunit of M. tuberculosis 
Acyl-CoA Carboxylase 81
Construction of pUS 1705 81
Mutagenesis of the AccAl subunit of M. tuberculosis acyl-CoA carboxylase 82
Construction of pUS 1703 and pUS 1704 84
Construction of pUS 1706 and pUS 1707 84
Construction of mycobacterial transformants 87
4.3. Assessment of the Activity of Acyl-CoA Carboxylase 87
Measurement of Growth of M. bovis BCG 87
Optimising Conditions for Enzyme Extraction 94
Acetyl-CoA Carboxylase Activity 98
4.4. Discussion 99
Chapter 5: Inhibition of Expression of the AccAl Subunit of Mycobacterial 
Acyl-CoA Carboxylase by a Complementary RNA Transcript
5.1. Introduction 102
5.2. Design and Construction of Antisense Expression Vectors 103
Construction o f pUS1708 andpUS1709 104
Construction ofpUSUlO andpUS1711 106
Construction of mycobacterial isogenic strains 106
5.3. Assessment of Acyl-CoA Carboxylase Activity 111
5.4. Proteomic Analysis of Mycobacterial Biotinylated Proteins 111
5.5. Discussion 115
Chapter 6: General Discussion 121
Reference List 129
Table o f Figures
Figure 1.1. Appearance of mycobacterial envelope in thin sections 8
Figure 1.2. Chemical structure of the mycolyl-AG peptidoglycan complex in
mycobacteria 1 2
Figure 1.3. Modified Minnikin model of the mycobacterial cell wall 16
Figure 1.4. The “ping-pong” kinetic mechanism of translocation of the carboxylated
biotinyl prosthetic group 27
Figure 3.1. Diagrams of pUS627 and pUS629 59
Figure 3.2. Growth curves of M. smegmatis mc^l55 in Sautons supplemented with
0.5 pg/ml of biotin and in Sautons containing 0.9 and 1.8 U/ml of avidin 61
Figure 3.3. Growth curves of M. smegmatis mc^l55, ms627 and ms629 in Sautons, 
in Sautons supplemented with 0.5 pg/ml of biotin and in Sautons containing 
0.9 and 1.8 U/ml of avidin 63
Figure 3.4. Adherence to n-hexadecane of M. smegmatis mc^l55, ms627 and ms629 67
Figure 3.5. Evaluation of the sonication protocols for the preparation of mycobacterial 
cell-free extracts 70
Figure 4.1. Sequence requirements for biotinylation of the 1.3 S subunit of
P. shermanii upon expression in E. coli 78
Figure 4.2. Biotinylation of the AccAl subunit mutant of M. tuberculosis 79
Figure 4.3. Construction of pUS 1940 and pUS 1705 83
Figure 4.4. Construction of pUS 1703 and pUS 1704 85
Figure 4.5. Plasmid map of pUS1703 and pUS1704; Chromatographs of the 5’
and 3’ end region of accAl gene; Restriction analysis of pUS1703 and pUS1704 8 6
Figure 4.6. Construction of pUS 1706 and pUS 1707 8 8
Figure 4.7. Plasmid map of pUS1706 and pUS1707; Chromatographs of the 5’
and 3’ end region of accAX gene; Restriction analysis of pUS1706 and pUS1707 89
Figure 4.8. Southern blot analysis of total DNA samples from M. smegmatis mc^l55 
and M. bovis BCG recombinant strains bearing the plasmids pUS1703 and 
pUS1704 90
Figure 4.9. Southern blot analysis of total DNA samples from M. smegmatis mc^l55
and M. bovis BCG recombinant strains bearing the plasmids pUS1706 and 
pUS1707 91
Figure 4.10. Growth curves of M. bovis BCG in simple Sautons and in Middlebrook
7H9 supplemented with GADC 93
Figure 4.11. Protein content and acetyl-CoA carboxylase activity of M. bovis BCG
extracts prepared by disruption of cells using the Ribolyser. 95
Figure 5.1. Integrated diagram of all plasmids referred in this chapter 105
Figure 5.2. Plasmid map of pUS1708 and pUS1709; Restriction analysis of both
plasmids. 107
Figure 5.3. Plasmid map of pUS1710 and pUS1711; Restriction analysis of both
plasmids 108
Figure 5.4. Southern blot analysis of total DNA samples from M. smegmatis mc^l55 
and M. bovis BCG recombinant strains bearing the plasmids pUS1708 and 
pUS1709 109
Figure 5.5. Southern blot analysis of total DNA samples from M. smegmatis mc^l55 
and M. bovis BCG recombinant strains bearing the plasmids pUS1710 and 
pUS1711 110
Figure 5.6. Profiles of biotinylated proteins present in M, bovis BCG and
M. smegmatis extracts 114
Figure 5.7. Profiles of biotinylated proteins present in M. bovis BCG and
M. smegmatis extracts 116
Figure 5.8. CLUSTAL W alignments of the first 243 bp of M. tuberculosis H37Rv
accAl, accPCl and accPCh genes. 120
Table o f Tables
Table 1.1. Nomenclature of mycobacterial acyl-CoA carboxylases 35
Table 3.1. Susceptibility of M. smegmatis mc^l55, ms627 and ms629 to
tetracyclines as a function of hydrophobocity 65
Table 3.2. Acetyl-CoA carboxylase activity of M. smegmatis mc^l55, ms627 and
ms629 grown in absence and presence of avidin 72
Table 3.3. Acetyl-CoA carboxylase activity of the former extracts treated with
0.25 ng/ml of biotin before the enzyme assay 72
Table 3.4. Acetyl-CoA carboxylase activity of M. smegmatis mc^l55 grown in the 
presence of avidin and treated with 0.5 |lg/ml biotin at three different stages 
of the experiment 74
Table 4.1. Plasmids used 81
Table 4.2. Specific activity of acyl-CoA carboxylase of M. smegmatis mc^l55
transformants grown under different conditions 97
Table 4.3. Specific activity of acyl-CoA carboxylase of M. smegmatis mc^l55
transformants at three different growth stages 97
Table 4.4. Specific activity of acyl-CoA carboxylase of M. hovis BCG Pasteur
transformants grown under different conditions 98
Table 4.5. Specific activity of acyl-Co A carboxylase of M. bovis BCG Pasteur
transformants at three different growth stages 98
Table 5.1. Plasmids used 104
Table 5.2. Specific activity of acetyl-CoA carboxylase of M. smegmatis mc^l55
transformants at three different growth stages 1 1 2
Table 5.3. Specific activity of acetyl-CoA carboxylase of M. bovis BCG Pasteur
transformants at three different growth stages 1 1 2
ABSTRACT
Mycobacterium tuberculosis, the etiological agent of tuberculosis, is surrounded by a 
complex envelope of unusually low permeability which contributes to antibiotic resistance 
and evasion of the host defence mechanisms. A distinguishing feature of mycobacteria is 
their high content of lipids, many of which are unique to this genus.
Acyl-CoA carboxylases catalyse the first committed step of lipid synthesis. Mycobacterial 
acyl-CoA carboxylases consist of two subunits, only one of which is biotinylated. The gene 
for the biotin containing subunit AccAl from M. tuberculosis has been isolated and 
sequenced at the University of Surrey.
To define the physiological role of mycobacterial acyl-Co A carboxylases, a combination of 
molecular biology approaches was used to cause a reduction in the activity of the enzyme. 
The following strategies were adopted:
i) Inhibition of acyl-CoA carboxylase by depletion of biotin both extracellularly and 
intracellularly. Extracellular depletion of biotin was achieved by adding avidin to the 
culture medium used to grow the mycobacterial strains. Intracellular depletion of biotin was 
attempted through the expression by a plasmid of an additional biotinylated protein, 
enzymatically inactive to capture most of the biotin present in the cell.
ii) Reduction of acyl-CoA carboxylase activity by producing an inactive hybrid 
enzyme containing a non-functional AccAl subunit. A mutation affecting biotinylation was 
introduced by site directed mutagenesis at the 3’ end of the accAl gene from M. 
tuberculosis. The mutated gene was expressed by a plasmid and controlled by the use of 
promoters of different strength.
iii) Diminution of the production of acyl-CoA carboxylase through interference with 
the expression of the biotinylated subunit of the enzyme by an antisense approach. A 
fragment of the 5’ end of the accAl gene containing the Shine-Dalgamo sequence and the 
translational start site was cloned in an opposite direction with respect to the promoter. The 
amount of anti-sense mRNA produced was controlled by the use of promoters of different 
strength.
A reduction in the activity of mycobacterial acyl-CoA carboxylase would be expected to 
impair lipid synthesis, and ultimately cause a decrease in the amount of lipids that constitute 
the cell wall. The lack of such effects may be ascribed to the presence of multiple acyl-Co A 
carboxylases, detected by the genome sequencing but not apparent at the time this work was 
performed.
An understanding of the biochemistry and molecular genetics of the cell wall lipids would 
provide a rational basis for seeking drugs targeted at the production of such specific 
compounds. Moreover, the mycobacterial cell wall is also important in pathology and 
further knowledge of the complex nature of its biosynthesis would enable to identify critical 
genes whose inactivation could lead to attenuation.
A
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CHAPTER 1
GENERAL INTRODUCTION
Chapter 1
1.1. TYiberculosis
At the turn of the twentieth century, tuberculosis, an old disease thought to have 
been brought close to extinction in the developed countries some 15 years ago, is 
reemerging. In 1993, the World Health Organisation (WHO) declared tuberculosis a 
global public health emergency, the first disease so far to warrant that designation.
1.1.1. The Origin and Spread of Tuberculosis
The tubercle bacillus, Mycobacterium tuberculosis, was discovered by Robert Koch 
in 1882 although, as Sir William Osier (1892) wrote, “the student who dates his 
knowledge of tuberculosis from Koch may have a very correct but a very 
incomplete appreciation of the subject”. The family Mycobacteriaceae antedates 
evolution of animal life and includes a number of saprophytic soil bacteria that play 
a vital role in decomposing dead vegetable matter (Haas and Haas, 1995). However, 
as early genera of the animal kingdom developed, mycobacteria capable of 
parasiting animals were produced by chance mutations. Eventually, Mycobacterium  
bovis, a mutant that could parasitise a wide variety of warm-blooded animals, 
evolved (Steele and Ranney, 1958). Mankind’s earliest experience with M. bovis 
probably was quite sporadic and caused by eating raw or inadequately cooked game. 
The disease must have remained endemic for many centuries, causing an occasional 
case of tuberculous spondylitis, evidence of which has been found in ancient Egypt 
(Zimmeman, 1977) and the high Andes Mountains of Peru (Salo, 1994). However, 
about 8,000 to 10,000 years ago, in Europe, the combination of two factors created 
the opportunity for the development of a human pathogen. Humans had begun to 
domesticate animals and started to include meat and dairy products in their diets 
(Clark, 1962) and children, with a random mutation that enabled them to metabolise 
lactose, were better nourished than their lactose-intolerant counterparts thus having 
a better chance of surviving and reproducing (Simoons, 1978). Although it has been 
speculated that drinking milk increased the frequency of childhood infection with 
milk-borne M. bovis, the resulting infection was often a self-limited enlargement 
and draining of the cervical lymph nodes (called scrofula), which only occasionally 
spread to other organs and could be fatal (Stead, 1997). The final stage from M. 
bovis to M. tuberculosis probably occurred when humans had to share their homes
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with cattle during the cold European winters for heat conservation, as well as 
security. This might have created the conditions for the development of a mutant, 
more pathogenic for humans. Like M. bovis, M. tuberculosis can not survive in the 
environment and is dependent upon transmission from host to host (Stead, 1997). 
M. tuberculosis had finally found its niche in humans and must have persisted as an 
endemic sporadic disease in Europe for many centuries until the conditions for the 
epidemic spread were in place.
The tuberculosis epidemic in Europe developed in a population in which both 
bovine and human tuberculosis had been endemic for centuries (Stead and Bates, 
1995). In very susceptible individuals, the disease killed the host before it could 
spread (Templeton et a l ,  1995). However, individuals favoured with greater 
resistance, gradually began to survive the primary infection and often developed 
chronic pulmonary tuberculosis, becoming a source of contamination of the 
population (Stead, 1997). During the Industrial Revolution in the eighteenth 
century, crowded cities and widespread poverty in Europe set off the epidemic 
(Bates and Stead, 1993). In that period, tuberculosis was called the “Great White 
Plague”. The particular combinations of factors that characterised this epidemic had 
never previously come together anywhere in the world.
Geographic separation or political boundaries isolated other populations from M. 
tuberculosis for centuries (Bates and Stead, 1993). For this reason, there is not one 
worldwide epidemic of tuberculosis but many separate epidemics as M. tuberculosis 
spread at different times into various populations. As Europeans colonised other 
geographic areas over the next two centuries, individuals with chronic pulmonary 
tuberculosis carried the infection to seaports around the world. Tuberculosis reached 
the coastal people of Africa and New Guinea early in the nineteenth century, 
although, only penetrated to the interior of Africa in about 1910 (Brown et a l ,  
1981). Tuberculosis among the Native Americans was not a major cause of death 
until the 1880s when they were settled on reservations (Ferguson, 1955). 
Tuberculosis was still unknown in the highlands of New Guinea as late as 1951 
(Brown e ta l ,  1981), and 1971 in high Amazon (Black, 1975).
The validity of this scenario for the evolution of M. tuberculosis is confirmed by 
modem studies in bacillary genetics. The M. tuberculosis complex comprising M. 
tuberculosis, M. bovis, Mycobacterium africanum and Mycobacterium microti lacks
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interstrain genetic diversity, and nucleotide changes are very rare (Musser, 1995). 
Sequence analysis of two megabases of 26 structural genes or loci in strains 
recovered globally revealed that the level of silent nucleotide variation in M. 
tuberculosis complex members is restricted and lower than observed in other 
pathogenic bacteria (Sreevatsan et a l,  1997). The lack of allelic variation in 
structural genes indicates that M. tuberculosis is evolutionarily young and has 
recently spread globally (Sreevatsan e ta l ,  1997). Species diversity is largely caused 
by two main processes. First, rapidly evolving insertion sequences, which means 
that mobile element movement is a fundamental process generating genomic 
variation (Bifani, 1996) in this pathogen. Second, genomic changes arising from 
drug selection increased through antibiotic use (Sreevatsan et al ,  1997).
Using the tool of comparative genomics, new deletions and insertions between M. 
tuberculosis and M. bovis BCG were identified, providing important information on 
both genome dymamics and differentiation in the M. tuberculosis complex (Gordon 
et a l ,  1999). These authors challenged the current hypothesis that M. tuberculosis is 
derived from M. bovis BCG. Instead, it was proposed that both species are derived 
from a common progenitor and that genetic differences reflect the adaptation of the 
bacilli to their particular niche.
1.1.2. Global Burden of Tuberculosis
One of the most frequent statements about tuberculosis is that the disease is 
emerging, reemerging, recalcitrant, resistant to treatment in many global areas and 
responsible for more human deaths than any other single infectious agent (Bnarson 
and Murray, 1996). According to the WHO there has been no significant decrease in 
the world-wide tuberculosis mortality since Koch’s time more than a century ago, 
and that both sanatoria and chemotherapy, which reduced tuberculosis in the more 
developed countries, had no profound effect on the global problem (Anon, 1996; 
Bloom and Murray, 1992).
Epidemiologists have estimated that, based on tuberculin skin test reactivity, about 
one-third of the world’s population, i.e. about 1.7 billion people, are infected with 
M. tuberculosis (Enarson and Murray, 1996). Furthermore, each year, 8-10 million 
new cases of tuberculosis occur, i.e. an estimated 90 million cases over this decade, 
and almost 3 million people die from tuberculosis per year, about 30 million over
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the decade (Enarson and Murray, 1996). According to WHO, 450,000 deaths per 
year due to tuberculosis in developing countries occur in children under 15 years of 
age, and the disease mostly affects younger, more productive adults (Anon, 1996). 
Tuberculosis is responsible for more human deaths than any other pathogen, i.e. 
26% of all preventable deaths, 7% of all deaths (Enarson and Murray, 1996).
Effective chemotherapy for tuberculosis first became available in the late 1940s. 
Although antitubercular agents have been made rapidly available in the 
industrialised world, accessibility to treatment remains inadequate in developing 
countries, limited by the cost of drugs and lack of the necessary public health 
infrastructure. In addition, failure to comply with the requisite six-month intensive 
course of treatment contributes for relapses and development of M. tuberculosis 
strains that are resistant to drugs currently used. The emergence of drug-resistant 
forms is today one of the most serious aspects of tuberculosis (Dooley et a l ,  1992; 
Bloom and Murray, 1992).
Another severe problem is the association of tuberculosis with the Human 
Immunodeficiency Virus (HIV) which is having a profound impact on the spread of 
the disease in both industrialised and developing countries (Ellner et a l, 1993). HIV 
seropositive individuals have increased susceptibility to tuberculosis. HIV infection 
is the greatest known risk factor for progression from latent to active tuberculosis 
due to depletion of the cellular immune response required to suppress the activation 
of dormant tubercle bacillus (Narain, 1992). This has already resulted in a 
considerable increase of tuberculosis cases specially in the African continent 
(Murray et a l,  1990).
1.1.3. The Biology of the Genus Mycobacterium
The genus Mycobacterium (literally fungus rodlet) was first introduced by Lehmann 
and Neumann (1896) to accommodate the causal agents of leprosy and tuberculosis. 
Although this genus includes two greatly feared human pathogens, the remaining 
species consist essentially of microorganisms that live harmlessly in the 
environment. The usual habitats of the great majority of the cultivable mycobacteria 
are water and watery environments (Collins et a l,  1984) as well as mud and soil, 
especially when enriched with organic matter such as compost or animal faeces. 
Some of these environmental mycobacteria are, however, able to cause disease in
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animals and humans, especially in immunosuppressed individuals (Kirschner et a l, 
1992). Again, it has been the HIV pandemic that has focused interest and attention 
on these opportunistic pathogens.
With the exception of M. leprae, which has still to be cultured in vitro, 
mycobacteria can be assigned to two groups primarily on the basis of growth rates 
(Goodfellow and Wayne, 1982). The so-called rapid growers include species which, 
under optimal nutrient and temperature regimes, produce visible colonies on solid 
media within seven days, whereas their slow growing counterparts require more 
than a week to form such colonies under comparable conditions. The tubercle bacilli 
are best recovered from clinical specimens on rich media but once isolated, M. 
tuberculosis is capable of adapting to growth on minimal media and, as with most 
species of mycobacteria, has simple nutritional requirements. From the genome 
sequence, it is clear that M. tuberculosis has the potential to synthesise all the 
essential amino acids, vitamins and enzyme co-factors (Cole et a l, 1998). The 
tubercle bacilli can also metabolise a variety of lipids, carbohydrates, hydrocarbons, 
alcohols, ketones, and carboxylic acids (Wheeler and Ratledge, 1994). In addition, 
enzymes necessary for glycolysis, the pentose phosphate pathway, and the 
tricarboxylic acid and glyoxylate cycles are all present (Cole et a l,  1998). M. 
tuberculosis grows most rapidly when well aerated and does not appear to multiply 
under totally anaerobic conditions (Wayne, 1994). Nevertheless, M. tuberculosis 
has the ability to grow under different conditions (Segal, 1984) and has many of the 
enzymes required for anaerobic metabolism as, for example, components of several 
anaerobic phosphorylative electron transport chains (Cole et a l, 1998). Two genes 
encoding haemoglobin-like proteins were also found in the genome sequence which 
may protect against oxidative stress or be involved in oxygen capture (Cole et a l ,  
1998). The virulence of this organism appears to be in part, a function of its ability 
to adapt its metabolism to environmental change, which permits survival and/or 
growth under the wide range of variation in partial oxygen pressures that may occur 
in healthy, inflamed or necrotic tissue.
The tubercle bacilli have a long generation time compared to that of most 
commonly studied bacteria. Under optimal conditions, M. tuberculosis requires 16 
to 18 hours to undergo one cycle of replication (Wayne, 1976). The reasons for this 
slow rate of growth are poorly understood. Originally, it was thought that the
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envelope being both thick and waxy would be relatively impermeable to the uptake 
of nutrients (Wheeler and Ratledge, 1994). Besides, construction of the cell wall 
complex structure containing lipids making up to 1 0 % of the dry weight of the 
mycobacteria (Dhariwall et a l,  1976) represents a great effort on the part of M. 
tuberculosis. Therefore, biosynthesis of the envelope might be rate limiting for 
growth. Another explanation is provided by the rate of nucleic acid chain 
elongation. It has been shown that both the time to replicate the genome (Hiriyanna 
and Ramakrishnan 1986) and the time to transcribe RNA genes (Harshey and 
Ramakrishnan, 1976) are related to the generation time. Escherichia coli which 
divides every 20 minutes, contains 7 rRNA opérons. In mycobacteria, the division 
between fast- and slow-growing species also reflects a natural division by the 
number of rRNA opérons (Bercovier et a l,  1986; Stahl and Urbance, 1990). For 
instance, Mycobacterium smegmatis which requires 3 hours on average to divide, 
contains 2 sets of rRNA genes whereas in such organisms as M. tuberculosis 
(Bercovier et a l ,  1986) and M. lepraemurium (Suzuki et a l,  1987), the functional 
RNA molecules are encoded by a single rm operon. This arrangement may be 
related to the slow growth of these species.
Mycobacteria are hydrophobic and readily enter aerosols when the water is 
disturbed as, for example, by waves in estuaries. In some regions, the number of 
environmental bacilli entering the atmosphere by this mechanism may be sufficient 
to cause cross reactivity on tuberculin testing and may be an important source of 
infection (Kirschner et a l,  1992). The hydrophobic nature of M. tuberculosis is 
responsible for the tendency to grow as mould-like pellicles on the surfaces of 
unagitated liquid media or with extensive clumping in stirred culture, unless a 
detergent is included in the medium. This hydrophobicity is due to the most 
characteristic feature of the mycobacteria: their highly complex lipid-rich cell walls.
It has been demonstrated that inert particles coated with trehalose 6 ,6 ’-dimycolate 
or cord factor (cell wall component extracted from M. tuberculosis) suspended in 
saline in a test tube, aggregate in veils that climb the wall of the container (Behling 
et a l ,  1993). This cord factor effect suggests a mechanism for the peculiar tendency 
of tubercle bacilli to accumulate at the interface and climb the walls of unshaken 
flasks.
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1.2. The Mycobacterial Envelope
The cell envelope that surrounds the tubercle bacillus plays an important role in the 
relationship between the parasite and the infected cells. Through this structure, M. 
tuberculosis adheres to animal cells for invasion, gains protection from the host 
defence mechanisms and triggers some of the damaging reactions experienced by 
the host. The involvement of the cell envelope in the pathogenesis of tuberculosis 
has been recognised for a long time. Its unique nature was first recorded by Robert 
Koch who commented on the unusual cell wall of M. tuberculosis and its 
importance in mycobacterial physiology.
Early research into the chemical structure and physical organisation of the 
mycobacterial envelope was motivated by the following observations: (i) virulent 
strains grow in the form of serpentine cords which are less evident in attenuated 
strains and absent in non-pathogenic species (Middlebrook et a l ,  1947); (ii) 
mycobacteria tend to grow as mould-like pellicles on the surface of liquid media 
(Goren and Brennan, 1979); (iii) granuloma formation is attenuated when guinea 
pigs are injected with delipidated bacillus (Asselineau and Asselineau, 1978; Goren 
and Brennan, 1979). For these reasons, the cell envelope is an obvious candidate for 
study and knowledge of its architecture, chemical nature and biosynthesis is vital to 
the understanding of drug and solute impenetrability (David et a l,  1987; Jarlier and 
Nikaido, 1990), antigenicity and immunoreactivity (Ada, 1987; Bhardwaj and 
Colston, 1988), immune complex deposition and sequelae (Hastings et a l ,  1988), as 
well as other aspects of immunopathogenesis such as granuloma formation in 
tuberculosis (Lucas, 1988) and disease persistence and recrudescence in leprosy and 
tuberculosis (Smith and Weigeshaus, 1989).
1.2.1. Envelope Components
The mycobacterial envelope possesses three structural components: plasma 
membrane, wall and capsule (Figure 1.1). A model of the envelope was first 
developed by Minnikin (1982) and, in spite of several improvements and 
modifications carried out in recent years, no major challenge or reinterpretation has 
been made. There are, however, some remaining discrepancies between the images
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Electron-dense layer
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Figure 1.1. Appearance of mycobacterial envelope in thin sections. A) Electron 
micrograph of envelope and part of cell contents of M. phei 425. Cells were fixed 
by freeze-substitution (Paul and Beveridge, 1992) to optimise preservation of 
structure and to reduce extraction of lipid contents by solvents used in processing. 
Bar indicates 30nm. B) Interpretation of image displayed in panel A in terms of 
layer structure showing the arrangement of capsule, wall and plasma membrane. In 
Brennan and Draper, 1994.
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provided by various ultrastructural techniques, and between those images and 
chemical knowledge.
The plasma membrane
The mycobacterial plasma membrane appears to be a typical bacterial membrane 
judging by its ultrastructure (Silva and Macedo, 1983a), chemical composition 
(Akamatsu et a l ,  1966; Goldman, 1970) and metabolic functions (Brodie et a l,  
1979). The appearance of the mycobacterial plasma membrane in thin sections is 
asymmetrical with the outer electron-dense layer being thicker than the inner layer. 
This is attributed to the presence of excess glycoconjugates in the thicker outer layer 
(Silva and Macedo, 1983a, 1984). The possible candidate molecules are 
phosphatidyl-myo-inositol mannosides (PIM) and the structurally related 
lipoarabinomannans (LAM) and lipomannans (LM) that have been found associated 
with the plasma membrane fraction (McNeil and Brennan, 1991). However, this 
asymmetrical appearance depends on fixation conditions (Silva and Macedo, 1983b, 
1989) raising an additional problem of interpretation.
Polar lipids, mainly phospholipids, assemble themselves in association with 
proteins, into a lipid bilayer. The phospholipids in mycobacterial envelopes are 
predominantly derivatives of phosphatidic acid. The most common are 
phosphatidylglycerol, phosphatidylinositol, phosphatidylethanolamine and 
cardiolipin (Minnikin, 1982). As well as phospholipids, other mycobacterial lipids 
are also present in the plasma membrane.
The Cell Wall
The mycobacterial cell wall structure is now well defined and understood. It 
consists of a covalently linked cell-wall skeleton plus a heterogeneous collection of 
wall-associated molecules. The cell-wall skeleton is the insoluble basis of the 
mycobacterial envelope, in other words, the material remaining after removal of all 
non-covalently bound wall-associated substances like soluble proteins, lipids and 
glycans (Kotani et a l ,  1959). Chemically, the cell-wall skeleton is composed of 
three covalently attached macromolecules: peptidoglycan, arabinogalactan and 
mycolic acids.
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Peptidoglycan
Peptidoglycan forms the basal layer of the cell wall to which arabinogalactan and, in 
turn, mycolates are covalently attached. The mycobacterial peptidoglycan is 
analogous to one of the most common types found in bacteria (Draper, 1982) and 
consists of chains of a glycan formed from alternating units of N-acetylglucosamine 
linked p i -4 to muramic acid (Adam et a l,  1969). However, its structure contains 
two exceptional features. The muramic acid is N-glycolylated instead of the more 
typical N-acetylation (Adam et al., 1969), and the substantial number of unusual 
cross-links between chains of peptidoglycan include bonds between two residues of 
diaminopimelic acid as well as between diaminopimelic acid and D-alanine 
(Wietzerbin et al., 1974). Tetrapeptide chains attached to the muramic acid residues 
cross-link the glycan chains. In all the mycobacterial species examined, except M. 
leprae, this tetrapeptide consists of L-alanyl-D-isoglutaminyl-meso-
diaminopimelyl-D-alanine in which the diaminopimelic acid is amidated 
(Wietzerbin et a l,  1970). In purified peptidoglycan of M. leprae, L-alanine is 
specifically replaced by glycine (Draper et a l,  1987).
Arabinogalactan
The arabinogalactan polymer is composed of D-arabinofuranosyl and D- 
galactofuranosyl with the arabinose residues forming the non-reducing termini 
(Misaki et a l,  1974). The galactan region of this molecule is covalently linked to 
the peptidoglycan (McNeil et a l,  1990) and, in turn, mycolic acids are attached to 
the terminal arabinose units (McNeil et a l ,  1991). The presence of a similar 
arabinogalactan was observed in all the rapid- and slow-growing mycobacterial 
species examined, as well as in the non-cultivable M. leprae (Daffe et a l ,  1993).
Mvcolic Acids
Mycobacterial mycolic acids are long-chain a-branched ^-hydroxy fatty acids 
(Asselineau and Lederer, 1950) containing up to 90 carbon atoms. They are 
synthesised by all mycobacteria, but similar shorter-chain substances occur in the 
related taxa, Nocardia, Corynehacterium and Rhodococcus. Mycobacterial 
mycolates may be grouped into structural types according to the absence or 
presence of defined oxygen functions, in addition to the common 3-hydroxyl and 1 - 
carboxyl groups. These functions include keto, carboxyl, methoxy and epoxy
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groups. Mycolic acids are present mostly as bound esters of arabinogalactan as well 
as in the form of extractable lipids, mainly as trehalose 6 ,6 ’-dimycolate (cord factor) 
(Minikin, 1982). Mycobacteria generally contain a complex mixture of different 
mycolates which are fractionable by chromatography on silicic acid columns or thin 
layer chromatography (TLC) plates (Daffe et a l, 1983; Minikin et a l,  1984). As 
most mycobacterial species synthesise different types of mycolates, analysis of the 
mycolate profiles contributes to the identification of strains to the species level 
(Daffe et a l ,  1983; Levy-Frebault and Portaels, 1992).
Mvcolvl-arabinogalactan-pentidoglvcan complex (mAGP)
The galactan region of the arabinogalactan is connected through a phosphodiester 
link to the C - 6  of muramic acid residues of the peptidoglycan (McNeil et a l  1990). 
The mycolic acids are attached to the arabinogalactan by an ester link to arabinose 
(Azuma et a l, 1968, 1969; Kanetsuma et a l,  1969). The exact location of the 
mycoloyl residues was determined by McNeil et a l  (1991) who demonstrated that 
mycolic acids are clustered in groups of four on the non-reducing pentaarabinosyl 
unit. The chemical structure of the mAGP is shown in Figure 1.2. In M. 
tuberculosis, about two-thirds of the available pentaarabinosyl units are substituted 
in this way while the remaining third is mycolate-free (McNeil et a l  1991). In M. 
leprae, M. bovis BCG and M. smegmatis the cell wall skeleton is less mycolated 
than that of the tubercle bacillus.
Mycolylarabinogalactan plays a critical role in determining the fluidity and 
permeability of the mycobacterial cell wall. Drugs that inhibit the biosynthesis of 
mycolylarabinogalactan are expected to increase fluidity of the lipid domain and, 
consequently, increase the permeability. Ethambutol primarily inhibits the synthesis 
of the arabinan of arabinogalactan (Mikusova et a l,  1995; Deng et a l,  1995) by 
inhibiting arabinosyl transferase activity (Lee et a l,  1995; Belanger et a l ,  1996). 
This results in a decrease in the amount of mycolic acids bound to the cell wall 
presumably because of the lack of new sites of attachment for the mycoloyl residues 
to the arabinan segments (Takayama and Kilbum, 1989; Silve et a l ,  1993). 
Addition of subinhibitory concentrations of ethambutol resulted, as predicted, in a 
significant increase in cell wall permeability to the lipophilic probes, 
chenodeoxycholate and tetracycline (Liu et a l,  in press).
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Figure 1.2. Chemical structure of the mycolyl-AG peptidoglycan complex in 
mycobacteria. The polysaccharide is composed of a galactan substituted by three 
arabinan chains. The galactan is terminated by a linker oligosaccharide attached to 
the peptidoglycan through a phosphodiester bond (McNeil et a l, 1990). Two-thirds 
of the terminal pentaarabinofuranosyl units of the polysaccharide are esterified by 
mycolic acids (McNeil et a l, 1991). The chemical structure of the terminal 
hexaarabinoside moiety of the arabinogalactan and the mycolic acid residues that 
are ester-linked to the polysaccharide is displayed on the top left corner. In Brennan 
and Nikaido, 1995.
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Porin proteins
A porin-type protein has been found in detergent extracts of Mycobacterium 
chelonae cell walls (Trias et al., 1992). The amount of hydrophilic molecules that 
are transported across mycobacterial envelopes, presumably by porins, has been 
measured using a series of p-lactam antibiotics of various polarities (Jarlier and 
Nikaido, 1990). The results revealed that M. chelonae transports these drugs at a 
very low rate comparable to that found in gram-negative bacteria. This indicates that 
the porin pathway is extremely inefficient in mycobacteria which can be explained 
by the following findings. First, unlike the porins of E. coli, the 59 KDa porin 
protein from M. chelonae is a minor component of the cell wall. Second, the 
mycobacterial porin has a specific activity at least 20-fold less than that of the E. 
coli porin. Finally, the porin in M. chelonae has point negative charges at the mouth 
and tends to exclude anionic solutes (Trias et al., 1992; Trias and Benz, 1993).
Pore-forming activity has also been detected in proteins isolated from the walls of 
M. smegmatis (Trias and Benz, 1994). Small quantities of a 23 KDa protein, tightly 
associated with the cell wall skeleton and with some of the properties expected of a 
porin, were obtained from the walls of M. tuberculosis by Hirschfield et al. (1990) 
although there is no information about the nature and amount of porin proteins in 
these organisms. Recently, an ompA homologue found in the M. tuberculosis 
genome has been expressed in E. coli and showed that the protein had a low pore- 
forming activity (Senaratne et ah, 1998). An antibody raised against this protein 
reacted with a protein in M. tuberculosis.
The capsule
The mycobacterial capsule has only recently been recognised as a structure although 
the earliest mentions of its existence go back to Chapman et al. (1959) and Hanks et 
al. (1961). A superficial layer occurring in all mycobacterial species examined, was 
described by Rastogi et al. (1986) who used a variety of special fixatives and stains 
in the preparation of specimens for ultrathin sectioning. This structure reacts 
strongly with ruthenium red although it is not certain which component of the 
envelope is responsible for the binding of the dye. The microscopic evidence for the 
capsule is now supported by knowledge of its chemical composition. The nature of
13
Chapter 1
the mycobacterial surface constituents has been resolved and shown to be composed 
by a significant amount of protein and polysaccharide (Ortalo-Magne et a l ,  1995; 
Lemassu et a l,  1996). The main components of the capsule are D-glucans, 
arabinomannan and small amounts of oligo- and polysaccharides (Daffe and Draper, 
1998).
1.2.2. Ultrastructure and Physical Organisation of the Envelope
The mycobacterial envelope has the same ultrastructural appearance in ultrathin 
sections of both intact bacterium and purified walls. As shown in Figure 1.1, the 
envelope is composed of an inner layer of moderate electron density, a wider 
electron-transparent layer and an outer electron-opaque layer of variable appearance 
and thickness (Imaeda et a l,  1968; Barksdale and Kim, 1977; Paul and Beveridge, 
1992). Because visible structure and chemical identity have been related to a great 
extent, it is possible to associate these layers with chemically defined substances.
The inner layer probably contains the peptidoglycan. Its moderate electron density 
is consistent with the staining properties of this molecule which contains carboxyl 
groups able to bind the metallic stains used in electron microscopy. Part of the 
arabinogalactan must be, as well, responsible for the staining of the inner layer since 
it is attached to many sites of the peptidoglycan (Beveridge and Murray, 1980). The 
electron-transparent layer appears to be the hydrophobic domain of the cell wall, the 
bulk of which consists of mycolate residues covalently bound to the 
arabinogalactan. Its transparency is caused by the poor penetration of the water- 
soluble stains into these hydrocarbon-rich regions. Removal of lipids, including 
covalently linked ester-bound mycolates, causes the disappearance of the electron- 
transparent layer (Draper, 1971). In intact mycobacteria, the outer margin of the 
electron-transparent layer is usually defined by material assumed to be capsular. 
The nature of the outermost electron opaque layer of the wall is controversial. This 
structure varies in thickness, electron density and appearance which is attributable 
to differences among species, in growth conditions and in preparation methods for 
microscopy. Probably, negatively charged head groups of lipids, proteins or 
carbohydrate material, such as lipoarabinomannan and capsular polysaccharides 
(glucans, mannans, arabinans), contribute to the binding of stains which allow the 
visualisation of this layer.
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In the “chemical” model proposed by Minnikin (1982) for the arrangement of the 
mycobacterial cell wall skeleton, the mycolic acids form a closely-packed 
monolayer positioned perpendicularly to the plane of the cell surface. The fatty acyl 
chains of the various wall-associated lipids intercalate with the mycolate chains and 
the complete structure forms an asymmetric bilayer (Figure 1.3). This model takes 
into consideration the various unsaturations and oxygen functions of the mycolic 
acids and the existence of the alkyl chains of the a-branches which are considerably 
shorter than the main alkyl chains, making, at the same time, such intercalation 
structurally plausible. The wall-associated lipids with polar groups of various 
degrees are exposed to the environment on the extreme outer margin of the wall.
Experimental support for this model has been provided by the quantification of 
lipids in the cell wall skeleton of M. bovis BCG as well as by X-ray diffraction 
studies of the cell wall purified from M  chelonae (Nikaido et a l ,  1993). These 
workers calculated that the amount of mycolic acids is sufficient to form a 
monolayer with an area similar to that of a mycobacterial cell. They also showed 
that purified walls of M. chelonae in aqueous suspension produced an X-ray 
diffraction pattern with reflections characteristic of close packed parallel 
hydrocarbon chains in a crystalline monolayer in a direction perpendicular to the 
cell surface. Furthermore, since there are two parallel branches in a single mycolic 
acid molecule, the extractable lipids should contain approximately twice as many 
fatty acid residues as mycolic acids. Analysis of a pure preparation of cell wall from 
M. chelonae showed that it contained a large amount of lipids with C 14 and C 19 fatty 
acids. The molar ratio between short-chain fatty acids and mycolic acids was found 
to be 2.3 ± 1 (Liu et a l, in press). Recently, the native organisation of the 
mycobacterial envelope has been studied using fluorescent lipophilic probes 
(Christensen et al, 1999). The differential localisation of probes influenced 
predominantly by their hydrophobicity, helped elucidating the distribution of lipids 
in the cell envelope.
An alternative model has been developed by Rastogi (1991) in which the 
amphipathic, wall-associated lipids form a superficial monolayer instead of 
intercalating with mycolates. This arrangement forms a bilayer structure with the 
outward-pointing hydrocarbon chains of the mycolic acids, in a pattern similar to
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Figure 1.3. Modified Minnikin model of the mycobacterial cell wall. The
arabinogalactan-peptidoglycan complex is shown with sugars represented as follows: A- L- 
arabinose; G- D-galactose; Rha- L-rhamnose; GlcNAc- N-acetyl-D-glucosamine. The 
proximal position of the longer meromycolate branch may be either cis- or trans- double 
bond, or cis- or rran^-cyclopropane group (solid squares). The distal position of the 
meromycolate branch can be cw-double bond, cw-cyclopropane group, or oxygen- 
containing groups (solid triangles). The lipids composing the outer leaflet differ from 
species to species. Those containing short-chain (Cie-is) fatty acids include 
glycerophospholipids and glycopeptidolipids. Those containing intermediate chain-length 
hydrocarbons include phenolic glycolipids, phtiocerol dimycocerosate, and others. In 
Brennan and Nikaido, 1995.
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that of a normal biological membrane. Drawbacks of this model are that the 
outermost material of the mycobacterial wall is now believed to be polysaccharide 
rather than lipid (Ortalo-Magne et a l,  1995; Lemassu et a l,  1996) and no 
appearance of a bilayer membrane has ever been observed on the outside of the cell 
wall skeleton. Other contributions to the model of the mycobacterial envelope have 
been made by McNeil and Brennan (1991), Liu et a l  (1995) and Barry and Mdluli 
(1996). Even though remarkable progress has been made in establishing the 
chemical composition and arrangement of the molecules that form part of the cell 
wall skeleton, there are still some important unsettled issues.
In the bilayer model of the mycobacterial cell wall, the mycolic acid-containing 
inner leaflet is expected to have very low fluidity. Mycolic acid hydrocarbon chains 
produce tightly packed, parallel arrays with high melting temperatures. This 
arrangement that is favoured by the presence of very few double bonds or 
cyclopropane groups. The outer leaflet, containing lipids with shorter fatty acids, 
should be more fluid than the outer leaflet, therefore, a steep gradient of fluidity is 
likely to exist across the thickness of the mycobacterial cell wall. This has been 
fully confirmed using spin-labelled fatty acid probes inserted into the outer leaflet of 
the cell wall isolated from M. chelonae. Electron-spin resonance spectra of these 
probes showed considerable fluidity in the outer leaflet, which decreased with 
increasing depth of probe insertion (Liu et a l ,  1995). The nature of the mycolic acid 
layer makes the mycobacterial cell envelope exceptionally impermeable. This may 
explain in part the permeability coefficients 2-5 orders of magnitude lower than that 
of E. coli (Connell and Nikaido, 1994).
It is known that pathogenic mycobacteria survive and thrive inside human 
macrophages normally able to kill and disintegrate microorganisms, and that 
residues of M. leprae and M. tuberculosis persist in previously infected tissues long 
after all the organisms are dead. Some of this resistance to destruction may be 
explained in terms of the chemical structure of the cell wall skeleton, where the 
layer of mycolate protects the arabinogalactan and peptidoglycan from the effects of 
the defence mechanisms of the host cell (Daffe and Draper, 1998).
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1.3. Lipid Synthesis in Mycobacteria
Mycobacteria produce a wide range of lipids some of which are very complex and 
unique (Minnikin, 1982; Brennan and Nikaido, 1995). Even though the list of 
lipidic components present in these organisms is extensive, a brief look at their 
diversity will be useful. In addition to the usual fatty acids found in membrane 
lipids, mycobacteria synthesise a variety of very long-chain saturated (C18-C3 2) and 
monounsaturated (up to € 2 0) n-fatty acids. The occurrence of mycolic acids (a-alkyl 
p-hydroxy long-chain fatty acids) is a hallmark of mycobacteria and related species. 
These lipids are major components of the cell wall, occurring esterified to 
arabinogalactan as well as esterified to trehalose to form “cord factor”. 
Mycobacteria also contain a diversity of methyl-branched fatty acids. These include 
tuberculostearic acid (10-methyl Cig fatty acid), phthienoic acid (trimethyl 
unsaturated C 2 7  acid), mycocerosic acids (tetramethyl-branched C2 8-C32 fatty acids), 
and multiple methyl-branched phthioceranic acids.
M. tuberculosis contains examples of several known lipid and polyketide 
biosynthetic systems, including enzymes usually found in mammals and plants as 
well as in other bacteria. Information about the genes involved in lipid metabolism 
revealed an impressive biosynthetic capacity coupled with an even more remarkable 
array of degradative, fatty acid oxidation systems. In total, there are 250 genes 
annotated in the database encoding distinct enzymes supposedly involved in fatty 
acid metabolism in M. tuberculosis compared with only 50 in Escherichia coli 
(Cole et a l ,  1998; Riley and Labedan, 1996). Wherever lipid synthesis occurs, the 
operating chemical mechanism is the same (Volpe and Vagelos, 1973). Fatty acids 
are synthesised by a common pathway which employs two enzyme systems 
functioning sequentially: acetyl-CoA carboxylases and fatty acid synthetases.
There are two fundamentally different arrangements of fatty acid synthetases. The 
aggregated or type I synthetases are polyfunctional entities present in animal tissues, 
fungi and some bacteria. The nonaggregated or type II synthetases are composed by 
separable enzymes that act individually but constitute a single functional system 
which occur in plants and most bacteria. All intermediates generated by the 
multienzyme aggregates remain enzyme bound throughout the synthetic process 
while the product of the first partial reaction is directly transferred to the second
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catalytic site. Conversely, in nonaggregated type n  systems each intermediate is 
released into solution so that the further progress of the reaction sequence depends 
on collision between substrate and enzyme at each step. The proteins of type II can 
be purified independently of the others in the pathway and are encoded by unique 
genes. There are often multiple enzymes that carry out the same chemical reaction, 
although they may differ in substrate specificity and hence physiological function. 
Both fatty acid synthetase I (FAS I) usually found in eukaryotes, and the fatty acid 
synthetase II (FAS II) usually found in prokaryotes, have been identified in 
mycobacteria (Brindley et a l,  1969; Block, 1977; Kikuchi et ah, 1992). 
Furthermore, the gene coding FAS I from M. tuberculosis H37Rv (Cole et a l ,  
1998) and M. bovis BCG (Fernandes and Kolattukudy, 1996) as well as the genes 
coding the different components of FAS II from M. tuberculosis H37Rv (Cole et a l,  
1998) have been identified by sequence data.
Mycobacterial FAS I is a single polypeptide with multiple catalytic activities. 
Cloning and sequencing of the synthetase gene revealed the following domain 
organisation: acyl transferase (AT), enoyl reductase (ER) -  dehydratase (DH), 
malonyl/palmitoyl transferase -  acyl carrier protein (ACP), p-ketoreductase (KR) 
and P-ketoacyl synthetase (KS) (Fernandes and Kolattukudy, 1996). The reactions 
catalysed by fatty acid synthetase complex are as follows:
A cetyl transacylation:
CH3.CO-C0A + HS-enzyme  CHg.CO-S-enzyme + CoASH
M alonyl transacylation:
HOOC.CH2.CO-C0A + HS-enzyme ----->► H00C.CH2.C0-S-enzyme + CoASH
Condensation reaction:
HOO C.CH 2 .CO -S-enzym e + CHs.CO -S-enzym e ^  H S-enzym e +  CO 2  +
CH 3 .CO.CH 2 .CO -S-enzym e
p-K etoacyl reduction:
CH 3 .CO.CH 2 .CO -S-enzym e + N A D PH   CH 3 .CH(OH).CH 2 .CO -S-enzym e +  NADP^
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p-H ydroxyacyl dehydration:
CH 3 .CH(OH ).CH 2 .CO -S-enzym e ^  H 2 O + CH 3 .CH :CH.CO -S-enzym e
2,3-fm »j-E noylacyl reduction:
C H 3.CH :C H .C0-S-enzym e + N A D H  ------>  H 20+CH 3.CH 2.CH 2.C0-S-enzym e +  NAD+
Long-chain transacylation:
CH 3 .(CH 2 )n. C O -S-enzym e + CoA SH  -------------- CH 3 .(CH 2 )n. CO -CoA  + H S-enzym e
n= 12 to 22
This multifunctional enzyme catalyses not only the synthesis of C 16 and Cig fatty 
acids, the normal products of de novo synthesis, but also elongation to produce C24 
and C26 fatty acids (Wood et a l,  1977; Kikuchi et a l,  1992). The bimodal 
distribution of products with the acids at Cie-Cig being more abundant than the acids 
at C2 4-C26 can be explained by the nature of FAS I. This enzyme appears to be a de 
novo synthetase that generates several shorter CoA esters, joined to an elongase that 
takes the 16-carbon acid and elongates it to 24 or 26 carbons (Kikuchi et a l  1992). 
Presumably, the shorter acids enter primarily into the synthesis of the conventional 
membrane lipids, while the longer chains serve as precursors for the more complex, 
fatty acid containing cell-wall materials (i.e. mycolic acids, cord factor). A single, 
flexible fatty acid synthetase that can deliver fatty acids of either size may therefore 
be advantageous to the mycobacterial cell (Bloch, 1977; Kikuchi et al. 1992).
The mycobacterial fatty acid spectrum, while persistently bimodal, changes from 
predominantly short chain (C16, Cig) to predominantly long chain (C2 4 , C2 6) and vice 
versa, mainly in response to acetyl-CoA/malonyl-CoA ratios (Flick and Block, 
1974) and the presence of complexing agents like mycobacterial carbohydrates 
(Peterson and Block, 1977). As observed by Ilton et al. (1971) and Mehdi et al. 
(1974), 0-methylated polysaccharides influence the nature of the end products and 
stimulate the rate of fatty acid synthesis in crude cell-preparations. The mechanism 
proposed for this stimulation consists in the formation of a ternary complex with the 
enzyme and the bound fatty acyl-CoA causing a rapid release of the product 
enhancing its rate limiting diffusion (Wood et a l,  1977). These polysaccharides
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release preferably Cie and Cig chains from the enzyme complex causing not only an 
increase in the rate of fatty acid synthesis but also a shift in the product distribution 
(Flick and Block, 1974; Wood et al. 1977). However, if the polysaccharide is 
absent, the Ci6 chain will tend to be elongated to a C24 chain (Peterson and Block, 
1977; Bannis et a l ,  1977). Whether the polysaccharides play a role in mycobacteria 
in vivo is not known (Kolattukudy et a l, 1997).
FAS n  consists of a dissociable system of mono-functional enzymes which act on a 
substrate bound to an acyl-carrier protein (ACP). However, the mycobacterial FAS 
II has one distinguishing feature. The priming substrate is not acetyl-CoA but 
palmitoyl-CoA (Odriozola et a l, 1977). Consequently, this system in mycobacteria 
is incapable of de novo fatty acid synthesis and functions only to elongate the 
products of FAS I and/or exogenous fatty acids acquired from the host (Ratledge, 
1982; Mdluli et a l, 1998). Another difference, is that addition of mycobacterial O- 
methylated polysaccharides causes neither an increase nor a decrease in enzyme 
activity (Odriozola et a l, 1977).
The structural relationships and relative roles among the various types of fatty acids 
synthetic enzymes in mycobacteria remains uncertain. It has been suggested that, in 
vivo, FAS I generates mainly Cig and Cig fatty acids due to the presence of 
complexing polysaccharides and, therefore, long chain fatty acid biosynthesis would 
have to rely on type II (ACP)-dependent system (Ratledge, 1982). Adaptation to 
environmental conditions might account, as well, for the existence of multiple 
biosynthetic systems. For instance, if exogenous fatty acids are available from either 
the culture media or the host, mycobacteria could use them as primers for 
elongation and production of the long and complex wall lipids (Ratledge, 1982; 
Kikuchi 1992).
Isoniazid inhibits some of the components of mycobacterial fatty acid synthetases 
(Kikuchi et a l, 1989; Banerjee et a l,  1994; Mdluli et a l ,  1998), although there is 
still debate about the primary target for the drug in M. tuberculosis. In response to 
isoniazid treatment, saturated € 26:0 accumulated on a 12 KDa acyl carrier protein 
(AcpM). A protein species purified from isoniazid treated M. tuberculosis was 
shown to consist of a covalent complex of isoniazid, AcpM and a p-ketoacyl ACP 
synthetase (KasA) (Mdluli et a l,  1998). Isoniazid also targets a long chain enoyl-
21
Chapter 1
ACP reductase (InhA), an enzyme essential for mycolic acid synthesis in M. 
tuberculosis (Quemard et a l,  1995). X-ray crystallography and mass spectrometry 
studies revealed that the activated form of the drug is covalently attached to the 
nicotinamide ring of nicotinamide adenine dinucleotide present in the active site of 
InhA (Rozwarski etal., 1998).
Other enzymes that can elongate fatty acids are also present in mycobacteria. 
Malonyl-CoA dependent elongating activities that produce fatty acids up to Cgg 
have been reported (Besra and Chatterjee, 1994). A reconstituted elongation system 
composed of a combination of the purified component enzymes catalyses elongation 
of Ci4  to C24 saturated and mono-unsaturated primers using malonyl-CoA as the 
chain extending unit (Kikuchi et a l,  1989). Finally, an acyl-CoA elongation by a 
single C2 unit using acetyl-CoA as the chain-extending moiety has also been 
reported (Kolattukudy et a l,  1997). The biological significance of these activities 
remains to be elucidated.
Synthesis of the various complex lipids in the cell is followed by extensive 
postsynthetic modifications and unsaturations, particularly in the case of mycolic 
acids, which involve a diverse array of enzymes. Mycolic acids are composed of a 
p-hydroxy acid with an a  side chain. The a  side chain is a 24- or 26- carbon 
saturated fatty acyl chain, but the p-hydroxy acid is complex and long (up to 56 
carbons) and may contain oxygen functions. The starting 24- and 26- carbon fatty 
acids are generated by synthetases and elongases described earlier. The complete 
process of mycolate synthesis involves fatty acid chain elongation, desaturation, 
cyclopropanation of the olefin and a Claisen-type condensation (Minnikin, 1982).
A cell-free extract mainly composed of cell walls that incorporates [^ tjace ta te  into 
mycolic acids has been described (Lacave et a l,  1990). Nevertheless, little is known 
about the enzymes that catalyse the individual steps postulated to be involved in the 
biosynthesis of mycolates, although desaturation and cyclopropanation have already 
been studied to some extent (Kikuchi et a l,  1989). The recent genomic data from 
M. tuberculosis H37Rv indicate that unsaturation of the meromycolate chain is 
carried out by three potential desaturases -  Des A l, Des A2 and Des A3 (Cole et 
a l,  1998) and a family of S-adenosyl-L-methionine-dependent enzymes uses the 
unsaturated meromycolic acid as a substrate to introduce cis and trans
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cyclopropanes (George et a l,  1995; Yuan et a l,  1995). Cyclopropanation is a major 
modification found in the mycolic acids of pathogenic mycobacteria which might 
have a role in survival in the hostile environment within the host (Kolattukudy,
1997). In addition, cyclopropanation has been shown to alter fluidity and 
permeability of the mycobacterial cell wall (Liu et a l,  1996a). Condensation of the 
meromycolate chain with a 26-carbon a-chain generates full-length mycolic acids. 
These molecules must now be transported to their final location to be attached to the 
terminal arabinan motifs of the arabinogalactan for final assembly of the cell wall. 
The transfer and subsequent transestérification is known to be mediated by three 
immunogenic proteins of the antigen 85 complex (Belisle et a l,  1997; Jackson et 
a l,  1999).
The multiple methyl-branched fatty acids produced by M. tuberculosis and M. bovis 
are generated by elongation of n-C\% and «-C20 fatty acids with methylmalonyl-CoA 
as the substrate (Asselineau, 1966). Incorporation of labeled propionate and 
methylmalonate into such molecules by a cell-free extract (Rainwater and 
Kollatukudy, 1983) lead to the purification and characterisation of a mycocerosic 
acid synthetase (MAS). This MAS is a multifunctional synthetase in the form of a 
dimer, each subunit containing an acyl carrier protein like segment (Rainwater and 
Kollatukudy, 1985). The molecular cloning and sequence of the mycocerosic acid 
synthetase gene {mas) and the organisation of the domains has also been published 
(Mathur and Kollatukudy, 1992). The active site areas of p-ketoacyl synthetase 
(KS) domain and the acyltransferase (AT) of MAS show a high degree of homology 
to their counterparts in the eryA  gene of S. erythraea, which encodes a polyketide 
synthetase specific for methylmalonyl-CoA, and a significantly lower degree of 
homology to the corresponding domains of the FASs that use malonyl-CoA to 
generate fatty acids. Therefore these two domains might be responsible for 
selectivity for methylmalonyl-CoA (Mathur and Kolattukudy, 1992).
Disruption of the gene that encodes MAS, and the biochemical analysis of the 
products generated by the mutant revealed that, although this strain was unable to 
produce long mycocerosic acids, it would still synthesise shorter chain C22 to C26 
mycocerosic acids (Azad et a l, 1996). This observation strongly pointed to the 
existence of an enzyme other than MAS responsible for the production of these
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acids. The discovery, purification and characterisation of an enzyme, called short 
chain mycocerosic acid synthetase (SMAS), which synthesises the shorter 
mycocerosic acids from methylmalonyl-CoA and C 12 to C20 acyl-CoA primers has 
been reported (Fernandes and Kollatukuddy, 1998). SMAS appears to be a dimer 
and immunologically distinct from any of the mycobacterial enzymes studied thus 
far. SMAS could therefore be responsible for the synthesis of the shorter 
mycocerosic acids found esterified to phthiocerol or the synthesis of the 
multimethyl-branched fatty acids, such as those found esterified in diacyl trehalose 
and the mycosanoic acids (Fernandes and Kollatukuddy, 1998).
Finally, because pathogenic mycobacteria are intracellular parasites, they inhabit a 
lipid-rich environment. Any fatty acids released from those lipids and taken into the 
mycobacterial cells will inhibit or repress fatty acid synthesis, de novo fatty acid 
biosynthesis is subject to strong metabolic control in mycobacteria: when fatty acids 
are available, repression (Ascenzi and Vestal, 1979) and feedback inhibition (Block, 
1977) occur. This is consistent with the observation that acetyl-CoA-dependent 
elongase activity in host-grown mycobacteria is elevated to levels similar to that 
found in the corresponding mycobacteria grown in the presence of lipid (Wheeler et 
a l,  1990). For example, the major activity for anabolism of fatty acids in 
mycobacterial species such as M. leprae, M. avium, M.microtti (Wheeler et al., 
1990) and M. leparemurium (Kusaka, 1977) involves direct incorporation of acetyl- 
CoA into growing fatty acyl chains. Therefore, it is plausible that the response to an 
exogenous supply of lipids is characterised by an acetyl-CoA dependent, fatty acyl- 
CoA elongation rather than malonyl-CoA-dependent elongase activity.
Exogenous lipids are rapidly catabolised through the p-oxidation cycle providing 
valuable acetyl-CoA units that can be used either to elongate fatty acids acquired 
from the host or to augment the reactions of the tricarboxylic acid cycle (Franzblau, 
1988; Wheeler and Ratledge, 1988). Wheeler et al. (1991), showed that all the 
enzyme activities for p-oxidation and acetyl-CoA dependent chain elongation exist 
in pathogenic mycobacteria. Although p-oxidation and chain elongation rely on the 
same enzymes working in opposite directions, it is inconceivable that these 
processes can occur simultaneously and be catalysed by the same enzymes (Wheeler 
et al., 1991). These authors suggested that two separate enzyme complexes, 
functionally identical but spatially distinct, must exist.
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1.4. Acyl-CoA Carboxylases
1.4.1. Mechanism of Action of Biotin Enzymes
The biotin-dependent enzymes constitute a diverse group which includes acetyl- 
CoA carboxylase, propionyl-CoA carboxylase, pyruvate carboxylase, 3- 
methylcrotonyl-CoA carboxylase, geranyl-CoA carboxylase, urea carboxylase, 
methylmalonyl-CoA decarboxylase, oxaloacetate decarboxylase, and 
transcarboxylase. These enzymes are involved in a variety of essential metabolic 
pathways such as lipogenesis, glucogenesis, and amino-acid metabolism and have 
been identified in all organisms (Dimroth, 1985). Biotin is an essential cofactor for 
these enzymes and, in general, serves as a covalently bound “CO2 carrier” for 
reactions in which CO2 is fixed into an acceptor (carboxylases), a carboxyl group is 
transferred from a donor to an acceptor (transcarboxylases), or a carboxyl group is 
removed from a donor (decarboxylases).
Acetyl-CoA carboxylase catalyses the first committed step in lipid biosynthesis 
which involves the carboxylation of acetyl-CoA to yield malonyl-CoA (Wakil et a l,
1983). There is now ample evidence that the overall reaction catalysed by acetyl- 
CoA carboxylase and other biotin-dependent carboxylases proceeds via two partial 
reactions, as follows:
E-biotin + ATP + HCO3 
E-biotin-COi' + R-H 
Sum: R-H + ATP + HCO3'
I
acetyl-CoA
propionyl-CoA
pyruvate
3-methylcrotonyl-CoA
geranyl-CoA
urea
- >
E-biotin-COz' + ADP + Pi 
E-biotin + R- CO2’
R-C02' + ADP + Pi
i
malonyl-CoA
methylmalonyl-CoA
oxaloacetate
3-methylgutaconyl-CoA
carboxygeranyl-CoA
N-carboxyurea
(1)
(2)
(3)
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The initial step involves the carboxylation of an enzyme-bound biotin prosthetic 
group to form a carboxybiotinyl enzyme in a reaction that requires ATP, Mg "^^  and 
bicarbonate. In the second step, the carboxyl group of carboxybiotin is transferred to 
an appropriate acceptor substrate depending on the specific enzyme involved 
(Northrop, 1969). Each partial reaction is catalysed specifically by a separate 
subunit through a mechanism called “two site” Ping-Pong (Figure 1.4). The 
function of biotin is to act as a swinging arm, becoming carboxylated at the active 
site of the biotin carboxylase subunit and transferring the carboxyl group at the 
active site of the carboxyltransferase subunit. The existence of different subsites for 
catalysis of each partial reaction has been unequivocally demonstrated with acetyl- 
CoA carboxylase of E. coli by two different groups - Vagelos and co-workers 
(Alberts and Vagelos, 1968; Alberts et a l,  1969; Alberts et a l,  1971; Fall and 
Vagelos., 1972) and Lane and co-workers (Dimroth et a l,  1970; Guchhait et a l ,  
1971; Guchhait et a l,  1974; Polakis e ta l ,  1974).
1.4.2. Biotinylation of Protein Domains
Biotin was isolated in 1936 from egg yolk by Kogel and Tonnis and later shown to 
be identical to vitamin H by Gyorgy et a l  (1940). By 1950, biotin had been 
implicated in a number of seemingly unrelated enzymatic or metabolic processes 
that can now be explained in terms of the role of biotin as a “CO2 carrier”. In the 
sixty years since this discovery, the role of biotin has been unequivocally 
established and much progress has been achieved in characterising a large number 
of biotin-dependent enzymes which carry out diverse types of reactions.
The biotinyl group is attached post-translationally by a biotinyl protein ligase (also 
known as biotin holoenzyme synthetase), which catalyses the formation of an amide 
linkage between the carboxyl group of the biotin and the N^-amino group of a 
specific lysine residue located in the C-terminal region of the enzyme (Lane et a l ,  
1964; Wood et a l, 1980). In E. coli, the biotinyl-lysine (biocytin) residue is 
positioned in an independently folded domain of about 80 amino acids (Chapman- 
Smith et a l ,  1994; Nenortas and Beckett, 1996), the structure of which has been 
established by means of X-ray crystallography (Athappilly and Hendrickson, 1995). 
Results from several laboratories show that this reaction is fairly general since the
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Biotin
ATP
\
AcCoAco;
Figure 1.4. The “ping-pong” kinetic mechanism of translocation of the 
carhoxylated hiotinyl prosthetic group. The ATF-dependent carboxylation of 
biotin takes place in site I. The carboxybiotin swings to the neighbouring site It 
where transfer of CO2 to an appropriate acceptor occurs. Adapted from Moss and 
Lane, 1971.
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synthetase from one organism will modify enzymes from heterologous sources, 
such cross-reactivity including several bacterial/mammalian interactions (Kosow et 
a l,  1962; McAllister and Coon, 1966). However, these synthetases are highly 
selective because biotin is attached to only one lysine &-NH2 group from among the 
many that are present in the protein. The broad specificity toward apoenzymes from 
different sources indicates that the structure of these enzymes in the vicinity of the 
biotin attachment site must be conserved. In fact, several similarities have been 
noted on the level of primary structure, and it has been proposed that these 
conserved features may be involved either in recognition by the synthetase or in a 
general mechanism of catalysis by biotin enzymes (Samols et a l,  1988).
Biotin-dependent enzymes contain the biotinyl-lysine residue located in a conserved 
sequence motif, Ala-Met-Lys-Met (AMKM) (Rylatt et a l,  1977; Sutton et a l,  1977; 
Maloy et a l ,  1979; Freytag and Collier, 1984; Lamhonwah et a l,  1986) present in a 
surface hairpin loop in one of the two p-sheets that make up the biotinyl domain 
(Athappilly and Hendrickson, 1995). Point mutagenesis and deletion experiments 
have revealed the functional role of specific residues or regions in the primary 
structures of these enzymes (Moss and Lane, 1971; Wood and Barden, 1977; 
Samols et a l ,  1988; Reche et a l, 1998). In vivo and in vitro experiments were 
carried out by Reche et a l  (1998) using mutant domains where the conserved 
AMKM motif of the biotin carboxyl carrier protein (BCCP), one of the three 
functional subunits in the acetyl-CoA carboxylase of E. coli, was systematically 
replaced. No biotinylation of the AMAKM and AKAMM mutants, in which the 
target lysine is moved one place, was observed in vivo or by purified biotinyl 
protein ligase in vitro. In the AKKMM and AMKKM mutant domains containing 
two potential biotinylation sites, only one residue, presumed to be that in its native 
position, was found to be biotinylated in vivo and in vitro. However, the 
biotinylation of the latter mutants was found to be significantly impaired. This 
observation is confirmed by previous studies carried out on the biotinyl domain of 
the a-subunit from human propionyl-CoA carboxylase (Leon-Del-Rio and Gravel, 
1994) and the 1.3S subunit of Propionibacterium shermanii transcarboxylase 
(Shenoy et a l ,  1988). These workers replaced the methionine residues flanking the 
target lysine on the biotinyl domain with leucine and demonstrated that the
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methionines were not essential for correct biotinylation of these proteins in vivo by 
E. coli biotinyl protein ligase. Nevertheless, further experiments performed with P. 
shermanii transcarboxylase, showed that carboxylation of the mutated biotin moiety 
was defective (Shenoy et a l, 1993). Two important conclusions emerge from these 
observations. Firstly, the presentation of the target lysine residue in the structure of 
the biotinyl domain is of crucial importance for the biotinylation reaction. Secondly, 
the methionine residues flanking the biocytin in the conserved tetrapeptide are 
important, but not essential, and appear to have been conserved in part to be 
compatible with the subsequent carboxylation reactions of biotin-dependent 
enzymes.
However, biotinylation of the relevant protein domains does not simply rely on 
recognition of the unique and well-conserved sequence motif AMKM but additional 
sites elsewhere on the domain are also of importance. It has been observed that, 
with very few exceptions, the biotinyl lysine is positioned exactly 35 amino acids 
upstream from the carboxyl terminus, and that the COOH-terminal sequences show 
appreciable homology (Sutton et a l, 1977; Maloy et a l, 1979; Freytag and Collier, 
1984; Lamhonwah et a l,  1987). Murtif and Samols (1987) investigated whether or 
not this sequence plays a role in directing the post-translational biotinylation of 
lysine by biotinyl protein ligase. These authors constructed a series of deletions and 
mutations which demonstrate that the COOH-terminal region is essential for biotin 
addition. Particularly, mutations that remove more than one amino acid from the 
COOH terminus destroy the capacity for biotin addition. Moreover, mutations that 
eliminate the hydrophobic side chain of the penultimate residue also abolish 
biotinylation. The importance of this residue is illustrated when the hydrophobic 
residue (isoleucine, valine or leucine) is substituted by glycine producing a mutant 
which is not biotinylated (Murtif and Samols, 1987).
Overall, it is the positioning of the target lysine residue at the tip of the p-tum in the 
biotinyl domain (Reche et a l,  1998) and the spatial relationship between the 
nonpolar hydrophobic COOH-terminal region and the lysine to be biotinylated 
(Murtif and Samols, 1987) that provide the correct conformation for the recognition 
process by the biotinyl protein ligase to occur.
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1.4.3. Structure of Biotin Enzymes
The structure of biotin enzymes has been derived from studies of their subunit 
composition and electron micrographs, and all of them appear to possess complex 
quaternary structures, being composed, in most instances, of non-identical subunits. 
All enzymes studied thus far are oligomeric and vary in structural complexity, 
ranging from unifunctional subunits to multifunctional allosteric enzymes that may 
have been originated by successive gene fusions along the evolutionary pathways 
(Toh et a l ,  1993; Obermayer and Lynen, 1976; Samols et a l ,  1988). As a result, 
although similar in function, this group of enzymes exhibit a great variety of 
structural features.
The architecture of biotin-dependent enzymes has been deduced mainly by the 
classical work of Vagelos and his co-workers (Alberts and Vagelos, 1972) and of 
Wood and his colleagues (Wood, 1972) using acetyl-CoA carboxylase from E. coli 
and transcarboxylase from Propionibacterium shermanii as models. These authors 
demonstrated that each component step of the reactions described on page 25 is 
performed by a different unifunctional subunit. The E. coli acetyl-CoA carboxylase 
is readily resolved into four essential protein components: biotin carboxylase, biotin 
carboxyl carrier protein and two similar but distinct carboxyl transferases (Lane and 
Polakis, 1975). Similarly, transcarboxylase is composed of three different 
polypeptides, each with a specific function, the most active form of the enzyme 
consisting of 30 polypeptide chains. However, there are enzymes composed of 
bifunctional subunits where the carboxyl-carrier function is integrated into the 
biotin carboxylase subunit. This is the case of P-methylcrotonyl-CoA carboxylase 
from Achromobacter, an enzyme which participates in the degradation of leucine 
via isovaleryl-CoA (Schiele et a l, 1975). On prolonged alkaline dialysis, the 
tetrameric complex dissociates reversibly into two polypeptides with different 
molecular weights. The larger chain which retains its biotin carboxylase activity 
upon dissociation, was also found to carry the biotinyl prosthetic group. The smaller 
subunit has no enzymatic activity when isolated and it is only after addition of the 
biotin containing chain that the overall activity is regained.
The examples discussed so far illustrate two types of biotin enzymes. Those that 
consist of different polypeptides each of which has a different function, and those
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which exhibit an integrated prosthetic group into one of the subunits. However, a 
third type of structural organisation is found in fungi. Pyruvate carboxylase and 
acetyl-CoA carboxylase from yeast are both tetramers in their reacting form that 
appear to be composed of four identical polypeptides each with a three-fold function 
(Utter et a l,  1975; Sumper and Riepertinger, 1972). Finally, acetyl-CoA 
carboxylases isolated from various avian and mammalian tissues contain the most 
integrated structure encountered among biotin enzymes (Numa, 1974; Lane and 
Polakis, 1975). These carboxylases which retain their structural integrity during 
purification and have stable multisubunit structures, also share the property of 
polymerisation of the inactive protomer to form highly active filaments of several 
million daltons when activated by citrate (Lane et a l, 1979; Thampy and Wakil, 
1985). As an example, the rat-liver enzyme carries the functions of biotin 
carboxylase, biotin carboxyl carrier protein and carboxyl transferase as well as the 
regulatory function (Tanabe et a l, 1975).
The various types of carboxylases might represent different stages in the evolution 
of the enzyme system. Carboxylations may originally have been carried out by 
separate enzymes with an easily dissociable carboxyl-carrier protein. In the course 
of evolution, the increasing functional structuring of the cellular interior led to the 
formation of complexes with multifunctional polypeptide chains, probably as the 
result of gene fusion. In this way, the kinetics and regulation of the stoichiometric 
synchronous synthesis of the component proteins is facilitated, and the association 
process is made simpler (Obermayer and Lynen, 1976).
1.4.4. Mycobacterial Acyl-CoA Carboxylases
Acyl-CoA carboxylase has been purified and characterised from M. smegmatis 
(Henrikson and Allen, 1979; Haase et a l,  1982)\ M. bovis BCG and M. 
tuberculosis (Rainwater and Kolattukudy, 1982) and shown to be an aggregated 
enzyme system. Under conditions that allow separation of the E. coli carboxylase 
into four components, the mycobacterial enzymes remained an intact entity. This
* It seems likely that this enzyme is the same as the acyl-CoA carboxylase studied by Erfle (1973). 
From information now available it is clear that ATCC 356 is in fact a strain o f M. smegmatis and not 
of M. phlei. This culture had earlier been mislabelled (Hendren, 1974).
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constitutes a point of comparative interest in that these enzymes seem to be 
structurally related to the carboxylase multienzyme complexes of yeast and animal 
tissues rather than to the nonaggregated E. coli system.
The structure proposed for both M. smegmatis and M. tuberculosis acyl-CoA 
carboxylases is that of a multimeric enzyme composed of two dissimilar subunits, 
the larger of which carries a covalently bound biotin prosthetic group (Henrikson 
and Allen, 1979; Haase e ta l ,  1982; Rainwater and Kolattukudy, 1982). Information 
on the arrangement and function of the subunits was obtained by dissociation of the 
enzyme and isolation of the two types of subunits (Haase et a l,  1982). The larger of 
the M. smegmatis subunits, when isolated, retained the ability to carboxylate its 
biotin prosthetic group in the presence of ATP, Mg '^*’ and HCO3 ', but was unable to 
transfer the carboxyl group onto the appropriate substrate. Reassociation of the two 
subunits was necessary for overall carboxylase activity. This supports the 
hypothesis that the carboxyltransferase activity resides in the nonbiotinylated 
subunit. The genes from M. leprae and M. tuberculosis encoding a biotinylated 
protein have been cloned and sequenced. Analysis of the derived protein sequences 
demonstrated the presence of biotin-binding sites and putative ATP-bicarbonate 
interaction sites, consistent with proteins that comprise both biotin carboxylase and 
biotin carrier functions (Norman et a l,  1994).
The most notable property of mycobacterial acyl-CoA carboxylase is that it 
catalyses the carboxylation of both acetyl-CoA to malonyl-CoA and propionyl-CoA 
to methylmalonyl-CoA (Henrikson and Allen, 1979; Haase et a l,  1982; Rainwater 
and Kolattukudy, 1982; Ratledge, 1982). Because no other acyl-CoA carboxylase 
was observed during the purification procedures, the present carboxylase might 
provide malonyl-CoA for the synthesis of n-fatty acids as well as methylmalonyl- 
CoA for the synthesis of methyl branched mycocerosic acids. If the evidence for a 
single enzyme catalysing both carboxylation reactions is correct, a control 
mechanism should exist to direct the formation of malonyl-CoA and 
methylmalonyl-CoA as required for optimum growth of the cell. Further evidence to 
support this hypothesis comes from the effects of sulfate and palmitoyl-CoA upon 
both reactions. Inorganic sulfate was shown to raise the activity for acetyl-CoA 
carboxylation substantially and of propionyl-CoA carboxylation only slightly, 
indicating that the relative specificity of the enzyme for the two substrates can be
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modulated (Erfle, 1973; Block, 1977). In M. smegmatis, this change in substrate 
specificity was accompanied by conformational changes in the biotin-free 
(transcarboxylase) subunits (Hasse et a l,  1982). Furthermore, both activities are 
also modulated by palmitoyl-CoA. Acetyl-CoA carboxylation is more sensitive to 
palmitoyl-CoA than the carboxylation of propionyl-CoA, a response which may be 
related to end-product inhibition of straight-chain fatty acid synthesis (Block, 1977; 
Volpe and Vagelos, 1976). The differential effects of sulfate and palmitoyl-CoA on 
carboxylation rates of acetyl- and propionyl-CoA suggest that the enzyme can be 
manipulated to accelerate one pathway in preference to the other. On the other hand, 
the physiological significance of sulfate as a metabolic regulator is questionable and 
the palmitoyl-CoA effects occur only at concentrations that may be outside the 
physiological range (Bloch, 1977).
Based on the fact that carboxylase activity purified as a single enzyme, the concept 
that mycobacteria contained only one acyl-CoA carboxylase system was sustained 
for about 25 years. However, the genome sequence of M. tuberculosis published in 
June 1998 shows that there are three potential complete carboxylase systems, each 
consisting of an a - and |3-subunit, as well as three (3-subunits without an a - 
counterpart. Two of these carboxylase systems (accAl, accDl and accA2, accD2) 
are probably involved in degradation of fatty acids, as they are adjacent to genes for 
other known degradative enzymes. They may convert propionyl-CoA to succinyl- 
CoA, which can then be incorporated into the tricarboxylic acid cycle (Cole et a l,
1998). This is supported by the early work of Stejmholm et a l  (1962) who reported 
the formation of methylmalonyl-CoA and succinyl-CoA in extracts of M. 
smegmatis. Methylmalonyl-CoA, which is produced by carboxylation of propionyl- 
CoA, is the precursor of methyl-branched fatty acids such as phthienoic and 
mycocerosic acids. Since M. smegmatis does not contain these lipids it appears that 
propionate is metabolised via methylmalonyl-CoA to succinate. This reaction is 
catalysed by methylmalonyl-CoA mutase, an enzyme reported to be present in this 
strain (Stejmholm et a l  1962). The carboxylases with a presumed synthetic role 
(flccA3, flccD3, accDA, accD5 accD6) are more difficult to understand. The three 
extra p-subunits might direct carboxylation to the appropriate precursor or may 
simply increase the total amount of carboxylated precursor available if this step 
were rate-limiting (Cole et a l,  1998).
33
Chapter 1
To finalise this section, it is important to mention that research carried out over the 
last 30 years has produced only a limited number of papers on mycobacterial acyl- 
CoA carboxylases. Still, each group of researchers employed different designations 
for the enzyme subunits and respective genes. In order to improve the understanding 
of the terms used in subsequent chapters of this thesis. Table 1.1 attempts to 
reconcile and clarify the various nomenclatures used so far in the literature. The 
designations for the E. coli genes are also included because they influenced some of 
the terms adopted for mycobacteria.
1.4.5. Regulation of Acyl-CoA Carboxylases
Acetyl-CoA carboxylase catalyses the initial and key step in the fatty acid 
biosynthetic pathway. For this reason, the carboxylase-catalysed reaction affords the 
earliest point at which control of lipogenesis can be exerted (Numa and Tanabe,
1984). In animals (Goodridge, 1985), plants (Ohlrogge and Jaworski, 1997) and in 
yeast (Wakil et a l ,  1983) there is evidence that the carboxylation of acetyl-CoA is 
effectively the rate-determining reaction and a major regulatory point in fatty acid 
production.
In animal tissues, long-term regulation of the enzyme is accomplished by control of 
its synthesis at the level of gene expression and by changes in the rate of protein 
degradation (Bai et a l ,  1986). Short-term regulation is achieved by modulating the 
enzyme activity allosterically by citrate or covalently by 
phosphorylation/dephosphorylation via kinases and phosphatases, although these 
concepts are subjected to ample controversy (Kim, 1983).
Citrate is known to be an essential activator of animal acetyl-CoA carboxylase 
(Thampy and Wakil, 1985; Thampy and Wakil, 1988a) and, because citrate is a 
precursor of acetyl-CoA, it is also regarded as a feed-forward activator (Lowenstein, 
1968). This regulation is mediated through conformational changes involving a shift 
from the inactive protomeric form of the enzyme to an active high molecular weight 
polymeric form. Acetyl-CoA carboxylase is also regulated by a covalent 
modification mechanism involving interconversion between the phosphorylated
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Table 1.1. Nomenclature of mycobacterial acyl-CoA carboxylases
Reference Microorganism Subunit designation Gene designation
Henrikson and 
A llen, 1979
H asse etal., 1982
M. smegmatis
A subunit -  biotin free 
(57 KDa)
B subunit -  biotin containing 
(64 KDa)
Rainwater and 
Kolattukudy, 1982
M. tuberculosis 
M. bovis BCG
a subunit -  biotin containing 
(63 KDa)
(3 subunit -  biotin free (60  
and/or 57 KDa)^
Norman e ta l ,  1995
M. tuberculosis 
M. leprae
BCCP -  biotin containing  
(70.6 KDa predicted size)
BCCP -  biotin containing  
(64.0  K Da predicted size)
flccBC (corresponds to 
accA l)
C ole etal., 1998 M. tuberculosis
a subunit -  biotin containing  
(70.6; 70.7; 63.8 KDa  
predicted sizes)
(3 subunit -  biotin free (56.7; 
56.2; 51.7; 56.2; 59.4; 50.1 
KDa predicted sizes
$
accAl; accA2‘, accA3 
accDl', accD2\ accT>3
$
accDA, accDS’, accD6
R ock and Cronan, 
1996
E. coli BCCP and BC  
CT -  two subunits
accBC  operon  
accA  and accD
Abbreviations: B C C P  -  B iotin  C arboxylase Carrier Protein; B C  -  B io tin  C arboxylase; C T  
-  C arboxyl Transferase
$
accAX R v2501c accDl R v2502c accDA R v3799c
accA l R v0973c accD l R v0974c accDS R v3280
accA3 R v3285 accD3 R v0904c accD6 R v2247
 ^ In the hands o f these workers, the enzyme preparation from M. tuberculosis and M. bovis BCG  
showed three major bands on SDS-PAGE gels. The a-subunit with a molecular weight o f 63 KDa 
and two other non-biotinylated subunits of 60 and 57 KDa.
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(inactive) and the dephosphorylated (active) form (Kim, 1983; Thampy and Wakil, 
1988b). Acetyl-CoA carboxylase may be present in vivo in polymeric form, the 
degree of polymerisation being dependent on the state of phosphorylation. In the 
phosphorylated form, the enzyme is inactive and exists mainly as an octomer, 
whereas in the dephosphorylated form, the carboxylase is active and highly 
aggregated.
The control of acetyl-CoA carboxylase activity by allosteric effectors reflects the 
physiological role that the products of the pathway play in various organisms. For 
instance, in animal tissues, the majority of fatty acids produced are stored in the 
form of glycerides as a reserve source of energy, and just a minor part is used as 
structural components of membranes in the form of phospholipids, glycerols, and 
cholesterol esters. Biosynthetic processes leading to the storage of energy are 
frequently regulated by feed-forward activation (Lane et a l,  1979). Contrary to 
animal systems, in prokaryotes fatty acids are primarily incorporated into 
phospholipids, which in turn are used as structural components of membranes. 
Consequently, regulation of fatty acid synthesis in bacteria and yeast will have to be 
coordinated with the rate of synthesis of cell membrane components and the rate of 
cell proliferation (Cronan and Vagelos, 1972).
Feedback mechanisms allow a fine-control of biosynthetic pathways. Whenever the 
end product of a biochemical reaction builds up in the cell to excess levels, it 
inhibits the activity, in most cases, of a regulatory enzyme providing an almost 
instantaneous control of the flux of metabolites through the pathway. It has long 
been considered that, in animals (Nikawa et a l,  1979) and yeast (Kamiryo et a l, 
1976), fatty acid synthesis is partly controlled by feedback inhibition of acetyl-CoA 
carboxylase by long-chain acyl-CoAs. However, intracellularly, the concentration of 
free unbound acyl-CoA esters is tightly controlled by feedback inhibition of the 
acyl-CoA synthetase and is also buffered by specific acyl-CoA binding proteins 
(Faergeman and Knudsen, 1997). This observation emphasises the difficulty in 
extrapolating in vitro enzyme studies to in vivo conditions. Correct experiments on 
the effects of acyl-CoA on cellular functions and enzymes should be carried out at 
physiological concentrations in the presence of the appropriate acyl-CoA-buffering 
binding proteins before conclusions are drawn.
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Long term regulation of acetyl-CoA carboxylase in vivo and in various in vitro 
culture systems is accomplished by changes in mRNA metabolism. In mammalian 
tissues, five different forms of acetyl-CoA carboxylase mRNA were identified (Luo 
et a l ,  1989). The occurrence of this variety of mRNAs is the result of the 
functioning of two independent promoters and differential splicing of the primary 
transcripts (Kim et a l,  1996). The physiological significance of the different 
molecules of mRNA, with all forms containing the same coding sequence is not 
known. However, the generation of multiple mRNAs may provide an additional 
way of regulating acetyl-CoA carboxylase both at the transcriptional and 
translational level (Lopez-Casillas and Kim, 1991).
Although the best evidence available so far implicates acetyl-CoA carboxylase 
activity as a primary determinant of the rate of lipid synthesis, the concept of a 
single rate-limiting reaction is an over-simplification. For instance, in 
Saccharomyces, common DNA sequences have been identified in the promoters of 
many genes involved in lipid metabolism (Chirala, 1992; Schuller et a l ,  1992), 
indicating that the enzymes of fatty acid synthesis are coordinately regulated. 
Control over flux is frequently shared by more than one enzyme in a pathway, and 
furthermore, the relative contribution of different enzymes to control is variable.
1.5. This Thesis
The overall aim of this investigation was to elucidate the mechanisms and control of 
lipid synthesis in mycobacteria in relation to cellular physiology and pathogenicity, 
and specifically the role of acyl-CoA carboxylases in these processes. This thesis 
focuses on different approaches of interfering with the biotinylated subunit of acyl- 
CoA carboxylase with the purpose of producing and studying mutants defective in 
the enzyme concerned.
Chapter 3 concentrates on strategies for the depletion of biotin aimed at reducing the 
activity of acyl-CoA carboxylase. Chapter 4 describes the production of an inactive 
hybrid enzyme composed by a mutated AccAl subunit. In Chapter 5, the main 
theme is the application of an anti-sense methodology designed to interfere with the 
expression of the biotinylated subunit of acyl-CoA carboxylase. A brief study of the 
expression of the enzyme through the application of proteomics is also included in
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this chapter. The repercussions of the strategies described above on the physiology 
of the mycobacterial cell were assessed using M. smegmatis and M. bovis BCG. 
Finally, Chapter 6  integrates data presented in Chapters 3 to 5, focuses on 
unresolved questions and discusses the current state of the art on M. tuberculosis 
carboxylase systems.
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MATERIALS AND METHODS
Chapter 2
2.1. Materials
Reagents and kits used in this study are listed below under the various suppliers.
Advanced Biotechnologies Ltd., UK 
Red hot thermostable DNA polymerase.
Amersham International pic., UK
Hybond™ -N  Nylon membranes; Hybond™ -C  Super nitrocellulose membranes; 
Rainbow™ coloured protein molecular weight markers (high molecular weight 
14.300-220.000); streptavidin-peroxidase conjugate; sodium [^"^Cjbicarbonate, pack 
size ImCi (code CFA.3).
Applied Biosystems
Reagents and other components for the synthesis of oligonucleotides.
Bio-Rad Laboratories Ltd., UK
Protein Assay Kits (cat n°500-0002)
Boehringer Mannhein Ltd., UK
Taq DNA polymerase; Ultrapure PCR nucleotide mix; Calf intestine alkaline 
phosphatase (CIP); Restriction enzymes and buffers; Ultrapure agarose; BM 
Chemiluminescence Blotting Substrate POD for detection of proteins (Western 
blotting) and nucleic acids.
Clontech Laboratories Inc., USA 
Advantage™ PCR-Pure Kit (cat n° 1111-1/2).
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Difco
Bacto Middlebrook 7H9 (dehydrated); Bacto Middlebrook 7H11 agar (dehydrated); 
Middlebrook OADC enrichment.
Genosys
Custom made oligonucleotides.
Gibco-BRL
T4 DNA ligase.
National Diagnostics
Protogel™ (30% acrylamide and 0.8% bisacrylamide stock solution [37:5:1]).
New England Biolabs 
Restriction enzymes and buffers.
New-Brunswick Scientific Biologicals 
Unisolve E -  scintillation fluid.
Oxoid
Bacteriological agar n°l; Nutrient broth n°2; Tryptone; Yeast extract; general 
ingredients for media preparation.
Sigma
All chemicals unless otherwise stated; biotinylated molecular weight markers for 
SDS-PAGE gels.
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Ultra-Violet Products Ltd.
Gel Documentation System (GDS).
Whatman Laboratories Ltd. 
Whatman 3MM filter paper.
2.2. Bacterial Strains Used
Strains Remarks Source/Reference
E. coll DH5a A recombination deficient 
suppressing strain used for plating 
and growth of plasmids and 
cosmids
Sambrpok et at., 1989
E. colt JMllO A strain that will not modify sites 
blocked by dam méthylation and 
will support growth of vectors 
carrying amber mutations
Sambrook et a l, 1989
M. smegmatis mc^l55 Efficient plasmid transformation 
mutant of mc^
Snapper gr a/., 1988
BCG Pasteur Vaccine strain Laboratory’s collection
2.3. Recipes and Protocols
2.3.1. Culture media
Luria-Bertani Broth: 10 g/1 Bacto tryptone, 5g/l yeast extract, 10 g/1 NaCl, pH 7. 
Luria-Bertani Agar: As LB broth with bacteriological agar 1.5% (w/v).
SOC: 20 g/1 Bacto tryptone, 5 g/1 yeast extract, 0.5 g/1 NaCl, KCl 2.5 mM, MgS0 4  
20 mM, glucose 20 mM, pH 7. Sterile MgCL was added to 10 mM prior to use.
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Nutrient Broth «*2: 25 g of dehydrated NB n°2, 0.2% (v/v) glycerol, 0.05% (v/v) 
Tween 80.
Nutrient Agar n'"2i As NB n°2 without Tween 80 and with bacteriological agar 
1.5% (w/v).
Sautons Broth: 0.5 g/1 KH2PO4 , 0.5 g/1 MgS0 4 7 H2 0 , 2g/l citric acid, 4g/l L- 
Asparagine, 0.05 g/1 Ferric amonium citrate, 28 g/1 glycerol and 0.2 g/1 Tween 80, 
pH 7.4.
Sautons Agar: As Sautons broth without Tween 80 and with bacteriological agar 
1.5% (w/v).
Middlebrook 7H9: 4.7 g of dehydrated 7H9 formula in 900 ml of distilled water 
containing 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80. OADC (Oleic acid. 
Albumin, Dextrose, Catalase) enrichment was added to 10% (v/v) after autoclaving.
Middlebrook 7H11: 21 g of dehydrated 7H11 formula in 900 ml distilled water 
containing 0.2% (v/v) ml glycerol, dissolved by heating and autoclaved. OADC 
enrichment was added to 10% (v/v) to melted media cooled to 55°C.
All culture media were prepared using distilled water and autoclaved at 121 °C for 
15 minutes. The appropriate concentrations of antibiotics were added whenever 
applicable. Usually, 100 |Xg/ml of ampicillin or 50 |ig/ml of kanamycin were used to 
culture E. colt transformants and 15 |Xg/ml of Kanamycin for mycobacterial 
transformants. Antibiotics were filter sterilised and stored at 4°C.
2.3.2. General buffers and stock solutions
Phosphate Buffered Saline (PBS): 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HP0 4 , 
1.4 mM KH2PO4 , pH 7.3.
Tris-EDTA (TE) p H  7.5: 10 mM tris-HCl pH 7.5, 1 mM EDTA pH 8.0.
Tris-EDTA (TE )p H  8: 10 mM tris-HCl pH 8 , 1 mM EDTA pH 8.0.
Im M  Hepes p H  8
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2.3.3. Polymerase Chain Reaction
PCR amplification was performed using the Hybaid OmniGene or Perkin Elmer 
GeneAmp thermal cyclers. A standard reaction contained 0.25 mM each dNTP 
(dATP, dGTP, dCTP, dTTP), 100 pmol each oligonucleotide primer, 1 ng DNA 
template, lU  Taq DNA polymerase and 12% (v/v) glycerol in Ix PCR buffer. 
Typical PCR reaction conditions consisted of an initial dénaturation step at 96°C for 
10 minutes, followed by 30 cycles of amplification with dénaturation at 96°C for 1 
minute, primer annealing at 58°C for 2 minutes and extension at 72°C for 1 minute. 
The final cycle was extension at 72°C for 10 minutes. Detailed PCR procedures are 
explained whenever appropriate in chapters 4 and 5.
2.3.4. Synthesis of oligonucleotide primers, primer deprotection and 
precipitation
Primer sets were synthesised on an Applied Biosystems 381A synthesiser 
(performed by Sue Wall or Tina G’Shaughnessy, Microbiology Genetics Group). 
All reagents and instructions for synthesis were obtained from Applied 
Biosynthesis. Deprotection and removal of oligonucleotides from the synthesis 
column was achieved by passing 1.5 ml of cold 35% (v/v) ammonia solution 
through the column at a rate of 0.2 ml/20 minutes. The eluate was incubated at 55°C 
for 18-24 hours. Aliquots of 250 pi were dispensed in microcentrifuge tubes and 
DNA was precipitated with 0.1 volume of 3M sodium acetate (pH 5.2) and 3 
volumes of cold 100% (v/v) ethanol, overnight at -20°C. Oligonucleotides were 
recovered by centrifugation at 10,000 g for 30 minutes at 4°C. The supernatant was 
discarded and the pellet washed in 70% (v/v) ethanol, dried in an oven and 
resuspended in 50 pi of water. The concentration of the oligonucleotides was 
estimated by spectrophotometry and 100 pmol/ml aliquots were stored at -20°C.
Alternatively, synthetic oliginucleotides were purchased from Genosys 
Biotechnologies.
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2.3.5. Small scale preparation of plasmid DNA
Solution I  - Resuspension buffer 50 mM glucose, 25 mM tris-HCl pH 8 , 10 
mM EDTA pH 8
Solution II  -  Bacterial Lysis Solution 0.2 M NaOH, 1% (w/v) SDS; prepare fresh
Solution III -  Neutralising solution 60% (v/v) 5M potassium acetate, 11.5% (v/v) 
glacial acetic acid, pH 4.8
Solution IV 50 mM Tris, 100 mM sodium acetate, pH 8
Plasmid DNA was routinely extracted from E. coli by alkaline lysis. A 3 ml 
overnight culture (16-18 hours) was centrifuged at 1 0 , 0 0 0  g for 1 minute and the 
supernatant discarded. The remaining pellet was resuspended in 100 pi of solution I 
followed by addition of 200 pi of freshly prepared solution II. The contents were 
mixed by inversion and placed on ice for 5 minutes. Subsequent addition of 150 pi 
of solution ni was followed by vortexing and incubation on ice for 5 minutes. The 
mixture was centrifuged at 10,000 g for 5 minutes to remove precipitate. The 
supernatant containing crude plasmid DNA was transferred into a microcentrifuge 
tube and 1 ml of cold (-20°C) absolute ethanol was added. This was gently mixed, 
incubated on ice for 3 minutes and centrifuged for 5 minutes. The supernatant was 
carefully discarded, the DNA pellet resuspended in 100 pi of solution IV containing 
100 pg/ml RNAse and incubated at 37°C for 20 minutes. Plasmid DNA was 
purified by phenol:chloroform extraction and precipitated by addition of 250 pi of 
absolute ethanol. The solution was mixed, incubated on ice for 5 minutes and the 
DNA precipitate was then collected by centrifugation at 10,000 g for 5 minutes. The 
pellet was washed with 1 ml 70% (v/v) ethanol, centrifuged at 10,000 g for 2 
minutes and dried in an oven prior to resuspension in 25-50 pi of TE buffer or 
water.
2.3.6. Phenol/Chloroform extraction of DNA
Phenol:Chloroform and DNA solution were mixed in equal volumes. The aqueous 
and organic phases were separated by centrifugation at 10,000 g for 1 minute. The
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Upper aqueous layer containing the DNA was transferred to a new tube and mixed 
with an equal volume of chloroform. After another centrifugation step, the upper 
phase was retained.
2.3.7. DNA precipitation
To a given volume of DNA solution, 0.1 volume 3M Na Acetate and 2.5 volumes 
100% ethanol were added. Samples were placed at -20°C for 18 to 24 hours and 
centrifuged at 10,000 g for 30 minutes at 4°C. The supernatant was discarded and 
the DNA pellet was washed with 1 ml of 70% (v/v) ethanol. The resulting pellet 
was air dried and resuspended in an appropriate volume of TE or water.
2.3.8. Quantitation of nucleic acids in aqueous solution
The concentration and purity of nucleic acids in aqueous solutions were determined 
by spectrophotometry at the wavelengths of 260 and 280 nm. A pure solution of 
DNA has a peak absorbance at 260 nm and a 260:280 nm ratio of 1.8 (Sambrook et 
a l,  1989). The concentration of nucleic acid was calculated according to the relation 
A26o=1 is equivalent to 50 pg/ml of double stranded DNA or 33 pg/ml of 
oligonucleotide.
Whenever accuracy was not required, a visual comparative intensity method was 
used. The DNA sample was electrophoresed on an agarose gel containing ethidium 
bromide adjacent to a known amount of a DNA molecular size marker. The quantity 
of DNA in the sample was estimated by comparison of the intensity of fluorescence 
of the DNA band of interest with that of an appropriate marker band of a similar 
size.
2.3.9. Agarose gel electrophoresis
50x TAE 270 mM Tris, 7.0 mM EDTA, 1.15% (v/v) glacial acetic acid
6x Loading buffer 40.0% (w/v) sucrose in water, 0.25% (w/v) bromophenol blue
Gels of appropriated concentration (w/v) were prepared in Ix TAE and subjected to 
electrophoresis at 5-10 V/cm in a horizontal submarine gel tank with samples
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loaded in Ix loading buffer. Gels were then stained in an ethidium bromide bath 
(0.5 pg/ml in IxTAE). DNA was observed using an ultra-violet transilluminator and 
photographed on a gel documentation system (UVP Imagestore).
2.3.10. DNA extraction from gels and purification of DNA from solution
Specific DNA fragments were excised from agarose gels under UV 
transillumination and purified using the Advantage™ PCR-Pure BIND Kit 
according to the manufacturer’s instructions. The gel slice was weighed to estimate 
the volume (Ig = 1ml). For TAE-buffered gels, SALT™ solution was added to 3x 
the volume of the gel slice followed by incubation at 55°C for 5-10 minutes. 
Occasionally, the tube was inverted or gently flicked to mix the contents and 
promote melting. Incubation was prolonged until the agarose was completely 
liquefied. A minimum of 5 pi PCR-Pure BIND™ was added to the suspension 
which was incubated for 5 minutes at room temperature with occasion flicking of 
the tube. The suspension was then centrifuged at 10,000 g for 5 seconds and the 
supernatant discarded. The pellet was washed once with 1 ml of WASH™ solution 
and centrifuged at 10,000 g for 5 seconds followed by complete removal of the 
WASH™ solution. The pellet was dried at 37°C and resuspended in water or TE 
buffer equivalent to 2x the volume of BIND™ added previously. After incubating at 
room temperature for at least 5 minutes to elute the DNA, the suspension was 
centrifuged at 10,000 g for 1 minute. The supernatant was transferred to a new tube, 
centrifuged again to remove any residual BIND™, and the yield of purified PCR 
product assessed by agarose gel electrophoresis.
Purification of DNA from solution was performed in a similar manner. The DNA 
concentration was estimated and three volumes of SALT™ were added to the DNA 
solution and mixed well. Subsequent steps were as described above.
2.3.11. Restriction endonuclease digestion of DNA
Digestion of DNA was performed using the required restriction enzymes in the 
appropriate Ix restriction buffer followed by incubation at the optimum temperature 
recommended. The total reaction volume was altered according to the amount of 
DNA to be cut. The digestion products were then analysed by agarose gel 
electrophoresis.
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2.3.12. Déphosphorylation of DNA
DNA was dephosphorylated using 1 U of calf intestinal alkaline phosphatase (CIP) 
in the supplied buffer diluted to Ix, with subsequent incubation at 37°C for 1 hour. 
Another 1 unit of CIP was added and a second incubation took place at 55°C for one 
more hour. The reaction was terminated by inactivation of the enzyme at 75°C for 
1 0  minutes.
2.3.13. Ligation of DNA fragments
DNA fragments were ligated in a 3:1 molar ratio of insert DNA to vector using T4 
DNA ligase in the supplied Ix buffer. The reaction was incubated at 11°C for 18-24 
hours.
2.3.14. Transformation of E. coli DH5a
One pi of ligation products was added directly to 20 pi of E. coli D H 5a competent 
cells. As positive control, 1 ng of plasmid DNA was used. After gentle mixing, the 
cells were incubated on ice for 30 minutes, heat-shocked for 45 seconds in a 42°C 
water bath, and placed on ice for 2 minutes. Recovery of cells was achieved by 
addition of 80 pi SOC and incubation at 37°C for 60 minutes prior to selection of 
transformants on LB agar supplemented with the appropriate antibiotics.
Preparation ofE. coli DH5a competent cells
Prepared according to the laboratory protocol by Sue Wall or Tina O’Shaughnesy, 
Microbiology Genetics Group.
2.3.15. Transformation of E. coli JM llO
E. coli JM llO  competent cells were transformed by electroporation. 20 to 40 pi of 
cells were mixed with 1 ng of DNA and kept on ice for 1 minute. The mixture was 
transferred to a cold 0 . 2  cm electroporation cuvette which was placed in a chilled 
safety chamber slide. Cells were pulsed at 200 Q, 25 pF and 2.5 Kv. 1 ml of SOC 
was immediately added and resuspended cells were allowed to recover at 37°C for 1 
hour before plating on selective medium.
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Preparation of E. coli JMllO competent cells
E. coli JM l 10 cells were grown in 1 litre of LB broth at 37°C with vigorous shaking 
to an ODôoo of 0.5 to 1.0. In the following steps, cold containers and solutions were 
used. To harvest, the flask was chilled on ice for 30 minutes, after which the culture 
was centrifuged at 3.000 rpm for 15 minutes at 4°C. The supernatant was removed, 
the pellet resuspended in 1 litre of cold sterile water and centrifuged again. This 
procedure was repeated twice, firstly with 0.5 litre of 1 mM Hepes and secondly 
with 20 ml of 10% (v/v) glycerol. Finally, the cells were resuspended in 2 ml of 
cold 10% glycerol. Aliquots were distributed into prechilled cryotubes and 
immediately stored in liquid nitrogen.
2.3.16. Transformation of mycobacteria
The required amount of competent mycobacterial cells was allowed to thaw on ice. 
Prior to use, the cells were washed in 10% (v/v) glycerol at 4°C and resuspended in 
the same volume of ice cold 10% glycerol. For each transformation, 100 pi aliquots 
of competent cells were electroporated with 50-100 ng of DNA in 0.2 cm 
electroporation cuvettes, using the BioRad GenePulser set at 2.5 kV, capacitance 25 
pFD and resistance 600 il. M. smegmatis mc^l55 cells were recovered in 900 pi of 
Nutrient Broth n°2 at 37°C for 2 hours before plating on Nutrient Agar containing 
15 pg/ml of kanamycin. Colonies of antibiotic resistant transformants were visible 
after 3 to 4 days of incubation at 37°C. For recovery of M. bovis BCG, Middlebrook 
7H9 medium supplemented with OADC was used and cells were incubated 
overnight in a shaker incubator. Transformants were selected on Middlebrook 7H11 
containing 15 pg/ml of kanamycin. Colonies were obtained after 3 to 4 weeks of 
incubation at 37°C. Positive colonies were then isolated and screened for possession 
and integrity of the plasmid.
Preparation of mycobacterial competent cells
M. smegmatis mc^l55 cells were grown in 50 ml of Nutrient Broth n°2 at 37°C in a 
shaker incubator set to 240 rpm for 24 to 36 hours. M. bovis BCG Pasteur was 
grown for 5 days in tissue culture flasks containing 100 ml of Middlebrook 7H9 
supplemented with OADC at 37°C stationary. On the fourth day, isoniazid was 
added to 0.05 pg/ml and the culture re-incubated for a further 18 hours. Cultures
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were chilled on ice for 30 minutes and harvested by centrifugation at 3,000 rpm for 
10 minutes at 4°C. The pellet was resuspended and washed in 25 ml of ice cold 1 
mM Hepes pH 7.4, centrifuged and washed once more in 25 ml of cold 10% (v/v) 
glycerol. Finally, the pellet was resuspended in 2 ml of 10% glycerol and aliquots 
stored at -70°C (Snapper et a l,  1990).
A recent alternative protocol was also used. The primary difference between the two 
protocols is the temperature at which competent cells are prepared and 
electroporated. Briefly, cells were harvested by centrifugation, washed twice at 
room temperature (19 - 23°C) with 10% glycerol and resuspended in 1 ml of 10% 
glycerol. 0.2 ml of resuspended cells were mixed with 50-100 ng of DNA and 
placed in a 0.2 cm cuvette (Wards and Collins, 1996). Electroporation, recovery and 
selection of transformants was done as described above.
2.3.17. Chromosomal DNA extraction from mycobacteria
Before harvesting mycobacterial cells, cycloserine to 1 mg/ml was added for 5 
hours to M. smegmatis mc^l55 and for 18 hours to M. bovis BCG. The cultures 
were then centrifuged at 10,000 g for 10 minutes and the supernatant discarded. The 
remaining pellet was resuspended in 400 pi of 0.3 M sucrose in TE. Freshly 
prepared lysozyme was added to a concentration of 2 mg/ml and incubated at 37°C 
for 1 hour. EDTA, SDS and pronase were then added to 50 mM, 1% (v/v) and 0.2 
mg/ml respectively, and the mixture incubated at 55°C for 1 hour. This was 
followed by phenol:chloroform extraction and ethanol precipitation. The pellet was 
resuspended in 400 pi of TE and treated with RNAse A (final concentration 100 
pg/ml) for 30 minutes at 37°C. Chromosomal DNA in solution was again purified 
by phenol : chloroform extraction and ethanol precipitated. The DNA pellet was 
resuspended in water or TE.
2.3.18. Southern blotting
Gel electrophoresis and Southern transfer
Dénaturation solution 0.5M NaOH, 2.5M NaCl
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Neutralising solution 0.5M Tris-HCl, 2.5M NaCl, pH 7.5
20xSSC 3M NaCl, 0.3 M sodium citrate, pH 7
1 pg of genomic DNA was incubated with 20 units of restriction enzyme for at least
2  hours, after which samples were run on agarose gel of appropriate concentration. 
The DNA was denatured by soaking the gel for 30 minutes to 1 hour in denaturing 
buffer with constant agitation. The gel was then rinsed briefly in distilled water and 
neutralised by soaking in neutralising solution for 30 minutes to 1 hour. After this, 
the gel was placed inverted on a 20x SSC-saturated Whatman 3MM filter paper 
supported by a glass plate with both ends of the paper dipped into a bath of 2 0 x 
SSC. A piece of positively charged nylon membrane was placed on top of the gel 
and overlaid with two sheets of filter paper and tissue paper approximately 1 0  cm 
thick. A weight of about 500 g was placed on the top of the whole structure and left 
overnight to allow full transfer of DNA. The following day, the membrane was 
rinsed in 2x SSC, and backed at 80°C for 2 hours to permanently immobilise the 
DNA.
Prehybridisation and hybridisation
lOx Blocking reagent 1 0 % (w/v) blocking reagent in buffer 1 dissolved by 
heating and autoclaved. Stored at 4°C.
Prehybridisation buffer 5x SSC, 0.1% (w/v) N-lauroylsarcosine, 0.02% (w/v) 
SDS, 1.0% (v/v) blocking reagent
Hybridisation buffer As prehybridisation buffer with 5-25 ng/ml of 
Digoxygenin-labelled DNA
2x Wash solution 
O.lx Wash solution
2x SSC, 0.1% (v/v) SDS 
O.lx SSC, 0.1% (v/v) SDS
Prehybridisation and hybridisation were carried out in a Hybaid™ oven. 
Membranes, sandwiched between two pieces of nylon filter mesh, were initially
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incubated in prehybridisation buffer at 6 8 °C for up to 4 hours. Incubation in 
hybridisation buffer containing denatured digoxigenin-labelled probe took place 
overnight at the same temperature. Membranes were then treated twice with 2x 
wash solution at room temperature for 5 minutes and twice with O.lx wash solution 
at 6 8 °C for 15 minutes.
Chemiluminescent detection
Buffer 1 100 mM maleic acid, 150 mM NaCl, pH 7.5
Washing buffer 0.3% (v/v) Tween 20 in buffer 1
Buffer 2 1 .0 % (v/v) blocking reagent in buffer 1
Anti-DIG-alkaline 
phosphatase conjugate
1:10000 (75 mU/ml) in buffer 2
Buffers 100 mM Tris-HCl, 100 mM NaCl, 50 mM MgCli, pH 9.5.
CSPD 1.0% (v/v) in buffer 3
Detection of DIG-labelled nucleotides hybridised to membrane-bound DNA was 
achieved with a chemiluminescent reaction according to manufacture’s protocols 
(Boehringer Mannheim). Membranes were initially equilibrated in buffer 1 and then 
incubated for 60 minutes in buffer 2  to prevent non-specific binding of antibody. 
Subsequently, the membranes were incubated with anti-DIG-alkaline phosphatase 
for 60 minutes. Unbound antibody-conjugate was removed by washing twice for 15 
minutes in washing buffer. Finally, the membrane was equilibrated in buffer 3, 
incubated with CSPD and exposed to X-ray film for variable lengths of time 
depending on the strength of the signal.
2.3.19. Digoxygenin labelling of DNA
DNA was labelled by incorporation of digoxygenin-11-dUTP using random primed 
method according to manufacturer’s instructions (Boehringer Mannheim). The 
DNA template was generated by PCR, boiled for 10 minutes and rapidly cooled on 
ice in order to produce single stranded DNA. Klenow enzyme, D IG -ll-dU TP,
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dNTPs and random hexanucleotides were added, in the recommended 
concentrations, for the synthesis of the complementary strand. The mixture was 
incubated overnight at 37°C to increase the amount of labelled DNA and the 
reaction was stopped by adding EDTA pH 8.0. The labelled DNA was ethanol 
precipitated with 4M LiCl in the presence of glycogen. The DNA was recovered by 
centrifugation at 10,000 g for 30 minutes at 4°C, washed with ethanol 70% (v/v), 
dried under vacuum and dissolved in TE. Concentration of the labelled DNA was 
estimated using Dig Quantification Teststrips. The probe was denatured before use.
2.3.20. SDS-PAGE and Western blotting 
Sample preparation
Mycobacterial cell free extracts were prepared either by sonication or shaking with 
glass beads as described in chapter 3 and chapter 4 respectively. Protein samples 
were diluted twofold in 2x loading buffer, boiled for 5 minutes and the required 
amount loaded onto polyacrylamide gels.
Denaturing (SDS) discontinuous polyacrylamide gel electrophoresis: 
Laemmli gel method^
2x Loading Buffer 75 mM Tris-HCl pH 6 .8 , 5% Mercaptoethanol, 
2% SDS, 10% glycerol, 0.1% bromophenol blue
4x Separating gel buffer, pH  8.8 1.5 M Tris-HCl pH 8 .8 , 0.4% (w/v) SDS
4x Stacking gel buffer, pH  6.8 0.5 M Tris-HCL pH 6 .8 , 0.4% (w/v) SDS
5x Running buffer pH  8.3 125 mM Tris base, 1.25 M glycine, 0.5% SDS 
pH 8.3
Coomassie Brilliant Blue Stain 0.15 g Brilliant Blue G, 25 ml methanol, 5 ml 
acetic acid, 70 ml water
Destaining Buffer 10% acetic acid, 30% methanol
 ^Laemmli (1970) Cleavage o f structural proteins during the assembly o f the head o f bacteriophage 
T4, Nature 227, 680-685.
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SDS-PAGE gels were cast using a Bio-Rad mini gel system (Mini-PROTEAN II 
dual slab cell). Polyacrylamide separating and stacking gels were prepared 
according to the recipes in Sambrook et al. (1989), volume 3, page 18.52. Usually, a 
concentration of 7.5% for the resolving gel which has an effective range of 
separation of 36-94 KDa and 5% for the stacking gel were used. The total amount of 
protein loaded in each well ranged from 25 jxg to 50 |ig and electrophoresis was 
carried out at 180 V until the tracking dye reached the lower edge of the gel. 
Whenever appropriate, gels were stained with Comassie Brillian Blue.
Transfer of proteins onto nitrocellulose membranes filters
Transfer buffer pH  8.3 39 mM glycine, 48 mM Tris base, 0.037% 
SDS, 20% Methanol
Ponceau S stain 2 g Ponceau S, 30 g trichloroacetic acid, 30 g 
sulfosalicylic, water to 1 0 0  ml
Membrane Blocking Solution 2% BSA in IxTSB
lOx Tris buffered saline (TBS) pH  7.6 2 mM Tris-HCl pH 7.6, 137 mM NaCl
TBS-Tween TBS plus 0.1% Tween-20
Following electrophoresis, the gel, nitrocellulose membrane and two sheets of Bio- 
Rad extra-thick filter paper were soaked in transfer buffer for 10 minutes. Transfer 
was carried out using a Semi-Dry™ blotter (Biorad). A “sandwich” of filter papers, 
nitrocellulose membrane and gel was assembled and transfer progressed at lOV for 
30 minutes. Blotted membranes were stained with Ponceau S which is a transient 
and washable dye used to detect total protein transfer.
Immunoblotting
The nitrocellulose membrane was incubated in blocking solution for 1 hour at room 
temperature with agitation, after which a suitable dilution of peroxidase-conjugated 
streptavidin in TBS-Tween was added. Incubation continued for a further hour. The 
membrane was washed 4 times in TBS-Tween for 10 minutes before being
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subjected to the chemiluminescent detection according to the manufacturer’s 
instructions. Premixed detection reagent was added and incubated for 60 seconds. 
Excess reagent was drained off and the blot was wrapped in Saran Wrap. X-ray film 
was exposed for 1 0  to 60 seconds.
2.3.21. Surface Enhanced Laser Desorption Ionization - SELDI
Total protein content of mycobacterial cell free extracts was estimated and samples 
were diluted to the same protein concentration in the appropriate sample dilution 
buffer (see chapter 5 for details).
For the selective binding of biotinylated proteins, a preactivated chip PS-1 was 
used. The spots were outlined using an hydrophobic pen and 2 pi of PBS was 
loaded to each spot. 1 pi of 1 mg/ml streptavidin was added to the spots where 
capture of the biotinylated proteins was going to take place, and 1 pi of 0 . 5  mg/ml 
BSA was added to negative control spots. The chip was incubated in a humid 
chamber at room temperature for 1 hour. To block the background, 1 pi of IM 
ethanolamine was added and the chip re-incubated in the humid chamber for 30 
minutes. The liquid was removed and the spots washed twice with 5 pi of PBS. 
Finally, the chip was washed in 10 ml of 0.1% Triton in PBS for 30 minutes 
(rolling), rinsed with PBS and assembled in a special rack that allowed a large 
volume of sample to be loaded.
Each extract was loaded to both a streptavidin (test) and BSA (negative control) 
coated spots. The chip was incubated in a humid chamber either at room 
temperature for 2 hours or at 4°C, overnight. Half way through incubation, the 
liquid was pipetted up and down. Once the incubation period finished, the contents 
of the wells were removed and the spots washed twice with sample dilution buffer, 
followed by washing with 5 pi of water. 0.5 pi of sinapinic acid matrix (saturated in 
phosphoramidite diluent plus TEA) was added to each spot and let to air dry. The 
chips were analysed using SELDI™ Protein Biology System.
2.3.22. Acetyl-CoA carboxylase assay
Mycobacterial cells were grown in liquid media, harvested and washed twice in 
PBS. Cells were disrupted either by sonication or shaking with glass beads as
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described in chapter 3 and chapter 4 respectively. Cell-free extracts were obtained 
after centrifugation at 40,000g in a Beckman centrifuge using rotor J21 and kept 
frozen for no more than one week until analysed. Total protein concentration was 
estimated and enzyme activity measured by incorporation of ^^0% into acetyl-CoA.
The enzyme assay was performed in a total volume of 100 pi containing 25 mM 
NaHCO] and 1,25 pCi N a H [^ t] 0 3 , 70 mM potassium phosphate pH 8 , 100 mM 
KCl, 15 mM MgCli, 3 mM ATP, Img bovine serum albumin/ml and 2 mM acetyl- 
CoA (Sigma cat n° A-2056). The reaction was started by adding 60 pi of bacterial 
extract. After an incubation of 30 minutes at 34°C, 100 pi 6  M HCl was added to 
stop the reaction. The content of the vials was taken to dryness at 100°C and the 
acid stable material transferred in 500 pi of water to scintillation vials containing 
Unisolve E. A Wallac 1410 scintillator was used for the determination of 
radioactivity. Controls without acyl-CoA or cell extract were also tested.
2.3.23. Determination of protein concentration
Total protein present in mycobacterial cell-free extracts was assessed using the Bio- 
Rad protein assay. The test is based on the differential colour change of a dye in 
response to various concentrations of protein. Beer’s law was applied for accurate 
quantitation of protein by selecting an appropriate ratio of dye volume to sample 
concentration that gave a linear extinction coefficient of the dye-protein complex 
solution over a wide range of concentrations.
A standard curve was prepared for each assay. For this purpose, serial dilutions of 
the protein standard containing 1 to 25 pg/ml were prepared. 0.8 ml of standards, 
appropriately diluted samples and sample buffer (“blank”) were placed in test tubes 
to which 0.2 ml of Dye Reagent Concentrate was subsequently added. Samples 
were vortexed avoiding excess foaming. OD595 was measured versus reagent blank 
within the period of one hour. The standard curve was plotted and the unknown 
protein concentrations extrapolated.
2.3.24. Microbial Adhesion to Hydrocarbon (MATH)
Mycobacterial cells were grown in liquid media, harvested by centrifugation at 
3,000 rpm for 5 minutes and washed twice in PBS. The bacterial suspension was
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placed in Baush and Lomb spectrophotometer tubes and adjusted to an ODggo of 0.5. 
Subsequently, 0.05, 0.1, 0.15 and 0.2 ml of n-hexadecane (Sigma cat n° H-0255) 
was added. The suspensions were vortexed at maximum speed for 2 minutes and 
left to stand at room temperature for 1 0  minutes. ODggo of the lower aqueous phase 
was measured. Results were expressed as the percentage of cells adherent to n- 
hexadecane.
2.3.25. Sensitivity tests to tetracycline and minocycline
Mycobacterial strains were grown to stationary phase and then diluted to 0.01 
ODsgonm- A 1/100 of this suspension was used to inoculate 4 ml of liquid Sautons 
containing antibiotics in the following concentrations: 4, 2, 1, 0.5, 0.25, 0.125, 0.06, 
0.03 pg/ml. Cultures were incubated shaking at 37°C for four days. Growth values 
were recorded spectrophotometrically at 580nm at 48, 72 and 96 hours.
2.3.26. Automated DNA sequencing
DNA was sequenced on a Perkin Elmer Applied Biosystem 373A automated 
sequencer using the dye terminator cycle sequencing method (run by Stephen Dyer, 
Microbiology Genetics Group). A minimum of 800 ng of purified PCR product was 
used. In general, both coding and complementary strands were sequenced with the 
sense primer and the anti-sense (0.1 pM each) respectively.
2.3.27. Sequence analysis
DNA sequence alignments and protein sequence alignments were performed using 
CLUSTAL W (1.74) multiple sequence alignment (Higgins and Sharp, 1988).
2.3.28. Statistical analysis
The descriptive statistics analysis and the Anova analysis of variance were 
performed using the Analysis ToolPak provided by Excel (Microsoft Office -  
Windows 97).
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STRATEGIES FO R BIOTIN DEPLETION AND TH EIR  IM PACT ON TH E 
ACTIVITY OEM . SM EG M ATIS  ACYL-CoA CARBOXYLASE
Chapter 3
3.1. Introduction
The purpose of the work presented in this chapter was to reduce the activity of acyl- 
CoA carboxylase by depleting biotin and, in this way, attempt to interfere with the 
lipid synthesis in mycobacteria. Two different approaches were used: addition of 
avidin to the medium in which mycobacteria were grown, and expression of an 
additional, inactive biotinylated protein expected to capture much or all of the 
intracellular biotin.
Avidin is a basic glycoprotein which binds to biotin with great affinity (Green, 
1963; Green, 1964). The interaction of avidin with biotin is unparalleled with regard 
to the strength of noncovalent binding between a protein and low molecular weight 
ligand. In addition to binding free biotin, this protein forms extremely tight 
complexes with the biotinyl prosthetic group leading to the complete loss of 
catalytic activity of all known biotin enzymes. Avidin was shown to inhibit the 
stoichiometric carboxylation of biotin as well as the transfer of the carboxyl group 
of carboxybiotin protein to the suitable acceptor (Alberts et a l,  1969; Polakis et a l ,  
1974). Wheeler et al. (1992) reported that, addition of avidin to the medium in 
which mycobacteria are grown profoundly depresses the levels of acyl-CoA 
carboxylase activity. This was attributed to the reduction in biotin availability and 
indicated that mycobacteria rely on exogenous sources to acquire the vitamin. Based 
on these facts, experiments designed to inhibit acyl-CoA carboxylase in M. 
smegmatis were carried out by growing this mycobaterial strain in the presence of 
avidin.
An additional way of specifically inactivating acyl-CoA carboxylase involved 
expression of an extra, inactive biotinylated protein to reduce or even eliminate the 
activity of the enzyme by capturing much or all of the intracellular biotin. In a series 
of experiments performed with the 1.3 S biotinylated subunit of P. shermanii 
transcarboxylase, it has been demonstrated that the complete biotinyl subunit is not 
required for biotin addition (Wood and Kumar, 1985; Cronan, Jr., 1990). In fact, the 
carboxyl-terminal domain of the subunit contains sufficient critical structures to 
account for their specific recognition by biotinyl protein ligase. Cronan Jr. (1990) 
found that the minimum size of the protein segment needed to allow biotinylation of 
fusion proteins is 75 amino acids. Subsequent work by Li and Cronan, Jr. (1992) on
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E. coli acetyl-CoA carboxylase, showed that fusion of the C-terminal 84 amino 
acids of BCCP to (3-galactosidase led to the production in vivo of biotinylated (3- 
galactosidase molecules. Chapman-Smith et al. (1994) also reported the expression 
of a sub-gene encoding the C-terminal 87 residues of the E. coli BCCP, generating a 
partly biotinylated protein in vivo.
Since the biotinylation site is relatively small and well conserved, the gene coding 
for a biotinylated fusion protein was constructed and expressed in M. smegmatis. 
The DNA sequence for the biotinylation region of the M. tuberculosis accA l gene 
of acyl-CoA carboxylase was ligated to the 5’ end sequence plus promoter region of 
a suitable mycobacterial gene on a shuttle plasmid. This biotinylated protein, being 
unable to assemble with the transcarboxylase subunit, is enzymatically inactive. 
Nevertheless, it is expected to lower the level of biotin available intracellularly 
causing a reduction in the acyl-CoA carboxylase activity. The primary effects of a 
severe reduction of acyl-CoA carboxylase activity are expected to be quantitative 
and/or qualitative changes in the lipid composition of the cell envelope. Alterations 
of the cell envelope are likely to have secondary consequences on parameters such 
as, antibiotic sensitivity and cell surface properties. These parameters were 
investigated in the presence of avidin and correlated with acyl-CoA carboxylase 
activity.
3.2. Experimental Strategy for the Intracellular Depletion of Biotin
The shuttle plasmid pUS629 containing 255 bp of the 3’-terminal region of the M. 
tuberculosis acc A l  gene ligated to the 5’-terminal sequence (plus promoter region) 
of the M. bovis BCG hsp6t) gene, was transformed into M. smegmatis mc^l55. This 
strain, designated ms629, is expected to express a non-functional biotinylated fusion 
protein designed to cause intracellular depletion of biotin. The plasmid pUS627 
which lacks the DNA sequence encoding the 85 aminoacid residue of the C- 
terminal biotinyl domain of AccAl, was also transformed into M. smegmatis. This 
strain, designated ms627, was used as one of the controls for the experiments. The 
other control included was the wild type strain of M. smegmatis mc^l55. The 
schematic representation of the plasmids pUS627 and pUS629 can be seen on 
Figure 3.1. Construction of plasmids, transformation of M. smegmatis mc^l55 and 
assessment of in vivo biotinylation were performed by Dr. E. Norman.
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Figure 3.1. Diagrams of pUS627 and pUS629
The control p lasm id p U S 627  consists o f  an expression  vector based on p U C 19 carrying the 
K anam ycin-resistance gen e (am in og lycosid e 3 ’-phosphotransferase) from  T n 903, a 
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end o f  the accA l gen e from  M. tuberculosis ligated to the 5 ’-term inal sequ en ce o f  the hsp6Qt 
gene.
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Post-translational modification of the 85 aminoacid polypeptide expressed by 
pUS629 was analysed by SDS-PAGE and the extent of biotinylation considered to 
be satisfactory. The consecutive study of these recombinant strains forms part of the 
work presented in this chapter.
3.3. Effect of Biotin Depleting Conditions on the Growth of M.
smegmatis
The growth rate of M. smegmatis mc^l55, ms627 and ms629 was measured using 
three different culture conditions. Firstly, these strains were grown in Sautons. 
Secondly, the culture medium was supplemented with biotin (0.5 |ig/ml - same 
concentration as in Middlebrook 7H9) in order to study the effect of addition of this 
vitamin on the growth rate. And lastly, mycobacterial cells were exposed to a series 
of increasing concentrations of avidin (0.9 to 1.8 U/ml) incorporated in the growth 
media.
The inocula for the growth experiments were prepared by subculturing the test 
organisms from a 15% frozen glycerol stock through Nutrient Broth, followed by a 
second passage in Sautons incubated until stationary phase (3 days old). These 
cultures were then diluted in culture medium to an ODggo of 0 . 1  and 1 0 0  jLil of each 
dilution was used to inoculate 4 ml of Sautons dispensed in Bausch and Lomb 
spectrophotometer tubes (10x100 mm). The depth of the liquid in the tubes was 
approximately 40 mm. All incubations were done vertically with shaking at 37°C 
and the ODggo of cultures was determined after vortexing, every 4 hours for a total 
of 72 hours. The rate of evaporation was negligible, therefore, there was no need for 
the observed optical densities to be corrected. Counts of viable units of bacilli were 
determined by plating appropriate dilutions onto Sautons agar (data not shown). All 
experiments were performed in duplicate and repeated on three different occasions.
Figure 3.2 displays the growth curves obtained when M. smegmatis mc^l55 was 
grown in the presence and absence of biotin as well as in the presence and absence 
of avidin. Sautons is a minimal defined medium which should not contain biotin. 
However, it is possible that such substance may be present in trace amounts as a 
contaminant of one or more of the several components. Besides, vitamins are known
60
Chapter 3
Sautons 
Sautons + Biotin 
Sautons + 0.9U Av 
Sautons + 1 8U Av2.5
0.5
72 140
Time/Days
Figure 3.2. Growth curves of M. smegmatis mc^l55 in Sautons, in Sautons 
supplemented with 0.5 pg/ml of biotin and in Sautons containing 0.9 and 1.8 
U/ml of avidin. The optical densities at 580 nm  were determ ined every 4 hours. 
Readings were not corrected for loss of linearity.
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to serve as cofactors in the catalysis by enzymes in extremely low levels. As 
mentioned earlier, avidin binds biotin with great affinity and can be used to 
sequester medium biotin, thus making it unavailable for the cells in culture. When 
grown in plain Sautons, M. smegmatis mc^l55 entered the logarithmic phase of 
growth after an initial lag phase of 12 hours. Active multiplication slowed down at 
about 48 hours and cells gradually went into stationary phase. Addition of 0.5 |Xg/ml 
of biotin to the culture medium did not have any visible beneficial effect as the 
growth curve overlaps with that obtained in the absence of biotin. On the contrary, 
addition of 0.9 and 1.8 U/ml of avidin delayed the start of cell division, which 
originated an extended lag phase. The effect of extracellular depletion of biotin was 
observed only during the first stages of growth. Both concentrations of avidin 
produced the same effect since the two growth curves are identical.
Figure 3.3 shows the effect of the intracellular depletion of biotin on the growth of 
M. smegmatis, assessed by studying the strain ms629. The control strain M. 
smegmatis mc^l55 exhibits a shorter lag phase and, overall, higher optical density 
readings than ms627 or ms629 (Figure 3.3 A). Because both latter strains contain 
plasmids, selective pressure was maintained by constantly adding 15 pg/ml of 
Kanamycin to the culture medium whereas the wild type strain was grown without 
antibiotic. In the absence of kanamycin, the three test organisms proved to have 
similar growth curves (data not shown) demonstrating that either the antibiotic or 
the presence of the plasmid creates an extra stress that seems to be responsible for 
the decrease in the growth rate. The growth dynamics of ms627 and ms629 was 
comparable at all times and no difference was noticed between the strain containing 
the control plasmid (pUS627) and the strain expressing the inactive biotinylated 
protein (pUS629). The addition of 0.5 pg/ml of biotin to Sautons medium failed to 
stimulate the growth of the strains under study, particularly that of ms629. As 
displayed in Figure 3.3 B, these growth curves are very similar to those obtained in 
the absence of biotin. M. smegmatis mc^l55, ms627 and ms629 were also grown in 
the presence of 0.9 and 1.8 U/ml of avidin. The strains cultured with or without 
avidin reached confluence at the same time, implying that cell multiplication was 
not impaired (Figure 3.3 C). Therefore, measurement of the growth rates in the 
presence of avidin did not uncover any difference between ms629 and the control
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Figure 33* Growth curves of M. smegmatis mc^l55, ms627 and ms629 in Sautons (A), 
in Sautons supplemented with 0.5 pg/ml of biotin (B) and in Sautons containing 0.9 
and 1.8 U/ml of avidin (C). m s627 and m s629 w ere cultured in the presence o f  15|a.g/ml o f  
K anam ycin. T he optical densities at 58 0  nm  w ere determ ined every 4  hours. R ead ings w ere  
not corrected for lo ss o f  linearity.
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strains. This indicates that the growth of M. smegmatis mc^l55 might not be 
contingent on biotin depletion both intfacellularly and extracellularly.
Although depletion of biotin did not affect growth pattern, the possibility that more 
subtle changes could have occurred was taken into consideration. Further 
investigations involved verification of alterations of the cell envelope composition 
and measurement of acyl-CoA carboxylase activity.
3.4. Assessment of Cell-Surface Characteristics
3.4.1. Susceptibilities to tetracyclines of varying hydrophobicities
One of the ways of assessing the result of an experimental variation or mutational 
event relies on the relative susceptibility of the altered bacteria and their controls to 
a wide variety of unrelated antibiotics, detergents and dyes (Coleman and Leive, 
1979; Nikaido, 1976). The model proposed by Minikin (1982) for the physical 
organisation of the mycobacterial cell wall with lipids assembled in two leaflets of 
different fluidity, is reminiscent of the outer membrane of the Gram negative 
bacterial For this reason, the permeability of the cell wall of the mycobacterial 
strains to hydrophobic solutes was experimentally determined using a method 
described for measurement of outer membrane permeability of E. colt (Leive et a l,  
1984). This assay measures changes in hydrophobic permeability based on the 
susceptibility of the microorganism to tetracyclines of various hydrophobicities and, 
therefore, should prove useful in distinguishing mutants with alterations of the cell 
wall.
To compare the degree of hydrophobic permeability of ms629 relative to ms627 and 
M. smegmatis mc^l55, the susceptibility to tetracycline and minocycline was 
determined. These tetracyclines are equally effective against gram-positive 
organisms (Blackwood and English, 1977) and apparently share the same 
mechanism of action (Levy, 1981). It is important to note that minocycline has a 
higher degree of hydrophobicity than tetracycline.
 ^ The Gram negative outer membrane forms an asymmetric lipid bilayer with an outer leaflet 
composed exclusively o f lipopolysaccharide (LPS) and an inner leaflet containing phospholipids.
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The three mycobacterial strains were grown to stationary phase and then diluted to 
0.01 ODggQ. A 1/100 dilution of this suspension was used to inoculate 4 ml of liquid 
Sautons containing antibiotics in the following concentrations: 4 , 2 , 1 ,  0.5, 0.25, 
0.125, 0.06 and 0.03 )Lig/ml (the appropriate concentration range of had been 
previously determined). The cultures were incubated shaking at 37°C for four days 
and growth values were recorded spectrophotometrically at 580 nm after 48, 72 and 
96 hours. Two separate determinations were done. Table 3.1 shows the minimal 
inhibitory concentrations (MIC) obtained.
Table 3.1. Susceptibility of M. smegmatis mc^l55, ms627 and ms629 to tetracyclines as 
a function of hydrophobocity
Antibiotic M. smegmatis mc^l55 ms 627 ms 629
Tetracycline
48h 72h 96h 48h 72h 96h 48h 72h 96h
0.25 0.5 1 0.125 0.5 1 0.25 0.5 1
Minocycline 0.06 0.25 0.5 0.03 0.125 0.25 0.06 0.25 0.5
MICs are expressed as micrograms of antibiotic per milliliter. MIC was defined as the 
lowest concentration of antimicrobial agent at which the organism showed no visible 
growth.
The MICs of tetracycline and minocycline for M. smegmatis, ms627 and ms629 
were very similar indicating that these strains are equally susceptible to each of the 
antibiotics. Differences in susceptibility to drugs sharing the same mode of action 
but with diverse hydrophobicities presumably reflect differences in cell wall 
permeability. From the results obtained, there is no evidence that the lipid 
composition of the cell wall of ms629 has been altered.
All three strains showed greater susceptibility to minocycline than tetracycline. 
These results are in accordance with previous observations that the most active 
drugs against mycobacteria are hydrophobic compounds of low polarity due to their 
solubility into the fats of the cell wall (David et a l ,  1987). Antibacterial agents of 
the lipophilic classes are thought to utilise the lipid bilayer pathway to cross the cell 
wall of mycobacteria rather than the porin pathway which is extremely inefficient in
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these microorganisms (Trias et a l, 1992; Trias and Benz, 1994). As a consequence, 
within each class of antibiotic, the more lipophilic derivative proves to be more 
active against mycobacteria.
3.4.2. Hydrophobicity measurements
The aim of the present series of experiments was to determine possible changes in 
the overall lipid composition of the cell wall of the strains under study, on the basis 
of their physicochemical cell-surface properties. A number of methods for studying 
hydrophobic interactions of cells has been reported in the literature although no 
single technique adequately describes cell-surface hydrophobicity since the 
experimental conditions employed and various non-hydrophobic effects interfere 
with the end result. It is likely, however, that the various methods used to measure 
hydrophobicity detect quantitative and qualitative differences of the lipophilic 
residues present on bacterial surfaces.
The outer cell surface of M. smegmatis mc^l55, ms627 and ms629 was studied by 
microbial adhesion to hydrocarbon (MATH), a simple and rapid quantitative assay 
based on the affinity of cells to n-hexadecane. This method was originally 
developed by Rosenberg et a l  (1980) and later modified by Ofek et a l  (1983). The 
modification introduced permits the recording of turbidity of the bacterial 
suspensions in the same tube during the assay, and also to follow the kinetics of the 
mycobacteria-hexadecane interaction. Briefly, the strains were grown to stationary 
phase in plain Sautons and in the presence of 0.9 and 1.8 U/ml of avidin. The cells 
were harvested, washed, resuspended in PBS, and adjusted to an optical density of 
about 0.5 at 580 nm. Then, 50 |xl of n-hexadecane was added, the suspensions were 
vortexed and left standing to allow separation of layers, at which time the optical 
density of the aqueous phase was again measured. This was repeated another three 
times until a total volume of 200 |il of n-hexadecane was reached. The cumulative 
percentage of bacteria that adhered to n-hexadecane was estimated and the results 
obtained are illustrated on Figure 3.4.
As a common feature, most of the cell population adhered to the organic phase in 
the first two stages of the assay, the removal rate reaching the peak at 1 0 0  |il of n- 
hexadecane. Overall, M. smegmatis mc^l55, ms627 and ms629 showed the same
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Figure 3.4. Adherence to n-hexadecane of M. smegmatis mc^l55, ms627 and ms629.
Strains w ere grow n until stationary phase in liquid Sautons (A ) and in Sautons con ta in ing  
0 .9  U /m l (B) and 1.8 U /m l (C ) o f  avidin. C ells w ere harvested, w ashed and suspended  in 
P B S . T he bacterial suspension  w as adjusted to O D 5 8 0  o f  about 0 .5  (Ao) and 4 x  50  |xl o f  n- 
h exad ecan e w as added and m ixed  uniform ly. A fter phase separation, the absorbance o f  the 
low er aqueous phase w as recorded in the sam e tube (At). T he percentage o f  bacteria that 
adhered to n-hexadecane (Ao-A,/Ao x 100) w as plotted against the n -h exad ecane vo lu m e.
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affinity towards the organic phase regardless of the plasmid content and culture 
conditions. The MATH profile of the strains grown in the presence of 0.9 and 1.8 
U/ml of avidin indicates that the chemical composition of the cell surface does not 
seem to have been affected by the unavailability of extracellular biotin. These 
results suggest that the potential biotin depletion, which was expected to cause a 
reduction in the lipid synthesis, failed to produce changes in the phenotypic 
appearance of the cell surface of the strains under study.
One last remark on these experiments concerns the easy detachment of adhering 
mycobacterial cells from the organic phase upon gentle movements of the test tube. 
On the contrary, Rosenberg et al. (1980) while studying the adherence of 
Acinetobacter calcoaceticus to hydrocarbons, described this upper layer as a cell- 
stabilised emulsion that did not break even after several days. Although unexpected, 
this indicates that other factors than hydrophobicity interfere with MATH for 
mycobacteria. It has been demonstrated that adhesion-based methods to assess 
microbial cell-surface hydrophobicity actually measure an interplay of the 
hydrophobic and electrostatic cell-surface properties (Busscher et a l ,  1995; Van der 
Mei et a l,  1995), since hydrocarbon droplets in most buffers appear negatively 
charged. Hydrophilic microorganisms do not adhere to the hydrocarbon phase 
regardless of the absence or presence of electrostatic repulsion (Van der Mei et a l, 
1993), while hydrophobic cells, such as mycobacterial cells, only adhere to the 
hydrocarbon phase when electrostatic repulsion is moderate or absent (Geertsema- 
Doombushe/fl/., 1993).
3.5. Acyl-Co A Carboxylase Activity 
Optimising conditions for enzyme extraction
Any assay for measuring enzyme activity poses the problem of having to lyse cells 
efficiently and prepare an extract while causing as little damage as possible to the 
enzyme. Therefore, it was essential to establish the best conditions for obtaining 
cell-free extracts before acetyl-CoA carboxylase activity of the mycobacterial 
strains was studied. For this purpose, M. smegmatis mc^l55, ms627 and ms629 
were grown as described in section 3.3 until mid-log and stationary phase were 
reached. Then, cells were harvested, washed twice, resuspended in 2 ml of PBS and
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lysed by ultrasonic disruption while kept in ice-water mix. The sonicator (Vibra 
Cell™ -  Sonics and Materials) was set to amplitude 30 and sonication for 1 (SI), 2 
(S2), 3 (S3), 4 (S4), 5 (S5) and 6  (S6 ) minutes with 6  second pulses was compared. 
The sonicate was centrifuged at 40,000 g and the cell debris discarded. The efficacy 
of each procedure was evaluated by titration of protein content and determination of 
acetyl-CoA carboxylase activity (Figure 3.5).
No marked difference was noticed in the protein content of the extracts obtained by 
sonication SI to S4 although a two fold increase in yield was achieved with S5 and 
S6 . One important observation is that, as a whole, the protein content of the mid-log 
phase cultures is extremely low when compared to that of the stationary phase 
cultures. However, this does not mean that young cells are more resistant to lysis 
but, instead, is the result of the low cell density of mid-log phase cultures. This fact 
is more evident for the strains bearing plasmids as discussed earlier (see section 
3.2).
Acyl-CoA carboxylase activity was assessed using acetyl-CoA as substrate. The 
differences between the various sonication protocols did not prove to be significant 
although S5 and S6  were slightly detrimental for the activity of the enzyme. 
Preventing the temperature from rising during the lysing process was highly 
important since acyl-CoA carboxylase is rather thermal sensitive (Rainwater and 
Kolattukudy, 1982). For instance, enzyme activity was barely detected in one 
particular extract that overheated during sonication (result marked with an arrow on 
Figure 3.5). In all the subsequent experiments, sonication at amplitude 30 for 2 
minutes with 6  second pulses was the procedure adopted for the lysis of 
mycobacterial cells. This protocol provided extracts with reasonable protein content 
and minimal damage to the activity of the enzyme.
From these results, it started to become apparent that acyl-CoA carboxylase activity 
of ms629 did not seem to be lower than that of the controls ms627 and M. smgmatis 
mc^l55. Nevertheless, further experiments were carried out, details of which are 
described in the following section.
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Figure 3.5". Evaluation of the sonication protocols for the preparation of mycobacterial 
cell-free extracts Top) protein content; Bottom) acyl-CoA carboxylase activity. Total 
protein w as assessed  u sing  the B io-R ad  protein assay (see  Chapter 2). E n zym e activ ity  w as  
assayed  according to W heeler et al. (1992 ) u sing acety l-C oA  as substrate. C ontrols w ithout 
acety l-C oA  or ce ll extract w ere also tested and the readings w ere n eg lig ib le  (results not 
sh ow n). T he protein content is expressed  in |Ltg o f  protein per ml o f  extract. E nzym e activ ity  
is expressed  in pm ol o f  '"^COz fixed  per m inute and per m g o f  protein. Experim ental 
con d itions are d isplayed  on the x axis. Constant setings: am plitude 30  and 60  secon ds pulse. 
S I =  sonication  for 1 min; 8 2  =  2 min; S3 = 3 min; S 4  = 4  min; S5 =  5 min; S 6  =  6 m in.
; =  Sam ple overheated during sonication.
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Measurement of acyl-CoA carboxylase activity under biotin depleting 
conditions
Acyl-CoA carboxylase activity of M. smegmatis mc^l55, ms627 and ms629 was 
assessed both in the absence and presence of avidin. This study involved stationary 
phase cultures only (3 days old), considering that, as shown in the previous section, 
the protein content of mid-log phase cultures was very low. The cell free extracts 
were prepared and either analysed immediately or kept frozen at -20°C for no more 
than a week. Under these conditions, the amount of acyl-CoA carboxylase loss is 
estimated as low as 25% (Wheeler et a l,  1992). The results obtained are presented 
in Table 3.2.
Interestingly, acetyl-CoA carboxylase activity of ms629 was similar to that of the 
control strains. On its own, this result suggests that either intracellular depletion of 
biotin, caused by the plasmid expressing the nonfunctional biotinylated protein, is 
insufficient or that a metabolic control of biotin synthesis might be in place. 
Keranan (1972) and Dakshinamurti et a l  (1985) have shown that HeLa cells do not 
require biotin, and that cells made deficient by adding avidin to the medium 
contained more biotin, perhaps owing to their ability to synthesise this vitamin. If 
the same is valid for M. smegmatis, this would explain the results obtained with 
ms629.
Addition of 0.125 and 0.250 U/ml of avidin to the culture medium where M. 
smegmatis, ms627 and ms629 were grown did not cause a reduction of the activity 
of acyl-CoA carboxylase. On the contrary, addition of 0.5 U/ml of avidin caused up 
to a forty fold reduction in the levels of the enzyme. It is possible that this steep 
reduction was due to carry over of avidin present in the medium into the cell free 
extract. To establish if this was the case, 0.25 pg/ml of biotin was added to the cell 
free extracts and the enzyme assay repeated (Table 3.3). Considering that most of 
the avidin had already been removed by washing the cells, the amount of biotin 
added was clearly in excess. Therefore, this concentration of biotin was expected to 
counteract the effects of an avidin carry over and/or even stimulate the activity of 
the enzyme. However, the results of this experiment are very similar to those 
obtained originally (see Table 3.2).
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Table 3.2. Acetyl-CoA carboxylase activity of M. smegmatis mc^l55, ms627 and ms629 
grown in absence and presence of avidin
M. smegmatis mc^l55 ms627 ms629
No avidin 371.8 372.2 516.9
0.125 U/ml avidin 445.8 320.2 320.7
0.250 U/ml avidin 297.1 321.4 471.1
0.50 U/ml avidin 11.7 11.6 10.3
Values are pmol CO2 fixed per minute and per mg of protein (two extracts were used to 
obtain each value). Counts of controls without acetyl-CoA or cell-free extract were 
negligible (data not shown) and, therefore, non-specific fixation of "^^ COz was very low.
Table 3.3. Acetyl-CoA carboxylase activity of the former extracts treated with 0.25 
pg/ml of biotin before the enzyme assay
M. smegmatis mc^ 155 ms627 ms629
No avidin plus 0.25 
qg/ml biotin
404.6 334.5 494.4
0.125 U/ml avidin 
plus 0.25 fig/ml biotin
493.8 341.9 287.1
0.250 U/ml avidin 
plus 0.25 |Lig/ml biotin
302.4 275.9 453.2
0.5 U/ml avidin plus 
0.25 fig/ml biotin
39.8 14.3 28.1
Values are pmol CO2 fixed per minute and per mg of protein (two extracts were used to 
obtain each value). Counts of controls without acetyl-CoA or cell-free extract were 
negligible (data not shown) and, therefore, non-specific fixation of '^^ C0 2  was very low.
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Addition of biotin to the cell free extracts may have had no effect if the avidin was 
already bound irreversibly to the biotinylated protein. In order to test this 
hypothesis, subsequent determinations of the enzyme activity were carried out after 
biotin was added at three crucial stages of the experiment. First, M. smegmatis was 
grown in the presence of 0.125, 0.5 and 2 U/ml of avidin and 0.5 lig/ml of biotin 
was added to the enzyme assay. Secondly, the same concentration of biotin was 
added to the PBS used to wash the bacterial suspension before sonication, so avidin 
molecules would be already saturated even if carried over. Lastly, M. smegmatis 
was cultured simultaneously in the presence of avidin and biotin in the 
concentrations mentioned above. The results of these investigations are shown in 
Table 3.4 and seem to indicate that reduction of acyl-CoA carboxylase activity is 
partially due to avidin carryover. Addition of biotin to the enzyme assay failed to 
improve enzyme activity of the extracts obtained from strains grown in the presence 
of the highest concentration of avidin (0.5 U/ml and 2 U/ml). However, when biotin 
was added to both culture medium and PBS used to wash the bacterial suspension, 
acyl-CoA carboxylase activity of one of the extracts was greatly recovered (results 
marked with an asterisk on Table 3.4). This observation supports the view that 
carryover of avidin is only overturned by addition of biotin at early stages of the 
experiment.
As acyl-CoA carboxylase activity of the strain grown in the presence of 2 U/ml of 
avidin was not improved by addition of biotin, this seems to indicate that genuine 
inhibition of the enzyme took place to some extent. It has to be noted that addition 
of a similar concentration of avidin to the culture medium had no effect either on 
growth pattern or on mycobacterial cell surface properties as measured by MATH 
(see section 3.3 and 3.4).
3.6. Discussion
That biotin should constitute an essential requirement for cells in culture would be 
expected from its obligatory involvement in carbohydrate and lipid metabolism as 
the prosthetic group of the carboxylases. However, the data presented in this chapter 
show that the strategies designed to deplete biotin in M. smegmatis mc^l55 failed to 
reduce the activity of acyl-CoA carboxylase and, ultimately, impair lipid synthesis 
and produce physiological changes in the cell wall.
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Table 3.4. Acetyl-CoA carboxylase activity of M. smegmatis mc^l55 grown in the 
presence of avidin and treated with 0.5 |Xg/mI biotin at three different stages of the 
experiment
No biotin added 0.5 pg/ml biotin added to the 
enzyme assay
No avidin 450.3 617.8
0.125 U/ml avidin 216.3 300.7
0.5 U/ml avidin 4.9 4.8
2 U/ml avidin 2.0 2.0
0.5 pg/ml biotin added to 
PBS used to wash the 
bacterial suspension
0.5 p-g/ml biotin added to the 
culture medium
No avidin 293.6 200.8
0.125 U/ml avidin 181.1 263.9
0.5 U/ml avidin 197.8* 177.7*
2 U/ml avidin 1.9 3.3
Values are pmol CO2 fixed per minute and per mg of protein (two extracts were used to 
obtain each value). Counts of controls without acetyl-CoA or cell-free extract were 
negligible (data not shown) and, therefore, non-specific fixation of '"^ C0 2  was very low.
74
Chapter 3
Various species of mycobacteria (M. microti and M. avium) seem to have the ability 
to synthesise sufficient biotin to support a relatively high activity of acyl-CoA 
carboxylase (Wheeler et a i,  1992). This also seems to be the case for M. 
tuberculosis since the genome sequence revealed the existence of six genes 
encoding enzymes involved in the synthesis of biotin (Cole et a l ,  1998). 
Furthermore, the results presented in this chapter indicate that M. smegmatis is 
capable of synthesising biotin. This strain was able to survive with little or no biotin 
present in the culture medium and ms629 successfully overcame intracellular 
deletion of biotin.
The biotin biosynthetic pathway and its regulation have been studied extensively in 
E. coli at both biochemical and molecular biological levels (Eisenberg, 1987; 
Cronan, 1989; Gloeckler, 1990). Biotin synthesis is blocked in vivo upon addition of 
high levels of exogenous biotin to the medium of growing E. coli cultures, whereas 
biotin starvation of E. coli biotin auxotrophs results in greatly increased 
transcription of the bio operon (Cronan, Jr., 1989). The genes that encode the 
enzymes involved in biotin production, are regulated, in E. coli, at the level of 
transcription by a classical repressor-operator mechanism (Barker and Campbell, 
1981b; Eisenberg, 1984; Cronan, 1989). The repressor protein, BirA, is also the 
enzyme (biotinyl protein ligase) that catalyses the covalent attachment of biotin to 
the enzymes that use this vitamin as a co-factor (Barker and Campbell, 1981a; 
1981b; Eisenberg et a l,  1982). The corepressor is not biotin but biotinoyl-AMP, the 
product of the first half-reaction of the ligase (Prakash and Eisenberg, 1979). 
Repression of bio operon transcription occurs when the supply of biotin is in excess 
of that needed to biotinate apo-protein. Under these conditions the BirA-biotinoyl- 
AMP complex accumulates, binds to the bio operator, and represses transcription. 
Maximal rates of bio operon transcription (derepression) occur when the biotin 
supply is severely limited. Since any biotinoyl-AMP synthesised is rapidly 
consumed in biotination of acceptor apo-protein molecules, no significant amount 
of BirA-biotinoyl-AMP complex accumulates. In these circumstances, the bio 
operator is seldom occupied and transcription is maximal.
Another feature of the regulatory system is that, at a given physiological 
concentration of biotin, the rate of operon transcription depends on the supply of the 
biotin acceptor protein (Cronan, 1989). It has been shown that an increase in the
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level of apo-protein decreases the level of the Bir-A-biotinoyl-AMP repressor 
complex which results in increased transcription of the operon (Cronan, 1989). The 
rate of biotin synthesis is sensitive not only to the intracellular concentration of 
biotin, but also to the supply of the unmodified target protein to which the biotin 
must be attached in order to fulfil its metabolic role. Thus, accumulation of the 
unmodified protein increases the rate of synthesis of biotin needed for the 
posttranslational modification.
If inhibition of acyl-CoA carboxylase due to biotin depletion had been successful, it 
is likely that a decrease in the lipid content of the cell wall would have occurred. 
This, in turn, would have lead to changes in cell surface hydrophobicity. However, 
throughout this study, it was difficult to assess possible modifications in the cell 
wall composition of the different M. smegmatis strains, because no simple way of 
estimating an increase/decrease in hydrophobic permeability exists. Adhesion to 
hexadecane was the method chosen to relate the adhesive abilities of mycobacteria 
with chemical composition of their cell surface. However, there is still debate on the 
proper measurement of microbial hydrophobicity. The MATH test, although 
originally designed to measure cell-surface hydrophobicity is now considered to be 
an indirect assay (Geertsema-Doombush et a l, 1993). The most direct method, 
although not yet universally accepted, is based on water contact angle 
measurements on lawns of microorganisms, deposited on membrane filters 
(Busscher et a l,  1995; Van der Mei et a l, 1995).
Highly hydrophobic molecules of low polarity are readily taken up dissolved into 
the lipids forming the outer layers of the bacterial envelope, and appear to interact 
with structural lipids in the wall which may be antibiotic specific (David et a l ,  
1987). Moreover, a positive correlation between lipophilicity and efficacy has been 
reported in the literature for agents as fluoroquinolones (Yajko et a l,  1990), 
macrolides (Fernandes et a l,  1982) and rifamycins (Heifets et a l,  1990). For this 
reason, susceptibility testing to tetracyclines of various hydrophobicities was used 
to ascertain differences of the cell envelope permeability of different M. smegmatis 
strains.
Although the efficacy of tetracyclines can be correlated with the rate of diffusion, it 
is important to draw attention to the fact the main mechanism of resistance is efflux 
(Liu et a l ,  in press). Indeed, a gene that encodes a tetracycline efflux pump has
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been identified in Mycobacterium fortuitum  (Pang et a l ,  1994). A multidrug pump 
conferring high-level resistance to fluoroquinolones has also been discovered in M. 
smegmatis (Liu et a l,  1996b; Takiff et a l, 1996). Classically, the characteristic 
natural antibiotic resistance of mycobacteria is, to a great extend, attributed to the 
lipid-rich envelope that excludes and obstructs diffusion of drugs. Nevertheless, it 
seems likely that many of the resistance phenomena in mycobacteria are 
consequence of the synergism between cell-wall barrier and active efflux process 
(Liu et a l ,  in press).
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MUTAGENESIS AFFECTING THE CARBOXYL TERMINUS OF THE 
AccAl SUBUNIT OEM. TUBERCULOSIS ACYL-CoA CARBOXYLASE
Chapter 4
4.1. Introduction
It has been observed that, in most biotin enzymes, the biotinyl lysine residue of the 
conserved sequence Ala-Met-Lys-Met, is positioned exactly 35 amino acids from 
the carboxyl terminus (Sutton et a l,  1977; Maloy et a l, 1979; Freytag and Collier, 
1984; Lamhonwah et a l,  1986). Murtif and Samols (1987) investigated whether or 
not this feature plays a role in directing the post-translational biotinylation of lysine 
by biotinyl protein ligase. These workers introduced a series of deletions and 
mutations at the 3’ end of the gene coding for the 1.3 S biotinyl subunit of P. 
shermanii transcarboxylase expressed in E. coli, and assessed the degree of 
biotinylation of the various COOH-terminal mutants. A summary of the results 
obtained is presented in Figure 4.1.
g
121 122 123
N—  
N—  
N-— 
N —
N —
N —
Lys De Gly -c
Lys -c
Lys Gly -C
Lys Gly Gly -c
a
Lys Leu Gly -c
a
Lys Val Gly -c
Figure 4.1. Sequence requirements for biotinylation of the 1.3 S subunit of P. 
shermanii upon expression in E. coli. The COOH terminus of the 1.3 S subunit is 
represented as a bar and the last 3-amino acids residues are shown. The top bar corresponds 
to the 123-amino acid wild type subunit. The mutants are represented below and the 
biotinylation potential of each is indicated by the presence or absence of the symbol Ç ]  . 
(Murtif and Samols, 1987).
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Mutations that removed more than one amino acid from the COOH terminus of the 
123-residue polypeptide eliminated the capacity for biotin addition. Successful 
biotin addition was observed only when a hydrophobic residue (isoleucine, valine or 
leucine) was present at position 122. Substitution with glycine abolished 
biotinylation. Consequently, it was proposed that the conformation of the COOH- 
terminal region provides the necessary parameters for the recognition and 
biotinylation of a polypeptide by biotinyl protein ligase. Particularly important, is 
the hydrophobicity of the region conferred by the presence of the nonpolar amino 
acid isoleucine, which disruption eliminates biotinylation (Murtif and Samols,
1987).
The gene of the AccAl subunit of M. tuberculosis acyl-CoA carboxylase has been 
sequenced and the results show a clear correlation to biotin-dependent enzymes 
from a wide variety of sources (Norman et a l,  1994). The predicted amino acid 
sequence contains a number of characteristics, such as, the tetrapeptide Ala-Met- 
Lys-Met located 35 residues from the carboxyl terminus, and the hydrophobic 
aminoacid isoleucine at the ante-penultimate position of the COOH-terminal 
sequence. Based on the similarities between the conserved regions of the AccAl 
subunit of acyl-CoA carboxylase of M. tuberculosis and the 1.3 S subunit of P. 
shermanii, a mutation aimed at affecting biotinylation was introduced at the end of 
the COOH-terminus by replacing the hydrophobic amino acid isoleucine 652 for 
glycine (Figure 4.2).
N—
N-
g 651 652 653 654
Arg lie Lys Asp
Arg Gly Lys Asp
-C
-C
Figure 4.2. Biotinylation of the AccAl subunit mutant of M. tuberculosis. T he C O O H  
term inus o f  the A c c A l subunit is represented as a bar and the last 4-am ino acids residues  
are show n. T he top bar corresponds to the w ild  type subunit. T he mutant is represented  
b elo w  and the predicted b iotinylation potential o f  each is indicated by the p resen ce or 
absen ce o f  the sym bol .
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This chapter describes the construction and cloning of the accW  3'end mutant, and 
the consequences on the acyl-CoA carboxylase activity of M. smegmatis and M. 
bovis BCG. The strategy adopted consisted in the expression of the accA  1 mutated 
gene using a shuttle vector, in a mycobacterial cell which also contains the wild 
type gene. Therefore, the mutant and wild type versions of AccAl are likely to 
compete for binding to the transcarboxylase subunit (AccDl?) and a mixture of 
active and inactive dimers will assemble. The final activity of the enzyme is 
expected to be influenced by the ratio of wild type and mutant AccAl subunits 
which was controlled by using promoters of different strength to express the 
mutated subunit gene. The following drawing shows schematically the concept 
described above.
&
Wild type AccAl
Active
Competition for binding expected to reduce level o f  
active acyl-CoA carboxylase
A ccDl
Mutant A ccAl
Inactive
Although the gene under study belongs to M. tuberculosis, experiments were carried 
out using M. bovis BCG as well as M smegmatis, bearing in mind that a hybrid 
enzyme might not be formed in the latter due to differences between the two 
species.
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4.2. Construction of the Expression Systems for the AccAl subunit 
of M. tuberculosis Acyl-CoA Carboxylase
All mutant and control plasmids were derived from a shuttle plasmid containing the 
E. coli and mycobacterial origin of replication, as well as the ampicillin and 
kanamycin resistance genes. Two different expression vectors containing the 
promoter for the 18KDa antigen from M. leprae and the promoter for the heat shock 
protein Hsp60 from M. bovis BCG were constructed. The COOH-terminal mutation 
of the accA l gene from M. tuberculosis was generated by PCR site-direeted 
mutagenesis and, subsequently, the mutated gene was cloned into the two 
expression vectors mentioned above. In turn, the wild type accAl gene was also 
produced by PCR and inserted into the same expression vectors to create the control 
plasmids. Table 4.1 lists the plasmids mentioned in this chapter including 
designation and description.
Table 4.1. Plasmids used
Plasmid Properties
pUS1834 Mycobacterium-E. coli shuttle vector
pUS 1940 pUS1834-based 18KDa promoter expression vector
pUS1705 pUS1834-based hsp6Qt promoter expression vector
pUS1703 accAl wild type in pUS 1940
pUS1704 accAX mutated in pUS1940
pUS1706 accAl wild type in pUS1705
pUS1707 accAl mutated in pUS1705
Construction of pUS1705
The promoter region for the M. bovis BCG Pasteur heat shock protein Hsp60 was 
amplified by PCR using 1 ng of genomic DNA as template. The forward primer 
60SapF ( 5 ’-CGGGATCCGCTCTTCAAGCGACCACAACGACGCGCCCG-3’) and the
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reverse primer Hsp60R ( 5 ’-AAATGCTCTAGAGGCATGCGTCTTGGCCATT-3’) were 
designed to contain BamHI and Xbal restriction sites respectively (in bold). The 
amplification was carried out in 25pi volume containing Ix buffer, 0.25 mM 
dNTPs, 100 pmol of each primer, lU of Taq polymerase and 12% glycerol. The 
thermalcycler programme consisted of 1 cycle of dénaturation (96°C, 10 min) 
followed by 30 cycles of amplification consisting of dénaturation (96°C, 1 min), 
annealing (58°C, 2 min) and primer extension (72°C, 1 min). An extra extension 
step (72°C, 10 min) took place at the end of the PCR reaction. The 421 bp product 
was purified and double digested with the restriction enzymes BamHI and Xbal. 
The fragment was repurified and cloned into the BamHI-Xbal site of pUS1834 
giving rise to the expression vector pUS1705 (Figure 4.3). After cloning, the DNA 
sequence of the hsp60 promoter was verified and proved to be as predicted.
Mutagenesis of the AccAl subunit of M. tuberculosis acyl-CoA carboxylase
The site-directed mutation of the accAX gene which affects residue 652 (He) present 
in the carboxyl terminus was generated by PCR. A reverse mutant primer was 
synthesised where the triplet ATC  coding for isoleucine in the wild type gene was 
replaced by the triplet GGC coding for glycine. In the following graphic description 
of the primer strategy, the underlined nucleotides indicate the changes that were 
introduced in order to create the desired mutation. Restriction sites are displayed in 
bold.
6 5 1 6 5 2 6 5 3 6 5 4
T i e L y s A s p Reverse mutant primer -  A2
G TA CTG GGG A T C AAG GAG TAG- i
3 ' -G A G GGG TGG CCG TTG GTG ATG A G A T C T G G T A A A -5 '
A r g G l y L y s A s p *
6 5 1 6 5 2 6 5 3 6 5 4
A .r g T i e L y s A s p Reverse wild type primer - BCCPRw
U 1 A L. 1 vj GCG AGG A T C AAG GAG TAG-
;
3 ' -G A G GGG TGG TAG TTG GTG ATG A G A T C T G G T A A A -5 '
A r g T ie L y s A s p
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The forward primer was designed to contain 12 specific base pairs preceding the 
initiation codon of accAl which include the genes’ natural ribosome-binding site 
(RBS). Stop codons were placed in the three possible open reading frames in order 
to stop translation from a start codon present immediately downstream of the 
ISKDa and hsp60 promoters used to drive both mutant and wild type accA l. The 
sequence of the sense primer can be seen below; the restriction site and the putative 
RBS (GAGG) are in bold, stop codons are underlined.
Forward primer -  A l
5 ' -A A A T G C T C TAG ATAG GATGTGAGGCG ATG  T - 3 '
3 ' -C C T A C A C T C C G C  TAG A A A  CTG TGG C A T - 5 '
Amplifications were carried out using a plasmid as template and the thermalcycler 
parameters were as previously described. After digestion of the PCR products with 
the restriction enzyme Xbal followed by a purification step, the resulting 1985 bp 
DNA fragments were cloned into the expression vectors.
Construction of pUS1703 andpUS1704
Both the acc A l  wild type gene and the I652G mutant were inserted into the Xbal 
site of pus 1940 which contains the promoter for the ISKDa antigen from M. 
leprae, resulting in vectors pUS1703 and pUS1704 respectively (Figure 4.4). The 
integrity of these two constructs was assessed by restriction mapping with the 
enzymes EcoRV, Xbal and Bglll which also provides information about the 
orientation of the insert. The nucleotide sequence of both extremities of acc A l  was 
determined by sequencing to confirm the start site of the gene as well as the 
presence or absence of the desired mutation (Figure 4.5).
Construction of pUS1706 andpUS1707
To produce vectors pUS1706 and pUS1707, the acc A l  wild type gene and the 
I652G mutant were cloned into the Xbal site of the expression vector pUS1705. In 
these constructs, the inserts are driven by the promoter for the heat shock protein
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Figure 4.5. A) Plasmid map o f pUS1703 and pUS1704 B) Chromatographs o f the 5 ’ end region o f  acc A 1 
gene showing the Shine-Dalgamo putative sequence and the translational start site and o f the 3 ’ end 
displaying the wild type sequence in pUS1703 and the I652G mutation in pUS1704 (the numbering on 
chromatographs refers to the position from the sequencing primers) C) Restriction analysis o f  pUS1703 and 
pUS1704. Lane M l is X/Hindlll marker; Lane M2 is 0 X 1 7 4  77aelll marker; lane 1 -  pUS1703 uncut; lane 2, 
3, 4 - pUS1703 cut with Afcal, EcoRv and Bglll respectively; lane 5 - pUS1704 uncut; lane 6, 7, 8 - pUS1704  
cut with Xbal, EcoRv and Bglll respectively.
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Hsp60 from M. bovis BCG (Figure 4.6). The verifications done on these two 
plasmids included restriction mapping and DNA sequencing (Figure 4.7).
Construction of mycobacterial transformants
The plasmids pUS1703, pUS1704, pUS1706 and pUS1707 were transformed into 
M. smegmatis mc^l55 and M. bovis BCG Pasteur. Subsequently, total DNA was 
isolated from each transformant and Southern blot hybridization experiments were 
performed to ascertain the condition of the plasmids (Figures 4.8 and 4.9). For this 
purpose, a DNA probe (A l/P l) which hybridises to the 5’ end of the acc A l  gene 
was generated by PCR and digoxegenin labelled by random primed DNA labelling. 
M. bovis BCG transformants were also tested with another probe (INS/BX) which 
hybridises to IS6110, an insertion sequence specific of the M. tuberculosis complex, 
and therefore validates the nature of the strain used.
All four M. smegmatis mc^l55 transformants contained plasmids that produced 
restriction fragments of the expected size as shown in Figures 4.8 B(I) and 4.9 B(I). 
However, only two of the M. bovis BCG transformants, those bearing the plasmids 
p u s  1703 and pUS1704, were correct. Deletions on the acc A l  gene seemed to have 
occurred in pUS1706 and pUS1707, a problem which persisted for the two series of 
transformations that were done (Figures 4.8 B(II) and 4.9 B(II)). This error was 
confirmed by plasmid rescue of the latter plasmids in E. coli followed by restriction 
analysis (data not shown). For this reason, the study of acyl-CoA carboxylase 
activity in M. bovis BCG was restricted to the recombinant strains containing 
pUS 1703 and pUS 1704.
4.3. Assessment of the Activity of Acyl-CoA Carboxylase 
Measurement of Growth ofM. bovis BCG
The study of M. bovis BCG growth dynamics was done both in medium containing 
simple, defined ingredients (Sautons) and, in more complex, rich medium 
(Middlebrook 7H9 supplemented with OADC). To reduce clumping, 0.05% Tween 
80 was added to both culture media. Growth was measured in three different ways. 
Large tissue culture flasks (600 ml capacity) containing 50 ml of media and small 
flasks (50 ml capacity) with 10 ml of media were incubated stationary at 37°C,
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Figure 4.9. A) Plasmid map of pUS1706 and pUS1707 displaying the region of hybridisation to the 
probe Al/Pl (shown in black) B) Southern blot analysis of total DNA samples from M. smegmatis 
mc^l55 (I) and M. bovis BCG (II) recombinant strains bearing the plasmids pUS1706 and 
pus 1707. Lane M is X/Hindill marker; lanes 1, 2, 3 -  purified pUS1706 cut with Xbal, EcoRv and 
Pstl respectively (positive control); lanes 4 , 5 , 6 -  total mycobacterial DNA cut with Xbal, EcoRv 
and Pstl respectively showing plasmid pUS1706 restricted fragments hybridising to the probe; lanes 
7, 8, 9 -  total mycobacterial DNA cut with Xbal, EcoRv and Pstl respectively showing plasmid 
pus 1707 restricted fragments hybridising to the probe. In B (I), untransformed M. smegmatis DNA 
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while Universal screw-capped tubes with 10 ml of culture media were incubated 
shaking at 225 rpm. The M. bovis BCG Pasteur strain used as inoculum for the 
growth curves was grown until stationary phase (ODggo of about 0.9) and a 100-fold 
final dilution was made directly into each culture vessel. Growth rates were 
measured by determining the ODggo of cultures and the counts of CFU per milliliter 
every 24 hours for a period of 10 days. Results of colony-counting are not presented 
due to inaccuracy and poor correlation with optical density readings. The ODggo is a 
linear function of cell concentration only over a range of readings up to 0.2. At 
higher cell concentrations, particle coincidence effects cause departure from 
linearity generating the discrepancies observed. However, for the purpose of this 
study, optical measurements were sufficient for following growth dynamics (see 
Figure 4.10 A and B).
In Middlebrook 7H9, an initial lag phase of about 2.5 days was observed before 
active growth started, and at 8 to 9 days, cultures reached early stationary phase. 
However, when Sautons was used the following was observed: i) M. bovis BCG 
entered stationary phase one day earlier (7^  ^ day); ii) cultures set up in small flasks 
or universal tubes exhibited a marked decline in optical density towards stationary 
phase, compared to the corresponding cultures in Middlebrook 7H9. This was 
caused, most likely, by limited oxygen access to the cultures due to the confined air 
space of the small containers. In Sautons (a minimal medium), the oxygen 
deprivation must have been potentiated by a shortage of nutrients and the reduction 
of growth became more apparent.
Based on the results obtained, it was decided that for future experiments M. bovis 
BCG strains should be cultivated in large culture flasks. Firstly, a more suitably 
growth curve was achieved. Secondly, optical density readings were more 
reproducible than those obtained under the other growth conditions. Lastly, a larger 
volume of culture provided a higher yield of protein which was found to be needed 
for more reproducible and accurate enzyme assays. Growth experiments for M. 
smegmatis mc^l55 had already been done and the results are presented in Chapter 3.
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BCG grown in 7H9 + OADC
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Figure 4.10. Growth curves of M. bovis BCG in M iddlebrook 7H9 supplem ented 
with OADC (A) and in Sautons (B). Optical densities at 580 nm were measured every 
24 hours and readings were not corrected for loss of linearity. Experiments were 
performed twice.
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Optimising Conditions for Enzyme Extraction
The preparation of a cell free extract without causing damage to the enzyme is one 
of the most important and delicate steps in enzymology. The ultrasonic disruption of 
mycobacterial cells, although cumbersome and prolonged, had been used until now. 
With the purchase of a Ribolyser™, a better way of lysing cells became available 
and this alternative method was tested and optimised. M. bovis BCG strains were 
grown at 37°C for 10 days in stationary culture flasks with 50 ml of Middlebrook 
7H9 OADC enriched. Cells were harvested by centrifugation, washed and 
resuspended in 500 |xl of sterile water. The cell suspension was mixed with glass 
beads and disrupted by vigorous agitation at three different speeds (4, 5 and 6) 
combined with increasing shaking times (1,2 and 4 minutes). The lysates were then 
transferred to a new tube and centrifuged at 15,000 rpm for 10 minutes. Figure 4.11 
shows the protein content and enzyme activity obtained under the range of lysing 
conditions assessed.
The results achieved indicate that although there is little difference in the amount of 
total protein extracted under the various lysing conditions, acetyl-CoA carboxylase 
activity is severely reduced when speed 6 is used. The loss of activity can be 
explained by the gradual increase in the temperature of the extracts as shaking speed 
increases. This is supported by the observation made by Rainwater and Kolattukudy 
(1982) that the rates of carboxylation of acetyl-CoA and propionyl-CoA decreased 
when the enzyme from BCG cells was held at 40°C for increasing periods of time. 
These authors found that inactivation of acyl-CoA carboxylase can reach 53% of the 
initial activity when the enzyme is kept for 5 minutes at 40°C and, 90% of the 
activity is lost after 20 min at the same temperature. Based on the data presented on 
Figure 4.11, the protocol adopted for the preparation of extracts from mycobacteria 
was shaking at speed 4 for 4x30 seconds, keeping the samples on ice during the 
intervals.
Acetyl-CoA Carboxylase Activity
In this study, the impact of mutagenesis of the AccAl subunit in the final activity of 
acyl-CoA carboxylase from M. smegmatis and M. bovis BCG was assessed using 
acetyl-CoA as substrate. Additionally, the effects of growth conditions and
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Figure 4.11. Protein content (top) and acyl-Co A carboxylase activity (bottom) of M. bovis 
BCG extracts prepared by disruption of cells using tbe Ribolyser. Total protein w as assessed  
u sing  the B io-R ad  protein assay (see  Chapter 2). E nzym e activity w as assayed  accord ing to 
W heeler et a i  (1 9 9 2 ) u sing  acety l-C oA  as substrate. Controls w ithout acety l-C oA  or ce ll extract 
w ere a lso  tested and the readings w ere n eg lig ib le  (results not show n). Experim ental con d itions  
are d isplayed  on the x axis. D uplicate assays w ere done for each extract. T he protein content is 
expressed  in p g  o f  protein per m l o f  extract. E nzym e activity is expressed  in pm ol o f  '"^COi fix ed  
per m inute and per m g o f  protein.
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age of culture on the activity of the enzyme were examined. All experiments were 
replicated three times, and in each run, the total protein content and enzyme activity 
of extracts was determined in triplicate.
M. smegmatis me 155 transformants were grown in Sautons and in Nutrient Broth 
(containing 15 |xg/ml of Kanamycin) to stationary phase (3 days), and cell-free 
extracts were prepared and analysed. Table 4.2 illustrates the effect of medium 
composition on acetyl-CoA carboxylase activity. The activity of the enzyme was 
also monitored at different stages of growth. For this purpose, the strains were 
grown in Nutrient Broth and harvested at log (40 hours), stationary (3 days) and late 
stationary phases (6 days). Results are given in Table 4.3.
Acetyl-CoA carboxylase activity of M  smegmatis mc^l55 was, on average, 1.5 fold 
higher in Nutrient Broth than in Sautons. This trend was observed for all the 
recombinant strains regardless of plasmid profile. In fact, no reduction in enzyme 
activity was achieved in the strains containing the plasmids pUS1704 and pUS1707 
which express the mutated AccAl subunit (Table 4.2). It was also noted that acyl- 
CoA carboxylase seems to be more active in the 3 days old cultures, although there 
were no differences between strains as a function of plasmid content (Table 4.3).
The influence of growth conditions on acetyl-CoA carboxylase activity of M. bovis 
BCG transformants was investigated using stationary phase cultures (13 days) 
grown in Sautons and Middlebrook 7H9 supplemented with OADC (containing 15 
pg/ml of Kanamycin). For the time course experiments, only the latter culture 
medium was used and the enzyme was assayed at log (4 days), late log (7 days) and 
stationary phases (10 days). Results obtained are presented in Tables 4.4 and 4.5 
respectively.
Overall, the specific enzyme activity of M. bovis BCG was higher in minimal media 
than in complex media. This observation is in agreement with Wheeler et a l  (1992) 
who found that mycobacteria (M. microti and M. avium) grown in the presence of 
liposomes (phosphatidylcholine, cholesterol and phosphatidic acid) and in richer 
media showed depressed levels of acetyl-CoA and propionyl-CoA carboxylase 
activity compared to the same strains grown in more simple media. Maximum 
enzyme activity, in both wild type and plasmid containing M. bovis BCG strains, 
was found at mid-log phase and was followed by a progressive decrease as the
96
Chapter 4
Table 4.2. Specific activity of acyl-CoA carboxylase in M. smegmatis mc^l55 
transformants grown under different conditions
M. smegmatis 
mc^l55
ms 1703* msl704* msl706* msl707*
Sautons** 120.3 ± 5.3 136.2 ±4.8 105.4 ±6.0 95.2 ±7.6 85.0 ±1.7
NB** 169.0 ±6.0 190.8 ± 3.2 158 ±8.0 98.8 ±2.6 170.5 ± 9.4
Values are pmol CO2 fixed per minute and per mg of protein +/- STDVP*. Counts of 
controls without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values > 0.5 -  growth conditions do not produce significantly different results.
Table 4.3. Specific activity of acyl-Co A carboxylase in M. smegmatis me 155 
transformants at three different growth stages
M. smegmatis 
mc^l55
ms 1703* msl704* msl706* msl707*
40 hours** 
log phase
76.9 ±35.6 71.2±11.9 59.0 ±10.9 83.8 ±40.6 74.5 ± 38.4
3 days** 
stationary
261.9 ±79.0 228.2 ±5.8 237.4 ±45.3 231.0 ±39.8 213.8 ±28.7
6 days** 
late stationary
150.2 ±16.2 104.5 ± 10.9 114.8 ±69.6 142.9 ± 22.2 191.9 ±34.4
Values are pmol CO2 fixed per minute and per mg of protein +/- STD VP. Counts of 
controls without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values < 0.5 -  growth stages are significantly different.
* STD VP stands for standard deviation of populations
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Table 4.4. Specific activity of acyl-Co A carboxylase in M. bovis BCG Pasteur 
transformants grown under different conditions
M. bovis BCG Pasteur BCG1703* BCG1704*
Sautons** 45.2 ±1.3 39.9 ±1.3 60.8 ±4.7
7H9 OADC** 16.4 ±0.7 14.8 ±1.9 14.4 ±0.6
Values are pmol CO2 fixed per minute and per mg of protein +/- STDVP^. Counts of 
controls without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values < 0.5 -  growth conditions produce significantly different results.
Table 4.5. Specific activity of acyl-Co A carboxylase in M. bovis BCG Pasteur 
transformants at three different growth stages
M. bovis BCG Pasteur BCG1703* BCG1704*
4 days** 
log phase
52.6 ± 10.3 42.6 ± 6.9 40.3 ±11.9
7 days** 
late log
33.5 ± 15.6 35.2 ± 12.6 35.0 ±12.7
10 days** 
stationary
26.6 ±2.1 29.2 ±5.6 26.4 ±4.5
Values are pmol CO2 fixed per minute and per mg of protein +/- STD VP. Counts of 
controls without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values > 0.5 -  growth stages are not significantly different.
STDVP stands for standard deviation o f populations
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cultures aged. These observations are applicable to all strains regardless of plasmid 
content.
In conclusion, the I652G mutation introduced into the acc PA gene encoded by the 
plasmids failed to cause reduction in acetyl-CoA carboxylase activity. However, as 
a result of this series of experiments, differences between the two mycobacterial 
species became apparent. Acyl-CoA carboxylase of M. smegmatis and M. bovis 
BCG seems to be influenced differently by media composition and growth stage.
4.4. Discussion
To date, mycobacterial mutant strains defective in acyl-CoA carboxylase have not 
been isolated. Detrimental effects of the accBC? deletion in M. bovis BCG making 
impossible for the mutant to be grown successfully in pure culture were reported by 
Nornan et al. (1995). This observation is supported by the account of a lethal 
phenotype engendered by disruption of the ACCl"^ gene in Saccharomyces 
cerevisiae (Hablacher et a l,  1993) and the suggestion that viable acetyl-CoA 
carboxylase mutants of Bacillus subtilis are not yet available because the activity of 
this enzyme is probably essential for growth (Perez et a l, 1998). The desire to 
produce viable mycobacterial mutants avoiding the gene replacement strategy led to 
the approach and experimental design presented in this chapter. By expressing the 
mutated gene using a shuttle vector in a cell which also has an intact copy in the 
chromosome, the biotinylated and nonbiotinylated versions of AccAl were 
expected to compete to bind to the transcarboxylase subunit and a mixture of active 
and inactive dimmers would assemble. The final activity of the enzyme would be 
influenced by the ratio of active and inactive AccAl units which was controlled by 
using different promoters to express the mutated subunit. The acyl-CoA carboxylase 
activity of M. smegmatis and M. bovis BCG transformants was determined under 
different growth conditions as well as at different growth stages. However, the 
results obtained indicate that there are no significant differences between the
 ^ accBC is the designation used by Norman et al. (1995) for the gene encoding the biotinylated 
subunit o f M. tuberculosis acyl-CoA carboxylase that has now been named as accAl (Cole et al., 
1988).
A C Cl gene is the designation given by Hablacher et al. (1993) to the acetyl-CoA carboxylase gene 
of Saccharomyces cerevisiae.
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Specific enzyme activity of the strains bearing the plasmids expressing the mutated 
AccAl subunit and the controls.
Acyl-CoA carboxylase has been purified and characterised from M. smegmatis 
(Henrikson and Allen, 1979; Haase et a l, 1982), M. bovis BCG (TICE) and M. 
tuberculosis H37Ra (Rainwater and Kolattukudy, 1982). In sodium dodecyl sulfate 
polyacrylamide gels, the M. smegmatis enzyme dissociated into two subunits with 
molecular weights of 57 and 64 KDa (Henrikson and Allen, 1979; Haase et a l,  
1982). However, the enzyme from both M. bovis BCG and M. tuberculosis showed 
three major bands upon electrophoresis. The extra band was justified by Rainwater 
and Kolattukudy (1982) as being either an impurity or derived from one of the 
subunits by proteolysis. Recently, the complete genome sequence of M. tuberculosis 
H37Rv unveiled the existence of three complete carboxylase systems (Cole et a l,
1988). This finding provides an explanation for the results obtained in this thesis as 
well as for the existence of a third band in the protein gels of the enzyme purified 
from M. tuberculosis and M. bovis BCG.
There is now a line of evidence indicating that the acyl-CoA carboxylase system of 
M. smegmatis could be very different from the system in M. bovis BCG and M. 
tuberculosis. At the time this experiments were planed, it was expected that both 
wild type and mutant accPA genes from M. tuberculosis expressed in M. smegmatis 
would assemble with the transcarboxylase subunit encoded by the host genome. 
This assumption was based on the fact that biotin enzymes are known to be well 
conserved in nature and therefore it seemed plausible that a hybrid enzyme would 
be easily formed. On the grounds of recent information this might not be the case. 
The M. tuberculosis gene expressed by the plasmids probably did not assemble with 
the native transcarboxylase subunit from M. smegmatis, fact that would account for 
the lack of difference between the enzyme activity of the mutant and control strains.
At the moment, all that is known about the three different carboxylase systems in M. 
tuberculosis and, if similar, M. bovis BCG is the sequence of the genes that encode 
the three a - and six (3-subunits of the enzymes. There is no information on synthesis 
coordination or assembly of the different subunits to form active enzymes. 
Moreover, the mechanisms regulating and controlling these three systems alone and 
in conjunction with the multitude of other enzymes involved in the lipid synthesis is
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unknown. Judging by the location in the genome, a cch l and accDl probably 
encode each of the two subunits forming one of the enzyme systems. However, 
there is no knowledge on important properties of this acyl-CoA carboxylase as, for 
instance, buffer and substrate preference, optimum pH, requirements for 
bicarbonate, ATP or magnesium and maximal enzyme activity. The acetyl-CoA 
carboxylase assay used was based on the method described by Rainwater and 
Kolattukudy (1982). These authors reported the biotinylated subunit of the enzyme 
as having a molecular-weight of 63 KDa which seems to correspond to acc A3. In 
which case, the enzyme assay conditions might have not been appropriate to detect 
the activity of the enzyme we focused on and, therefore, differences in behaviour 
between mutant and wild type would have not been detected.
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INHIBITION OF EXPRESSION OF THE BIOTINYLATED 
SUBUNIT OF MYCOBACTERIAL ACYL-CoA CARBOXYLASE 
BY A COMPLEMENTARY RNA TRANSCRIPT
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5.1. Introduction
Antisense methodologies produce inhibition of specific gene products by exploiting 
hybridisation of complementary nucleic acids and are based in the natural 
occurrence of antisense control documented in a variety of biological systems. 
Natural antisense RNAs are small, diffusible, regulatory molecules that inhibit the 
function of their target RNAs to which they are complementary. Antisense RNAs 
regulate functions as diverse as plasmid replication (Tomizawa et al., 1981; Wagner 
and Nordstrom, 1986), conjugation (Dempsey, 1987; Koraimann et al., 1991) and 
maintenance (Gerdes etal., 1986, 1988), transposition (Simons and Kleckner, 1983) 
and lysis-lysogeny decisions in bacteriophages (Krinke and Wulff, 1987; Liao et al., 
1987).
In the mid 1980s a series of experiments in bacteria, mammalian cells, Xenopus 
oocytes, and Drosophila indicated that the expression of an antisense RNA 
complementary to a specific mRNA was an effective way of blocking the 
expression of a specific gene. In this manner, the consequences of the lack of gene 
expression could be examined (Muzuno et al., 1984; Izant and Weintraub, 1985; 
Coleman et al., 1984; Melton, 1985; Kim and Wold, 1985). More recently, there has 
been considerable success in eukaryotic biotechnology related to the cloning and 
expression of antisense DNA. This strategy has been extensively used ranging from 
the production of transgenic plants and animals (Day et al., 1991; Ramirez, 1995) to 
nontoxic therapies for treating neoplasms (Helene, 1994; Ratajczak et al., 1992) and 
a variety of human infectious agents (Gagnon et a l,  1995; Ramazeilles et a l ,  1994).
Two models could explain RNA interference. One is direct interaction with the 
target gene, perhaps silencing transcription at the locus. The alternative is that 
interference may prevent the processing or translation of the endogenous transcript. 
However, several observations are most consistent with interference at a 
posttranscriptional step caused by decreased mRNA stability, or impaired mRNA 
processing, transport, or translation (Tabara et a l,  1998).
The targeted, intentional inactivation of a specific gene classically requires 
disruption or replacement of the gene in question with an inactivated allele. 
Construction of mutants using techniques such as transposon mutagenesis and gene
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replacement by homologous recombination showed to be promising when studying 
non-essential genes. This approach is not however useful for genes that are vital for 
the survival of the microorganism. In contrast, antisense repression can permit a 
substantial diminution without a complete block in the synthesis of the 
corresponding gene products and, therefore, overcomes the limitation of knock-out 
strategies (Spann et a l,  1996). Although this genetic tool has been used to a much 
greater extent in eukaryotes rather than in prokaryotes, it has been shown to be 
effective in reducing bacterial protein levels (Kemodle et a l,  1997; Pestka et a l, 
1984). In addition, a conditional antisense mutagenesis system which provides a 
way of studying the effects of inactivating essential genes in mycobacteria has been 
reported (Parish and Stoker, 1997).
This chapter describes the construction and use of RNA complementary to the 
acc A l  mRNA to partially block expression of the biotinylated subunit of acyl-CoA 
carboxylase. The acc A l  gene from M. tuberculosis is expected to share a higher 
degree of homology with the gene from M. bovis BCG rather than with the gene 
from M. smegmatis. For this reason, interference with expression of the biotinylated 
subunit is less likely to be successful in M. smegmatis than in M. bovis BCG. 
Nevertheless, experiments were carried out using both species with the aim of 
investigating the effect of decreased amounts of acyl-CoA carboxylase in 
mycobacteria.
5.2. Design and Construction of Antisense Expression Vectors
Plasmid-based antisense methods employ expression vectors which generate RNAs 
containing sequences complementary to key regions of specific genes. In most 
instances, any RNA segment of about 200 to 1000 nucleotides or greater appears to 
be capable of inducing interference (Tabara et a l,  1998). The two antisense 
expression vectors constructed were designed to direct sequestration of the 
translation initiation region involving the Shine-Dalgarno sequence and the start site 
of the acc A l  gene homologue of M. smegmatis and M. bovis BCG. For this 
purpose, a fragment of the 5’ terminus of the acc A l  gene of M. tuberculosis was 
cloned into the expression vectors pUS1940 and pUS1705 in an antisense 
orientation with respect to the endogenous gene. The cloning strategy adopted also 
permitted cloning of the sense gene fragments giving rise to the respective control
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plasmids. Table 5.1 lists the vectors mentioned in this chapter and Figure 5.1 
provides the integrated diagrams.
Table 5.1. Plasmids used
Plasm id Properties
pUS 1940^ pUS1834*-based 18KDa promoter expression vector
pUS1705^ pUS1834-based hsp60 promoter expression vector
pUS1708 Sense (5’ to 3’) acc A l  amino terminal fragment in pUS1940
pUS1709 Antisense (3’ to 5’) accAl amino terminal fragment in pUS1940
pUS1710 Sense (5’ to 3’) accAl amino terminal fragment in pUS1705
p u s n i i Antisense (3’ to 5’) acc A l amino terminal fragment in pUS1705
Construction ofpUS1708 andpUS1709
A  282 bp DNA fragment of the acc A l  gene was generated by PCR. The forward 
primer A l (5’-AAATGCTCTAGATAGGATGTGAGGCGATGT-3’) contains the 
natural Shine-Dalgamo region as well as the gene start codon (in bold), and the 
reverse primer PI (5’-AAATGCTCTAGAAGCCCGGATGGAT-3’) is complementary 
to nucleotides 243-231 of acc A l .  The PCR primers were designed so that the 
amplified fragment would contain Xbal restriction site (underlined) on both 5’ and 
3’ ends. The amplification was carried out in 25 pi volumes containing Ix buffer, 
0.25 mM dNTPs, 100 pmol of each primer, lU  of Tag polymerase and 1 ng of 
plasmid DNA as template. Products were obtained after 1 cycle of dénaturation 
(96°C, 10 min) followed by 30 cycles of amplification consisting of dénaturation 
(96°C, 1 min), annealing (58°C, 2 min) and primer extension (72°C, 1 min). An 
extra extension step (72°C, 10 min) took place at the end of the PCR reaction. The 
PCR product was purified and digested with Xbal, the restriction enzyme was 
removed by another purification step and the fragment was ligated to Xbal-cut
* For details on pUS1834, pUS1940 and pUS1705 please refer to Chapter 4.
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p u s  1940. Plasmids containing an insert were double digested with BamHI and 
EcoRV in order to determine the orientation of the cloned fragment. A plasmid 
containing the acc A l  fragment in the reverse orientation with respect to the 
promoter for the ISKDa antigen from M. leprae originated the antisense expression 
vector pus 1709. A plasmid with the insert in the same orientation as the promoter 
gave rise to the control sense vector pUSlTOS (Figure 5.2).
Construction ofpUSlJlO andpUSlJll
The NH2 terminus region of the accAl gene was cloned into pUSlVOS. The insert 
amplification, cloning procedures and selection of the sense control vector, 
pUSlTlO, and the antisense expression vector, pU S lT ll (Figure 5.3), were done as 
described in the previous section. The DNA sequence of the cloned fragment was 
checked in all four plasmids in order to verify its identity and orientation.
Construction of mycobacterial isogenic strains
The plasmids pUS1708, pUS1709, pUS1710 and pUS1711 were transformed into 
M. smegmatis mc^l55 and M. bovis BCG Pasteur. In order to confirm the presence 
and integrity of the plasmids, total DNA was isolated from each transformant and 
digested with BamHI-FcoRV and Pstl. Southem-blot hybridisation was performed 
using the probe A l/P l that corresponds to the entire cloned fragment of acc A l .  
Total DNA from M. bovis BCG transformants was also digested with Pstl and 
hybridised with the probe INS/BX which is specific for IS6110 (insertion sequence 
existent only in species of the M. tuberculosis complex). The presence of a fragment 
of the predicted size authenticates the nature of the strain used (results not shown). 
Both probes were generated by PCR and labelled with digoxigenin by random 
primed DNA labelling. Figures 5.4 and 5.5 display the Southern blot results as well 
as the map of vectors showing the position of hybridisation of probe A l/P l.
Plasmid rescue in E. coli and subsequent restriction analysis with the enzymes 
mentioned above, produced the expected result confirming the correctness of these 
plasmids once recovered from M. smegmatis mc^l55 and M. bovis (data not shown).
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5.3. Assessment of Acyl-CoA Carboxylase Activity
To determine the effect of the antisense expression vectors on mycobacterial acyl- 
CoA carboxylase activity, cell free extracts from the antisense (msl709, m slT ll 
and BGC1709 and BCG1711) and control strains (msl708, m sl710 and BGC1708 
and BCG1710) were prepared and the enzyme activity assayed^. M. smegmatis 
mc^l55 wild type and recombinant strains were grown in Nutrient Broth for 40 
hours (log), 3 days (stationary) and 6 days (late stationary)^. The results obtained for 
the enzyme activity using acetyl-CoA as substrate can be seen in Table 5.2. M. 
bovis BCG wild type and transformants were also assayed for enzyme activity at 
different stages of growth. All strains were cultured in Middlebrook 7H9 
supplemented with GADC for 4 days (log), 7 days (late log) and 10 days 
(stationary)"^ before cells were harvested and lysed. Experiments were performed in 
three different occasions, and in each run, the total protein content and enzyme 
activity of the extracts was determined in triplicate. The data obtained is presented 
in Table 5.3.
Judging from the two sets of results, expression of the segment of antisense mRNA 
complementary to the 5’ end of the acchX gene failed to reduce the activity of acyl- 
CoA carboxylase both in M. smegmatis and in M. bovis BCG. Maximum activity 
was observed at different growth stages according to the species involved. In M. 
smegmatis mc^l55, the enzyme is more active in the 3 days stationary phase 
cultures whereas in M. bovis BCG, the peak activity is obtained at early to mid-log 
phase. These results are in conformity with those presented in Chapter 4 and 
indicate that the two species may have different regulatory mechanisms for acyl- 
CoA carboxylase gene expression.
5.4. Proteomic Analysis of Mycobacterial Biotinylated Proteins
At this stage into the investigation of mycobacterial acyl-CoA carboxylases, the 
genome sequence of M. tuberculosis was published (Cole et a l, 1998) and shown to 
contain genes coding for three different enzyme systems. Consequently, it became
^Mycobacterial extracts were prepared as described in Chapter 4. Enzyme activity was assayed 
according to Wheeler et al. (1992) using acetyl-CoA carboxylase as substrate,
 ^M. smegmatis mc^l55 growth curves are discussed in Chapter 3.
M. bovis BCG growth curves are discussed in Chapter 4.
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Table 5.2. Specific activity of acetyl-Co A carboxylase in M. smegmatis mc^l55 
transformants at three different growth stages
M. smegmatis 
mc^l55
ms 1708* msl709* msl7I0* m sl7Il*
40 hours** 
log phase
76.9 ±35.6 62.7 ± 12.0 79.3 ±31.7 65.0 ±23.1 70.4 ± 25.3
3 days** 
stationary
261.9 ±79.0 207.7 ± 25.6 243.8 ± 59.8 224.7 ±42.7 219.9 ±31.0
6 days** 
late stationary
150.2 ±16.2 154.9 ± 34.5 165.7 ±31.1 139.9 ± 29.0 148.2 ±44.1
Values are pmol CO2 fixed per minute and per mg of protein +/- STDVP^. Counts of 
controls without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values < 0.5 -  growth conditions produce significantly different results.
Table 5.3. Specific activity of acetyl-CoA carboxylase in M. bovis BCG Pasteur 
transformants at three different growth stages
M. bovis BCG 
Pasteur
BCG1708* BCG1709* BCG1710* BCG1711*
4 days** 
log phase
52.7 ± 10.3 26.2 ±13.8 29.0 ±19.9 40.4 ±1.5 34.9 ±11.9
7 days** 
late log
33.5 ±15.6 30.8 ± 10.5 29.6 ±11.7 38.4 ± 14.2 38.4 ±14.1
10 days** 
stationary
26.6 ±2.1 27.9 ±1.0 28.5 ±0.9 27.2 ±1.4 23.6 ±5.2
Values are pmol CO2 fixed per minute per mg of protein +/- STDVP\ Counts of controls 
without acetyl-CoA or cell-free extract were negligible (data not shown).
* p values > 0.5 -  transformant strains are not significantly different from control.
** p values > 0.5 -  growth stages are not significantly different.
STD VP stands for standard deviation o f populations
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important to assess the number of possible biotinylated proteins in M. bovis BCG 
and their pattern of expression at different stages of growth, as well as to establish 
whether there is more than one carboxylase system in M. smegmatis. This study 
involved the application of proteomics using SELDI (Surface Enhanced Laser 
Desorption Ionization) and was made possible by a short term loan of the equipment 
by Ciphergen Biosystems, Inc. Two experiments using different sets of conditions 
were carried out, although the confirmation of results could not be done.
M. bovis BCG was grown in Middlebrook 7H9 supplemented with OADC and 
harvested after 5, 8 and 13 days, whereas M. smegmatis was grown in Nutrient 
Broth and harvested after 4 days. Cell free extracts were prepared as before. For the 
selective binding of biotinylated proteins, spots of an activated metal chip were pre­
coated with avidin. Bovine serum albumin (BSA) was used to pre-coat the negative 
control spots. Each mycobacterial extract was loaded to both a streptavidin and 
BSA coated spot. Samples were diluted in PBS containing 100 mM NaCl and 0.2% 
Triton, and 10 jig of total protein was loaded onto the chip which was incubated in a 
humid chamber at room temperature for 2 hours. Afterwards, the chip was washed 
twice in PBS plus 100 mM NaCl and 0.2% Triton to remove unspecific binding. 
Finally, an energy absorbing molecule, in this case, sinapinic acid in saturated 
solution, was added to the chip and allowed to dry. Analysis of the captured proteins 
was performed using a SELDI PBS. A laser beam hits the metal surface causing the 
release of proteins in an ionised form, which are then detected by a time of flight 
mass spectrophotometer (TOE).
The results obtained are presented in Figure 5.6. Lane 7, corresponding to M. 
smegmatis, shows the presence of a 63.9 KDa protein which probably is the 
biotinylated subunit of acyl-CoA carboxylase described by Henrikson and Allen 
(1979). This appears to be a genuine peak as it is not present in the negative control 
(lane 8). No other proteins were detected in the range of 40 to 80 KDa. M. bovis 
BCG extracts did not contain any proteins of the sizes predicted by the genome 
sequence for the a  and (3 subunits of M. tuberculosis acyl-CoA carboxylases. 
Nevertheless, a 44 KDa protein present in the 8 days culture extracts (lane 3) 
warrants further investigation.
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Figure 5.6. Profiles of biotinylated proteins present in M. bovis BCG (mid-log, late log and 
stationary phase) and M. smegmatis (stationary phase) extracts. Assay conditions were as 
follows: Diluent and wash solution: PBS + 1 0 0  mM NaCl + 0.2% Triton; Total 
protein: about 10 pg; Incubation conditions: at room temperature for 2 hours. Mass 
range displayed = 0 to 80 KDa.
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To further attempt detection of the enzyme subunits from M. bovis BCG, a second 
experiment was carried out. This time, the total protein loaded onto the chip was 
increased to 100 pg and incubation took place at 4°C overnight. The stringency of 
the washings was also lowered, and for that, PBS plus 0.2% Triton without salt was 
used. Under these conditions, peaks for three possible proteins with molecular 
masses of 54.4, 57.0 and 67.3 KDa are visible in the extracts of the 5 days old (mid­
log) M. bovis BCG (lane 1 on Figure 5.7). Unfortunately, the peak corresponding to 
the larger protein (67.3 KDa) overlaps with the peak for BSA in the negative control 
(lane 2). The 44 KDa protein observed in the previous experiment was absent (lane 
3) and no proteins of the appropriate sizes were detected in the 8 days (late-log) and 
13 days (stationary) cultures. The presence of the M. smegmatis biotinylated subunit 
was confirmed (lane 7).
Although these are only preliminary results, some conclusions can be drawn. 
Firstly, these experiments seem to indicate that expression of acyl-CoA 
carboxylases in M. bovis BCG is low, or at least substantially lower than in M. 
smegmatis. Secondly, the level of expression of these enzymes is apparently higher 
in younger cultures than in older ones. This hypothesis is supported by the 
observation that in M. bovis BCG, the highest enzyme activity was observed at mid­
log phase. Lastly, the evidence seems to indicate that M. smegmatis contains only 
one carboxylase system. The study of M. smegmatis biotinylated proteins was 
scaled down due to the limited number of samples that could be analysed in each 
experiment. Maximum activity of acyl-CoA carboxylase in M. smegmatis is reached 
around the third day of growth, and for this reason, only stationary phase extracts 
were assayed. The possibility that other enzyme systems may be expressed at 
growth stages that were not analysed in these experiments can not be discarded.
5.5. Discussion
There are several potential advantages of the antisense method for creating isogenic 
strains. First, the speed and technical ease with which this strategy can be 
implemented. Second, the expression of an antisense DNA fragment reduces the 
production of a protein without eliminating it completely. For genes that are 
essential, allelic inactivation is a lethal event whereas the antisense strategy permits 
reduced levels of production that may be sufficient for the microbe to survive.
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Figure 5.7. Profiles of biotinylated proteins present in M hovis BCG and M smegmatis 
extracts. Assay conditions were as follows: Diluent and wash solution: PBS + 0.2% 
Triton without salt; Total protein: 75-100 |Lig; Incubation conditions: overnight at 
4°C. Mass range displayed = 50 to 80 KDa.
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Lastly, the possibility of inhibiting multiple copy genes or gene homologues, as the 
expression of an antisense DNA fragment would be expected to act globally to 
reduce the formation of the proteins encoded by homologous genes.
Deletion of the accQC {accAl) gene in M. bovis BCG has been shown to be 
detrimental (Norman et a l, 1995). To avoid the lethal effects of an allelic 
inactivation, the antisense strategy was adopted to reduce the synthesis of acyl-CoA 
carboxylase in M. smegmatis and M. bovis BCG. Interestingly, another advantage 
for having used this strategy became apparent after the genome sequence of M. 
tuberculosis H37Rv was published. It is predicted that there are three genes {accAl, 
accA l, accA3) coding for biotinylated subunits of acyl-CoA carboxylase (Cole et 
a l,  1998) that were unknown at the time this work was performed. Thus, expression 
of the anti-flccAl mRNA also had the potential to reduce simultaneously the 
expression of the other two alleles.
Crowley et a l  (1985) showed that by using an antisense construct of the discoidin 
gene (developmentally regulated protein encoded by a three-member multigene 
family) transfected into Dictyostelium, the level of expression of the three 
endogenous discoidin genes was greatly reduced. These authors suggested that the 
reduction in discoidin production in strains carrying the antisense plasmid is due to 
the expression of an RNA from this construct that has strong homology to the 
discoidin mRNAs expressed by all members of the gene family.
To reduce the activity of mycobacterial acyl-CoA carboxylase, a fragment of the 
NH2  terminus of the M. tuberculosis accAX gene was expressed in an antisense 
orientation with respect to the endogenous gene. The working hypothesis for the 
mechanism that leads to the decrease in the production of a specific protein involves 
binding of complementary regions of the normal sense mRNA and the antisense 
RNA strand containing anti-Shine-Dalgamo sequences. Translation is repressed by 
the sequestration of the ribosome recognition element in the mRNA. The resulting 
duplexes are then rapidly hydrolysed by RNAse III (Gerdes et a l,  1992).
The antisense approach has however failed to produce significant differences in the 
activity of acyl-CoA carboxylase between mutant and control strains of both M. 
smegmatis and M. bovis BCG. M. tuberculosis and M. smegmatis bear considerable 
differences and, therefore, the genes encoding acyl-CoA carboxylase in both species
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are likely to be distinct. Consequently, the M. tuberculosis accAl antisense mRNA 
generated intracellularly might have lacked sufficient homology to hybridise and 
block translation of the correspondent mRNA expressed by the genome of M. 
smegmatis. In fact, the probe A l/P l, which corresponds to the entire cloned 
fragment of the M. tuberculosis accAX gene, does not hybridise to M. smegmatis 
genomic DNA in Southern blot experiments (Figure 5.5 B (I)). Moreover, M. 
smegmatis appears to have only one acyl-CoA carboxylase system composed by a 
64 KDa biotinylated subunit. This protein probably corresponds to the AccA3 
subunit of M. tuberculosis (63.8 KDa) rather than to the AccAl subunit (70.6 KDa).
Because M. tuberculosis and M. bovis BCG are closely related, the genes coding the 
acyl-CoA carboxylase systems of these two species are expected to share a high 
degree of homology. Alignment of the DNA sequences of M. tuberculosis accA l 
and accA l genes revealed that there is a 65% homology in the first 243 bp 
downstream from the initiation codon. The homology between accA l and acc A3 
for the same region is 63.4% (Figure 5.8). The similarities between the 5’ end of the 
three genes makes it tempting to speculate that the acc A l  anti-mRNA expressed 
should be able to interfere with the translation of all genes. Still, the strains bearing 
the antisense plasmid had similar levels of enzyme activity compared to the 
controls. Southern blot experiments show that the probe A l/P l hybridises to M. 
bovis BCG genomic DNA confirming that this strain contains, at least, the accA l 
gene (Figure 5.5 B (H)). Nevertheless, assuming that M. bovis BCG also has three 
carboxylase systems, hybridisation between the accAl antisense fragment and the 
accA l and accA3 mRNA might have not occurred in vivo, possibly due to higher 
stringency of physiological conditions.
The reasons presented above provide a reasonable explanation for the non-reduction 
of acyl-CoA carboxylase activity in both M. smegmatis and M. bovis BCG by the 
use of an antisense strategy. Finally, it may not always be possible to achieve 
antisense inhibition due to technical limitations of the methodology. One of the 
disadvantages of the antisense approach is that the anti-mRNAs produced are long 
read-through molecules without proper termination which are probably unstable. 
Another drawback of the system concerns the level of expression of acc A l  anti- 
mRNA which might have not been enough to reduce the activity of the enzyme.
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Finally, for better results it is also recommended the assessment of the optimal size 
and region for targeting by antisense fragments.
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CLUSTAL W ( 1 . 7 4 )  m u l t i p l e  s e q u e n c e  a l ig n m e n t
g a p  o p e in g  p e n a l t y =  1 0 0 . 0  ( 0 - 1 0 0 )
Gap e x t e n s i o n  p e n a l t y =  1 .0  ( 0 - 1 0 )
DNA w e ig h t  m a tr ix =  lUB  
K - t u p le s =
Gap o p e n in g =
a c c A l ATGTTTGACACC GTACTAGTGGCCAACCGCGGTGAGATCGCGGTTCGGGTGATTCGG
accA 2 ATGGGAATCACTCGAGTATTGGTTGCTAACCGCGGCGAGATCGCCCGGCGGGTG-TTCGC
*** *** *** * ** ** ******** ******** ****** ****
a c c A l ACGCTGC-GCCGGCTAGGCATCCGGTCGGTCGCGGTCTACAGCGACCCCGACGTCGATGC
accA 2 CACCTGCCGCCGGCTGGGGCTCGGCACCGTCGCCGTCTACACAGACCCGGATGCCGCGGC
* * * *  * * * * * * *  * *  * *  *  *  * * * * *  * * * * * * *  * * * * *  *  *  *  * *  * *
a c c A l  CCGCCACGTCTTGGAGGCGGACGCTGCGGTGCGGCTGGGGCCCGCCCCAGCACGCGAAAG
accA 2 ACCGCATGTCGCCGAGGCCGACGCCCGGGTCCGGCT--------------GCCGCAGACCACCGA--
*  * *  * * *  * * * * *  * * * * *  * * *  * * * * * * * *  *  *  *  *  *  *
a c c A l  CTACCTCGATATCGGCAAGGTGCTCGATGCTGCGGCGC— GCA-CCGGAGCCCAGGCGAT
accA 2 CTATCTG AACGCCGAGGCGATCATCGCGGCCGCGCAGGCAGCCGGAGCCGACGCGGT
*  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  * * * * * * * *  *  *  *  *  *
a c c A l
accA 2
CCATCCGGGCT 
GCATCCCGGCT 
* * * * * * * * *
CLUSTAL W ( 1 . 7 4 )  m u l t i p l e  s e q u e n c e  a l ig n m e n t
g ap  o p en  p e n a l t y =  1 0 0 . 0  
g ap  e x t e n s i o n  p e n a l t y =  1 .0  
DNA w e ig h t  m a tr ix =  lUB
a c c A l  ------------------------------------------------------------------------ ATGTTTGACACCGTACTAGTGGCCAACCGC
accA 3 GTGGCTAGTCACGCCGGCTCGAGGATCGCTCGGATCTCTAAGGTTCTCGTCGCCAATCGC
*  *  *  *  *  *  *  *  *  * * * * *  *  *  *
a c c A l GGTGAGATCGCGGTTCGGGTGATTCGGACGCTGCGCCGGCTAGGCATCCGGTCGGTCGCG
accA 3 GGCGAGATCGCAGTGCGGGTGATCCGGGCGGCCCGCGACGCCGGCCTGCCCAGCGTGGCG
*  *  * * * * * * * *  *  *  * * * * * * * *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *
a c c A l GTCTACAGCGACCCCGACGTCGATGCCCGCCACGTCTTGGAGGCGGACGCTGCGGTGCGG
accA 3 GTGTACGCCGAACCCGACGCCGAGTCCCCGCATGTTCGGCTGGCCGACGAGGCGTTCGCG
*  *  * * *  * * *  * * * * * * *  * * *  * * *  * *  * *  *  * * *  * * * *  * * *  *  *
a c c A l CTGGGGCCCGCCCCAGCACGCGAAAG--CTACCTCGATATCGGCAAGGTGCTCGATGCTG
accA 3 CTGGG— CGGCCAGACCTCGGCGGAGTCCTATCTGGACTTCGCCAAGATCCTCGACGCGG
* * * * *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  * * * *  *  * * * * *  *  *  *
a c c A l CGGCGCGCACCGGAGCCCAGGCGATCCATCCGGGCT
accA 3 CAGCCAAGTCCGGGGCCAACGCCATCCACCCCGGCT
*  * *  * * * *  * * *  *  * *  * * * * *  * *  * * * *
Figure 5.8. CLUSTAL W alignments of the first 243 bp of M. tuberculosis H37Rv 
accPil, accAl and acc A3 genes.
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GENERAL DISCUSSION
Chapter 6
It is important to note that this study has used M. smegmatis mc^l55 and M. bovis 
BCG as mycobacterial models although the gene under investigation belongs to M. 
tuberculosis H37Rv. The slow growth and pathogenicity of the tubercle bacillus, 
regardless of presenting a major challenge, hampers the course of laboratory 
research. Nevertheless, many important questions can be addressed by using fast 
growing mycobacterial relatives such as M. smegmatis. The advantages are 
illustrated by comparing the time required for obtaining recombinant mycobacteria 
from transformation experiments, which is 3 to 4 days for M. smegmatis mc^l55 
and 3 to 4 weeks for M. tuberculosis. Although time saving, this approach is not 
totally satisfactory since these two strains differ in many fundamental aspects. 
Consequently, there is the need to also make use of the attenuated anti-tuberculosis 
vaccine strain bacille Calmette-Guerin (BCG), which grows as slowly as M. 
tuberculosis but avoids safety risks related to cultivation and handling of highly 
pathogenic strains. Ultimately, the utilisation of a number of different mycobacterial 
systems is expected to be relevant to our understanding of M. tuberculosis.
Mycobacteria produce unusual cell walls with low permeability and a high content 
of unique lipids, glycolipids and polysaccharides. Although the ability of M. 
tuberculosis to cause disease has not yet been associated with any well-defined 
virulence factors, several of these lipidic moieties may contribute to mycobaterial 
longevity, trigger inflammatory host reactions and act in pathogenesis. Distinct 
biosynthetic pathways generate cell-wall components such as mycolic acids, 
mycocerosic acid, phenolthiocerol, lipoarabinomannan and arabinogalactan. This 
thesis deals with acyl-CoA carboxylase, the enzyme that catalyses the first 
committed step in lipid biosynthesis. The experimental strategies focused, in 
particular, on the biotinylated protein gene «ccBC cloned and sequenced by Norman 
et al. (1994), which is now designated accAl and known to be one of three 
biotinylated proteins encoded by the genome of M. tuberculosis H37Rv (Cole et al., 
1998). However, all experiments were planned and performed before the 
publication of the genome sequence, and therefore, without any knowledge of the 
existence of accA l and acc A3. This causes some uncertainty in interpreting the 
results obtained because conclusions can not be drawn without considering possible
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differences between the three acyl-CoA carboxylase systems. Furthermore, 
reviewing earlier literature becomes speculative and re-evaluation of many of the 
reported findings is urgently required.
This final chapter integrates data presented in Chapters 3 to 5, concentrates on 
unresolved questions and discusses the current state of the art on mycobacterial 
carboxylase systems. Taken together, the results obtained throughout this thesis 
demonstrate that:
i) In vivo inhibition of the activity of M. smegmatis acyl-CoA carboxylase 
could not be achieved by depletion of biotin, most likely due to the ability of this 
microorganism to synthesise the vitamin.
ii) Expression of the accAl mutated gene was not sufficient to cause a decrease 
in the final activity of mycobacterial acyl-CoA carboxylase. A possible explanation 
is that the remaining two active carboxylase systems may compensate for the lack 
of activity of the enzyme composed by AccAl/AccDl^'\
iii) Expression of an anti-accAl mRNA was not sufficient to reduce the final 
activity of mycobacterial acyl-CoA carboxylase. Although the 5’ end of the genes 
coding for the three biotinylated subunits are reasonably related (around 60% 
identity), hybridisation between an anti-sense mRNA of the acc A l  gene and the 
mRNA of acc A2  and acc A3 might have not occured in vivo. Therefore, an anti­
sense strategy aimed at interfering simultaneously with expression of all three 
biotinylated subunits needs to be redesigned.
iv) The level of acyl-CoA carboxylase activity in M. bovis BCG is considerably 
lower than in M. smegmatis. Maximum activity of the enzyme is also observed at 
different stages of growth suggesting that the two species might have different 
regulatory mechanisms.
The approaches in ii and iii rely on the similarity of enzyme structure and gene 
sequence between different species of mycobacteria. M. tuberculosis shares over 
99.9% identity at the DNA level with the other members of the tubercle complex 
(Gordon et al., 1999). Instead, there are considerable genetic differences between 
M. tuberculosis (slow grower) and M. smegmatis (fast grower). This perhaps
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provides the main explanation for the lack of inhibition of acyl-CoA carboxylase 
activity in M. smegmatis.
Speculation on the organisation ofM. tuberculosis acyl-CoA carboxylases
To the present date, acyl-CoA carboxylase has been purified and characterised from 
M. smegmatis (Henrikson and Allen, 1979; Hasse et a l, 1982), M. bovis BCG and 
M. tuberculosis (Rainwater and Kolattukudy, 1982). Judging by the size of the 
biotinylated subunit (63 KDa) upon SDS-PAGB gels, it seems that these workers 
purified from both M. smegmatis and M. bovis BCG, a carboxylase that corresponds 
to the M. tuberculosis enzyme system containing the Acc A3 subunit (64 KDa). 
Interestingly, in the hands of Rainwater and Kolattukudy (1982), the final enzyme 
preparation from M. tuberculosis and M. bovis BCG contained, not two, but three 
subunits of 63, 60 and 57 KDa. The larger subunit was shown to contain biotin, the 
middle sized assumed to be the non-biotinylated subunit, and the smaller protein 
considered to be either a proteolysis product or an impurity.
However, the recent information disclosed by the genome sequence provides a 
reasonable explanation for this finding. The genome of M. tuberculosis H37Rv 
encodes three biotinylated and six non-biotinylated subunits, which means that there 
are three “spare” non-biotinylated subunits (Cole et a l, 1988). The size of the 
protein (57 KDa) classified as an impurity by Rainwater and Kolattukudy (1982) is 
the same as the predicted sizes of three non-biotinylated subunits of M. tuberculosis 
(56.7 - accDl; 56.2 - accDl] 56.2 - accD4). Therefore, it is tempting to speculate 
that the Acc A3 subunit might assemble with more than one non biotinylated subunit 
in order to form a complete and active enzyme. The acc A3 gene and the four accD3 
to accD6 genes are scattered in the genome of M. tuberculosis allowing independent 
expression and regulation to take place. As a result, a combination of different 
enzymes can be produced. Instead, accAl and accDl as well as accA2 and accD2 
seem to be part of an operon. It seems plausible that the carboxylases encoded by 
these genes are composed of two subunits only. Nevertheless, the number of 
biotinylated (3) and non-biotinylated subunits (6) makes possible, if only
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mathematically, the existence of three carboxylase systems containing two 
transcarboxylase subunits each.
Modulation of specificity of acyUCoA carboxylase
Mycobacterial acyl-CoA carboxylases have the ability to use several CoA esters as 
substrate. The carboxylase of M. smegmatis functions as both propionyl-CoA and 
acetyl-CoA carboxylase (Haase et a l,  1982). The enzymes from M. tuberculosis 
and M. bovis BCG clearly prefer propionyl-CoA, but also carboxylate acetyl-CoA 
and butyryl-CoA (Rainwater and Kolattukudy, 1982). In general, acyl-CoA 
carboxylases are quite specific for their acyl-CoA substrates, presumably because of 
steric restrictions at their transcarboxylase sites. Therefore, some sort of modulation 
of specificity of the mycobacterial enzyme must be in place.
Hasse et al. (1982) made an interesting observation concerning the enzyme from M. 
smegmatis which is formed by a core of six biotin-free subunits (A subunits) 
attached to six biotin-containing subunits (B subunits) \  An insight into this 
structure was obtained by dissociation of the intact enzyme into an A3B3 form in the 
presence of 0.33M sodium sulfate which, surprisingly, is enzymatically active 
although differs from the AgBg form in substrate specificity. The A3B3 form has an 
increased activity with acetyl-CoA and a decreased activity with propionyl-CoA, 
contrary to the native form. This modulation of specificity to different acceptor 
substrates by sulfate had been already noticed by Erfle (1973) and was now shown 
to be accompanied by a partial dissociation of the quaternary structure of the 
enzyme (Hasse et a l,  1982). This dual substrate specificity raises a pertinent 
problem. Methylmalonyl-CoA, the product of the carboxylation of propionyl-CoA, 
is not a substrate for chain elongation by the M. smegmatis fatty acid synthetase 
(Erfle, 1973) in accordance with the absence of methyl-branched acids (mycocerosic 
or phthienoic acids) in this particular mycobacterial strain (Asselineau, 1966). 
However, the presence of methylmalonyl-CoA mutase has been detected in M. 
smegmatis (Stjernholm, 1962). This enzyme may convert methylmalonyl-CoA to
 ^ The various nomenclatures adopted for the mycobacterial acyl-CoA carboxylase are explained in 
detail on Table 1.1, page 35.
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succinyl-CoA, which can then be incorporated into the tricarboxylic acid cycle. In 
this respect, mycobacterial carboxylases might play key roles in two metabolic 
pathways, fatty acid biosynthesis and succinate metabolism.
The need for more than one carboxylase system
In higher eukaryotes, the specialisation of tissues requires complex responses of 
fatty acid synthesis at different developmental stages and under different 
physiological conditions. For controlling amounts of fatty acids, mammalian cells 
are endowed with two acetyl-CoA carboxylase systems (ACC-a and ACC-p). 
ACC-a is the rate limiting enzyme in the biogenesis of long-chain fatty acids, and 
ACC-p is believed to control mitochondrial fatty acid oxidation (Kim, 1997). 
Furthermore, the ACC-a contains two promoters that respond differentially to 
external agents leading to the tissue-specific generation of multiple forms mRNA 
(Kim et a l ,  1996). This may provide different tissues with an additional level of 
acetyl-CoA carboxylase regulation and control of fatty acid synthesis, both at the 
gene level and at the translational level. The new isoform ACC-p has been 
implicated as the acetyl-CoA carboxylase that controls fatty acid oxidation. 
Consequently, malonyl-CoA may not only provide the building blocks for the 
synthesis of fatty acids but act as a key regulatory agent of mitochondrial fatty acid 
oxidation in mammalian systems (McGarry et a l,  1978). The unique involvement 
of acetyl-CoA carboxylase in both fatty acid synthesis and degradation, together 
with its position in the metabolic pathway, requires a complex and interlocking 
regulatory mechanism for this enzyme. However, a clear division of tasks between 
mammalian ACC-a and ACC-p in fatty acid synthesis and oxidation, respectively, 
has not yet been defined experimentally.
Why M. tuberculosis H37Rv has the potential for synthesising three carboxylase 
systems is not known. A great deal of research is needed in order to clarify this 
aspect of the lipid metabolism in mycobacteria.
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Importance of acyl-CoA carboxylase in mycobacteria
Replacement of the accAl^  gene by homologous recombination in M. bovis BCG 
indicated that deletion of this gene might be detrimental to the mycobacterial cell 
(Norman et a l,  1995), although these effects may have arisen due to polar effects of 
the mutation. Nevertheless, some species of mycobacteria seem to be capable of 
surviving and growing without acyl-CoA carboxylase. Activity of this enzyme 
cannot be detected in M. lepraemurium (Kusaka, 1977) and is hardly detected in M. 
leprae (Wheeler et a l,  1992). This raises the debate about whether expression of 
this enzyme is universal among mycobacteria.
Reduction of the de novo fatty acid synthetase activity as a result of an external 
supply of lipids has been reported (Wheeler et a l  1990). In fact, acetyl-CoA- 
dependent elongase activity was shown to be enhanced when mycobacteria were 
grown in the presence of lipid whereas malonyl-CoA-dependent activity was 
reduced. This implies that, under these conditions, acyl-CoA carboxylase might be 
repressed. Therefore, mycobacteria are able to use acetyl-CoA directly to elongate 
fatty acids obtained from exogenous sources. Lipids of the mycobacterial cell wall 
would then be derived by elongation and transformation of the host’s fatty acids 
once acquired and transported into the cell (Wheeler et a l,  1990).
Role ofacyl-CoA esters
Long-chain fatty acids and their derivatives are involved in all aspects of cellular 
structure and function. They are the main energy reserve and the primary 
component of membranes, as well as part of lipid second messengers that perform 
indispensable regulatory functions by mediating the signal transduction of various 
external and internal agents (Faergeman and Knudsen, 1997). For a unicellular 
microorganism such as M. tuberculosis, the effects of environmental challenges will 
be experienced by the external face of the cell wall. For instance, the fluidity and 
phase state of bacterial lipid bilayers commonly change according to environmental 
conditions in order to maintain critical functions of the envelope as a semipermeable
 ^A ccA l is the designation adopted by Cole et a l  (1998) for the accBC gene cloned and sequenced 
by Norman et a l, (1994),
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and selective barrier. In E. coli, an intricate set of alterations in membrane lipid 
metabolism is evoked by conditions causing growth arrest. Under such 
circumstances, specific changes in the membrane lipid fatty-acid composition are 
necessary for survival of the cell. Membrane lipids are used as endogenous carbon 
energy reserves as well as precursors for reorganisation and remodelling of the lipid 
composition (DiRusso and Nystrom, 1998). M. tuberculosis H37Rv and M. bovis 
BCG undergo ultrastructural morphology modifications during stationary phase 
induced by low oxygen tension. The cell wall thickens, apparently, due to an 
increase in its lipid composition (Cunningham and Spreadburry, 1998). This 
transformation, which possibly is a manifestation of the dormant state of M. 
tuberculosis, may offer protection against hostile environments such as the toxic 
conditions associated with granulomas, enabling the long term survival of this 
pathogen.
Although the biochemistry of the pathway catalysed by acyl-CoA carboxylase is 
now well understood, much less is known about how mycobacteria control the very 
different amounts and types of lipids produced. Acyl-CoA carboxylase is one 
possible control point for the regulation of the rate of fatty acid synthesis. However, 
the biochemical modulators that act on this enzyme and the factors that in turn 
control these modulators are poorly understood. Or, perhaps, fatty acid biosynthesis 
is not controlled by one rate-limiting enzyme such as acyl-CoA carboxylase but 
rather by a number of component enzymes of this complex biosynthetic machinery.
In addition to fundamental questions with regard to each of the mycobacterial acyl- 
CoA carboxylase systems, the relationship between the three forms must be 
understood in order to comprehend how lipid synthesis occurs in mycobateria. If it 
is correct that two of the carboxylase systems are involved in degradation of fatty 
acids, the balance of the activity of the three isoforms should be the controlling 
factor of the amount of fatty acids in cells.
Understanding each enzyme systems’ structure and function as well as how the 
three systems interact and are regulated may be a key to the perception of how the 
acyl-CoA carboxylase systems control (or not) the lipogenic and nonlipogenic
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cellular events. This thesis reflects how little it is known about mycobacterial acyl- 
CoA carboxylases and their mechanisms of regulation.
Future work:
Finally, these are topics of the research that, one day, I would like to carry out:
i) Isolation and characterisation of each of the three acyl-CoA carboxylase 
systems. Identification of subunit composition and specificity of the different 
enzymes.
ii) Study of the differential expression of the several genes encoding the a - and 
p -  subunits of acyl-CoA carboxylase at different growth stages and under different 
growth conditions.
iii) Construction of mutants deficient in the synthesis of each of the three 
carboxylase systems.
These investigations would help to define the contribution of these enzymes to the 
lipid metabolism and cell biogenesis in mycobacteria.
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List o f work performed but not mentioned in this thesis
1. Contribution to the construction of a plasmid designed to mediate homologous 
recombination in M. bovis BCG as an initial training in molecular biology 
techniques. This plasmid was part of a different project and, therefore has not 
been included in this thesis.
2. The construction of the expression systems for the AccAl subunit of M. 
tuberculosis acyl-CoA carboxylase described in Chapter 4, was attempted using 
two different cloning strategies in addition to that described. Structural errors 
and instability of a pre-existing parent plasmid (pUS662) were the cause for the 
lack of success of this early work.
3. The production of mycobacterial cell wall mutants based on phenotypic 
differences in hydrophobicity was also tried. Following a brief period of mixing 
with n-hexadecane, the cells with higher surface hydrophobicity were expected 
to adhere to the organic phase whereas microorganisms containing a lower 
amount of lipids on the cell wall would remain in the aqueous phase. By 
repeatedly subculturing the aqueous phase it was hoped that eventually mutants 
deficient in cell wall lipids would be produced. Contamination of the lower 
aqueous phase with microorganisms adhered to the upper organic phase was 
difficult to avoid and constituted one of the drawbacks of the system. In 
addition, limitations of the MATH method for the assessment of changes in 
hydrophobicity of mycobacterial cells (see Chapter 3) also compromised the 
experiments. Due to the absence of significant results, this set of experiments 
has not been included in this thesis.
4. Preliminary studies of the regulation of the acyl-CoA carboxylase expression in 
M.bovis BCG grown under different conditions using RT-PCR were performed. 
The extraction of mycobacterial RNA free of genomic DNA was optimised and 
several pairs of primers spanning the acc A l  gene were tested in RT-PCR. This 
work was developed towards the end of this PhD and, unfortunately, could not 
be pursued due to time constraints.
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